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resumo 
 
As fosfatidiletanolaminas constituem a segunda classe de fosfolípidos mais 
abundantes nos organismos. Elas estão presentes nas membranas biológicas 
e nas lipoproteínas. As alterações estruturais dos fosfolípidos, ocorrem devido 
ao stress oxidativo e podem manisfestar-se em alterações das suas 
propriedades e funções. Já são conhecidas algumas condições 
fisiopatológicas, nas quais os fosfolípidos oxidados estão envolvidos, por 
exemplo sinalização celular, resposta imunitária, apoptose e doenças 
relacionadas com o envelhecimento. Por esse motivo, o interesse no estudo 
dos fosfolípidos oxidados e suas funções tem crescido nos últimos anos. 
Contudo, a maioria dos estudos realizados, focam a oxidação das 
fosfatidilcolinas, tendo sido dedicada pouca atenção a outras classes de 
fosfolipídos, como as fosfatidiletanolaminas. As fosfatidiletanolaminas, podem 
ainda sofrer outras modificações, devido ao grupo amina livre presente na 
cabeça polar, como por exemplo a glicação. As fosfatidiletanolaminas glicadas 
já foram detectadas em condições de hiperglicemia, em pacientes diabéticos, e 
tem correlação com a hemoglobina glicada. Sabe-se que a glicação de 
biomoléculas, pode aumentar as modificações oxidativas, que por sua vez, 
podem ser responsáveis pelo estado inflamatório, existente na diabetes 
mellitus. Tanto o stress oxidativo, como a inflamação estão relacionados com a 
diabetes e as suas complicações. A espectrometria de massa tem sido 
utilizada como uma importante tecnologia na detecção e caracterização de 
modificações oxidativas de fosfolípidos. Assim, neste trabalho pretendeu-se 
estudar as modificações oxidativas induzidas em fosfatidiletanolaminas 
glicadas, e os seus efeitos biológicos nos monócitos e células dendríticas do 
sangue periférico. Pretendeu-se ainda, estudar as alterações que ocorreram 
nas espécies de fosfatidiletanolaminas do fígado de ratos diabéticos. Os 
resultados obtidos permitiram identificar vários produtos de oxidação de 
fosfatidiletanolaminas glicadas, nomeadamente novos produtos formados pela 
oxidação da cabeça polar glicada. A oxidação na cabeça polar glicada foi, 
ainda, confirmada pela realização de experiências com spin traps combinadas 
com espetrometria de massa. Posteriormente, as fosfatidiletanolaminas 
oxidadas, glicadas e glicoxidadas demonstraram ter efeitos pró-inflamatórios, 
confirmados pelo aumento da estimulação monócitos e de células dendríticas, 
expresso no aumento do número de células produtoras de citocinas em 
comparação com o estado basal. As diferentes modificações de 
fosfatidiletanolaminas induziram estímulos distintos nos dois tipos de células. 
Sendo as fosfatidiletanolaminas glicadas e as glicoxidadas, os compostos que 
induziram um maior estímulo. Estes resultados sugeriram que as 
fosfatidiletanolaminas glicadas e as glicoxidadas podem estar associadas  com 
o estado inflamatório que decorre da hiperglicemia crónica. Ainda, a avaliação 
do perfil lipídico de extratos de fígado de ratos diabéticos demonstrou que a 
hiperglicemia induz inúmeras alterações das espécies de 
fosfatidiletanolaminas e das espécies de outras classes de fosfolípidos, em 
simultâneo com sinais de lesão hepática. Em conclusão, este trabalho 
demonstra a relação existente entre, a hiperglicémia, o stress oxidativo, a 
glicação e oxidação de fosfatidiletanolaminas e ainda a inflamação e 
compliações diabéticas. Portanto a contribuição da lipidómica é importante 
para compreender os efeitos prejudiciais da hiperglicemia não controlada, e 
por isso, merece ser mais explorado. 
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abstract 
 
Phosphatidylethanolamines (PE) are the second most abundant phospholipids 
found in biological membranes and in lipoproteins. In cases of oxidative stress, 
phospholipids may undergo structural changes that lead to alterations of 
phospholipids properties and functions. Oxidized phospholipids are known to 
be involved in various physiopathological conditions, such as signaling of 
inflammation, immune response, apoptotic events and in age related diseases. 
Because of such implications, the interest in the study of this subject is 
increasing. However, most of the studies performed only focused the role 
phosphatidylcholines and little attention has been paid to other phospholipid 
families, like phosphatidylethanolamines. Also, phosphatidylethanolamines can 
undergo other modifications, due to the free amino group present at polar head, 
such as glycation. Glycation of phosphatidylethanolamines was already 
reported to occur under hyperglycemia, in diabetic patients and to have 
correlation with glycated hemoglobin. The glycation of biomolecules increase 
oxidative modifications, which can be responsible for the low inflammatory 
state, typical of diabetes mellitus. Both oxidative stress and inflammation are 
related to diabetes and can be associated with diabetic complications. Mass 
spectrometry has been used as an important tool in the detection and 
characterization of these phospholipids’ oxidative modifications. So work aimed 
to study the oxidative modifications induced in glycated 
phosphatidylethanolamines, and their biological effects in blood monocytes and 
dendritic cells. It also aimed to evaluate the alterations of liver PE species 
under hyperglycemia in diabetic rats. The results allowed identifying various 
oxidation products of glycated phosphatidylethanolamines, including some new 
products with oxidation in polar head and in glucose. Oxidation in glycated 
polar head was confirmed by spin trapping experiments combined with mass 
spectrometry. Furthermore the oxidized, glycated and glycoxidized 
phosphatidylethanolamines showed pro-inflammatory effects, confirmed by the 
increase monocytes and dendritic cell stimulation with increased frequency of 
cytokine-producing cells, relative to the basal level. The different PE 
modifications induced different stimulus in the different cells, being the glycated 
and glycoxidized compounds the ones that induced higher stimulus. The results 
suggested that glycated and glycoxidized phosphatidylethanolamines could be 
associated with inflammatory status present in chronic hyperglycemia. In 
addition, the evaluation of lipid profile of liver extracts from diabetic rats showed 
that under hyperglycemia occurred changes in PE and other phospholipid 
species accompanied by signs of hepatic damage. In conclusion, this work re-
enforces the network between hyperglycemia, oxidative stress, PE glycation 
and oxidation, inflammation and diabetic complications. Thus the contribution of 
lipidomic to understand deleterious effects of uncontrolled hyperglycemia is a 
promising field of research that deserves to be further explored. 
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 General Introduction 
Lipidomics is a field of research, comprised in the vast metabolomics field. Lipidomics is 
specifically dedicated to the study of lipids and has been defined as the complete profile of lipids 
extracted from a cell, tissue or biological fluid (1, 2). However it is more than that, it is the 
comprehensive understanding of the biological roles of all lipids and lipid metabolism and function 
(1, 2). Thus, lipidomics intersects proteomics and genomics, in the way that includes proteins and 
genes that regulate lipid processes. The major challenges that lipidomics faces are the diversity 
and complexity of compounds that lipids embrace. Lipids “comprise an extremely heterogeneous 
collection of molecules from a structural and functional standpoint” (2). As result of this structural 
diversity, the last classification system developed by LIPID MAPS Consortium divided lipids into 
eight categories, namely fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, 
saccharolipids, polyketides, sterol lipids and prenol lipids (3). Each category is further divided into 
classes, subclasses and subgroups. Furthermore, such structural diversity reflects distinct 
functions on biological systems. Those biological functions range from roles in cell structure and 
organization, signaling events, energy storage, trafficking and sorting of macromolecules. Besides, 
in the last years, lipidomics field had a rapid development facilitated by advances in analytical 
techniques, in particular mass spectrometry (MS). MS became the core technology used in most 
lipidomic studies due to its high sensitivity and ability of providing structural information through 
tandem mass spectrometry experiments (MS/MS). The knowledge of how lipids contribute to cell 
and body function could be important to understand the lipid involvement in disease pathogenesis, 
which ultimately would lead to improvements in diagnostic and therapeutics (1, 2, 4). 
 
1. GLYCEROPHOSPHOLIPIDS: STRUCTURE, PROPERTIES AND FUNCTION 
 
Glycerophospholipids (PL) are present in all organisms, representing approximately 60 mol% 
of total lipids of a cell. As all lipid molecules, PL are soluble in organic solvents and contain long 
hydrocarbon chains (5, 6). In turn, glycerophospholipids are distinguished from the other lipids by 
the presence of a phosphate (or phosphonate) group esterified to the third hydroxyl group of a 
glycerol (2, 3).  
In general, the glycerophospholipids are derivatives of sn-glycero-3-phosphoric acid that 
contains at least one fatty acid residue attached to glycerol moiety and a polar head group attached 
to phosphoric acid (1). The diversity of glycerophospholipids is enormous, because of all the 
possible fatty acid and polar head group combinations in the glycerol backbone structure. The 
nature of molecules linked to phosphate forming different polar head groups is the basis for 
classification of PL into different classes (1, 5, 7). The major classes found are 
phosphatidylcholines (PC), phosphatidylethanolamines (PE), phosphatidylserines (PS), 
phosphatidic acids, phosphatidylglycerols, cardiolipins and phosphatidylinositols. Each class have 
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different biological characteristics, which is important for membrane dynamics (8). Additionally, the 
nature of the covalent linkage (ester, vinyl ether and alkyl ether linkage), between the aliphatic 
chain and sn-1 position of glycerol backbone, allow the subdivision into subclasses. Thus O-acyl, 
O-alkyl or O-alkyl-1’-enyl residues attached to glycerol characterize three PL subclasses. The most 
predominant subclass is the diacyl-, that corresponds to ester linkage at sn-1 position of glycerol 
(O-acyl residue), however in some tissues plasmenyl- and plasmanyl- subclasses (vinyl ether and 
alkyl ether linkage, respectively) can be found in high abundance (1, 5). Furthermore, at sn-2 
position of glycerol backbone is always an ester residue and the species that lack of the aliphatic 
chain in this position are denominated as lyso-PL (1). Besides the phospholipid characteristics are 
mainly dependent on the nature of the polar head group, they also depend on the fatty acyl chains, 
which differ on chain length and number and location of unsaturations (7). Figure I: 1 shows a 
representation of the glycerophospholipids core structure and the different classes and subclasses. 
 
FIGURE I: 1 – Glycerophospholipids general structure. The different polar head groups esterified at the sn-3 position are 
indicated, as well as the correspondent phospholipids classes. R1 and R2 represent the esterified fatty acids at the sn-1 and 
sn-2 position, respectively. Subclasses of phospholipids, formed by different linkage at the sn-1, are also represented. 
Adapted from Pufler and Murphy (7). 
 
The presence of phosphate group in glycerophospholipid structure provides important 
amphipathic properties. These amphipatic properties of phospholipids allow the spontaneous 
arrangement into micelles or bilayer vesicles in an aqueous environment. In the micelles or 
bilayers, the hydrocarbon tails form a hydrophobic core surrounded by polar heads that remain 
associated with water, creating an appropriate environment to membrane protein function and 
interactions (6). The PL characteristic bilayer arrangement, make them key components of 
biological membranes. The hydrogen bonds and electrostatic interactions between polar head 
groups and the hydrophobic interaction between the acyl chains are critical for proper membrane 
organization and function. Furthermore PL distribution among lipid bilayer is not homogeneous and 
several lipid microdomains can be formed, like highly ordered “lipid rafts”, rich in 
phosphatidylinositols, which are very important for cell signaling. Also the PL distribution between 
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leaflets is determined by polar head group. While phosphatidylcholines (with a larger head group) 
fit better in the outer leaflet of membrane, phosphatidylethanolamines (with a smaller head group) 
fits better in the inner leaflet, and lyso-phospholipids tend to favor the outer leaflet. Besides being 
the building blocks for biological membranes, they have other important biological functions, which 
are compartmentalization of cytoplasm, intracellular and extracellular adhesion of proteins, 
membrane trafficking events, cytoskeletal support, function as second messengers and as 
precursors of lipid mediators (5-7). 
 
1.1. PHOSPHATIDYLETHANOLAMINES 
 
Phosphatidylethanolamines have an ethanolamine molecule in the head group and 
constitute the second major glycerophospholipid class, after phosphatidylcholines. However in 
most prokaryotic cells, PE is a major PL class, together with cardiolipins and phosphatidylglycerols. 
PE is frequently the main lipid component of microbial membranes, whereas PC is not usually 
present (5, 9). In mammalian cells, PE account for 20 to 50% of the total phospholipids, being the 
total amount dependent on the tissue and/or organelles in study (10). PE is found in particularly 
high amounts in retinas (11), in brain and mitochondria (10). PE is also found in LDL (low density 
lipoprotein) and in human plasma, where they represent 5 % - 6% of total phospholipids (12). 
Additionally PE class can be discriminated in three PE subclasses, namely diacyl-PE, plasmenyl-
PE and plasmanyl-PE, which differ in the nature of the covalent linkage at the sn-1 position of 
glycerol, as represented in Figure I: 2. 
 
FIGURE I: 2 – Schematic representation of the different PE subclasses that can be found in animal tissues. The diacyl-PE 
subclass contains two O-acyl residues attached to glycerol. Plasmanyl and plasmenyl- contain one O-acyl residue at sn-2 
and, respectively, one O-alkyl and O-alkyl-1’-enyl residue at sn-1 position of glycerol. Where n represents the number of 
carbons and x represents the number of double bonds. 
 
1.1.1. PHOSPHATIDYLETHANOLAMINE BIOSYNTHESIS; HYDROLYSIS AND 
REMODELING 
 
In cells, there are two major pathways for de novo biosynthesis of 
phosphatidylethanolamine, namely cytidine diphosphoethanolamine (CDP-Etn) pathway and 
phosphatidylserine decarboxylation pathway (described below). Besides these two pathways, PE 
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can also be synthesized by enzymatic addition of an acyl chain to lyso-PE, mediated by lyso-PE 
acyltransferase (LPEAT) and by enzymatic base exchange with phosphatidylserines, mediated by 
PS synthase-2 (PSS2) (9, 10). In Figure I: 3 the referred pathways for PE synthesis are 
represented. 
 
 
FIGURE I: 3 – The metabolism of phosphatidylethanolamine (PE) in mammalian cells. PE synthesis via CDP-ethanolamine 
pathway initiates with ethanolamine (Etn) phosphorylation by ethanolamine kinase (EK), producing phosphoethanolamine 
(P-Etn), which is subsequently converted to CDP-ethanolamine (CDP-Etn) by the action of CTP:phosphoethanolamine 
cytidylyltransferase (ET). CDP-Etn is then combined with 1,2-diacylglycerol (DAG) in a reaction catalyzed by CDP-
ethanolamine:1,2-diacylglycerol ethanolaminephosphotransferase (EPT), an enzyme of the endoplasmic reticulum and 
nuclear envelope. PE synthesis via phosphatidylserine decarboxylation pathway occurs only in mitochondria, by the action 
of phosphatidylserine decarboxylase (PSD), which decarboxylates PS to PE. PE can also be produced from lyso-PE, in a 
reaction most likely catalyzed by an acyl-CoA-dependent acyltransferase (LPEAT). In endoplasmic reticulum exchange 
reactions between ethanolamine (Etn) for serine (Ser) head groups catalyzed by base-exchange enzyme, PS synthase-2 
(PSS2), converts PE into PS and vice-versa. Adapted from Vance (10). 
 
For CDP-ethanolamine biosynthetic pathway, two precursors are needed, ethanolamine, that 
comes from dietary sources and diacylglycerol formed from phosphatidic acid through the action of 
phosphatidic acid phosphohydrolase. The first step in phosphatidylethanolamine biosynthesis is the 
phosphorylation of ethanolamine by the cytosolic enzyme ethanolamine kinase (EK). The 
phosphorylated ethanolamine further reacts with cytidine triphosphate (CTP) leading to formation of 
cytidine diphosphoethanolamine (CDP-Etn), in a reaction catalyzed by CTP: phosphoethanolamine 
cytidylyltransferase (ET). Finally, in the endoplasmic reticulum membranes, the CDP-ethanolamine: 
diacylglycerol ethanolaminephosphotransferase (EPT), catalyses the reaction of CDP-
ethanolamine with diacylglycerol to form phosphatidylethanolamine (9, 10, 13). 
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The PS decarboxylation biosynthetic pathway is restricted to mitochondria, where the 
mitochondrial enzyme, PS decarboxylase is located, at external leaflet of inner membrane. Thus 
the inner membrane of mitochondria has higher PE content than the other organelles, being most 
of all PE made in situ through this pathway. A reaction catalyzed by PS decarboxylase (PSD) 
utilizes newly-synthesized PS to form PE. The PS is produced in endoplasmic reticulum (ER), so 
needs to be transferred from ER to the mitochondrial outer membrane, cross the outer membrane 
and then transferred to the outer leaflet of inner mitochondrial membrane, before the 
decarboxylation. This pathway reveals how PE and PS are inter-related and how their 
concentrations are tightly regulated (9, 10, 13). 
These two major biosynthetic PE pathways are essential in living systems and the 
elimination of either pathway is embryonically lethal (10). Still, the relative contribution of each 
pathway seems to be dependent on the cell type. Furthermore, each pathway occurs in different 
organelles, allowing PE compartmentalization. The PE formed by either pathway are substantially 
different, while the ethanolamine pathway, preferentially synthesizes PE containing mono- and di- 
saturated acyl chains at sn-2 position, the PS decarboxylation pathway preferentially produces PE 
containing polyunsaturated acyl chains at sn-2 position (9, 10). 
In addition to PE biosynthesis, the PE species, as well as the other phospholipids, are also 
subject to processes of enzymatic hydrolysis and remodeling, which control the final fatty acyl 
composition. Deacylation reactions are catalyzed by phospholipases A1 and A2, which hydrolyzes 
PL at sn-1 and sn-2 positions, respectively. After deacylation, reacylation reaction can occur 
mediated by various acyl-CoA:lysophospholipid acyltransferases. Phospholipases C or 
phosphodiesterases cleave the glycerophosphate bond. Finally, phospholipase D enzymes 
hydrolyze glycerophospholipids to generate phosphatidic acid and the respective head group (1, 9, 
14). 
 
1.1.2. PHOSPHATIDYLETHANOLAMINE FUNCTIONS 
 
Studies with E. coli, revealed the importance of phosphatidylethanolamine, whose presence 
is not required for life maintenance, but whose absence inhibit life processes. Studying E. coli 
membranes, in which PE is a major component, allowed the discovery of most of PE 
characteristics and functions (9, 13). PE alone tends to form inverted hexagonal phase by itself due 
to reduced head group size and hydratation, which confers to PE a cone shape. Polyunsaturated 
fatty acids, like arachidonic and docosahexaenoic acids, found in higher proportions in PE than the 
other phospholipids, favor this shape, increasing membrane fluidity. This is a critical factor that 
confers to PE ability to induce membrane fusion and cytokinesis (1, 10, 13). In the bilayers, PE is 
found preferentially at inner leaflet because of the negative curvature that PE promotes. The 
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membranes lacking PE show changes in their physical properties (1, 7, 8, 15). PE exerts a lateral 
pressure that stabilizes membrane proteins in their optimum conformations and, its ionizable amine 
group, can establish connections with proteins by hydrogen bonds (9). Due to the neutral or 
zwitterionic nature, in the pH range 2 to 7, it is believed that in bacterial membranes, 
phosphatidylethanolamine have a role in simply dilute the high negative charge density of the 
anionic phospholipids. This is important for lipid-protein charge interactions, either in 
transmembrane domains or cytoplasmic loops, determinants of membrane protein topology, which 
is the orientation of protein transmembrane domains with respect to the plane of the membrane 
bilayer. The cytoplasmic loops of integral proteins contain preferentially positive charged residues, 
and PE is believed to have a key function on that. PE inhibits the location of negative amino acids 
on the cytoplasmic side and it has an appropriate charge density to balance the charges of the 
membrane surface and the protein. However in some circumstances for support of protein function, 
PE allows the presence of negatively charged residues on the cytoplasmic side (9, 15). 
It seems that PE is involved in supporting or even stimulating membrane transport systems. 
PE acts as a ‘chaperone’, assisting the transition from the cytoplasm to the membrane, guiding 
proteins to adopt the correct folding, which is important for protein proper function (9, 13). Still, after 
correct position in membrane, PE continues to be needed to orient enzymes correctly in the inner 
membrane in a dynamic process that is sensitive to changes in membrane properties (9, 15). 
Further cellular internalization of the serpin, protein C inhibitor (PCI) is essentially supported by 
plasma membrane PE, whose conical shape represents an important factor for the interaction with 
PCI. The protein translocation across the plasma membrane, mediated by cell surface-exposed 
PE, is rapidly directed to the nucleus, both in vitro and in vivo (16). In the eye, 
phosphatidylethanolamine reacts with free all-trans-retinal in the photoreceptor outer segment 
membrane to form retinylidene-phosphatidylethanolamine, a high affinity substrate of ABCA4 
protein (a member of ABC transporters), that transports the retinoid compounds across the disk 
membranes (9, 17). 
Additionally, phosphatidylethanolamine is important in the sarcolemmal membranes of the 
heart because the sarcolemmal disruption is a consequence of altered transbilayer distribution of 
PE. Also, the ATP deficiency, observed during ischemia, leads to PE externalization (10, 18). As 
well, the PE externalization is found in irradiated cells (19). The PE high content of the inner 
mitochondrial membrane has been proposed to be important in optimization of oxidative 
phosphorylation (1). Nascent intracellular very-low-density lipoproteins are enriched in PE when 
compared to secreted very-low-density lipoproteins, revealing the involvement of PE in hepatic 
secretion of the density lipoprotein (9, 10). In very low density lipoproteins, but not in high-density 
lipoproteins, PE are the main active compounds leading to stimulation of the contact system 
coagulation and dependent thrombin formation, and thus, blood coagulation (20). 
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The PE subclass, PlasmenylEthanolamine (with a vinyl ether substituent at sn-1) is found at 
high concentrations, up to 70%, in some tissues, like the human brain (10, 21). These phospholipid 
species have important functions protecting cells from the effects of oxidation, as facilitators of 
membrane fusion and as reservoirs for arachidonic acid release (5). Arachidonic acid is an 
important precursor of biologically active lipid mediators like prostaglandins and leukotrienes (1). 
Plasmenylethanolamines seems to have some role in the prevention of atherosclerosis since 
plasmenylethanolamines serum levels are directly correlated with the levels of high density 
lipoprotein (HDL), directly correlated with low density lipoprotein (LDL) particle size and inversely 
correlated with LDL (22, 23). Finally, the plasmenylethanolamines were reported to be decreased 
in Alzheimer’s disease, changing membrane integrity, permeability, and loss of synapses and that 
decrease have correlation with the severity of dementia (24, 25). 
 
“The understanding of the pathologic processes to which lipids contribute has solified the 
importance of lipids, lipid metabolism and lipid oxidation” (6). So far, the lipids are known to be 
involved in many metabolic diseases such as obesity, atherosclerosis, stroke, hypertension and 
diabetes (2). In a way that can be due to altered biosynthesis, metabolism or structure. Besides, PL 
can undergo considerable structure transformations, such as oxidation, modification with sugar 
residues and other functional groups that could be relevant to disease development and 
progression. 
 
2. OXIDATIVE STRESS: OVERVIEW 
 
Aerobic organisms cannot live without oxygen, however living with oxygen is dangerous, 
because oxygen could be as indispensable as toxic for aerobic organisms (26). In consequence of 
normal aerobic metabolism, some oxygen reactive intermediates are formed with potential to 
damage cellular constituents. Oxidative stress is defined as an imbalance between oxidant and 
antioxidants, in favour of the oxidants, that may lead to damage (27-29). 
Major oxidants in living systems are free radicals and, because they contain unpaired 
electrons, are very reactive species (28). Hydroxyl radical (HO˙) and superoxide anion (O2˙-) are 
some examples of these free radicals, also named reactive oxygen species (ROS). Reactive 
nitrogen species (RNS), such as nitric oxide (NO˙) are other examples of free radicals. 
Peroxynitrite (ONOO-) it is not a free radical, but it is also an important oxidant in biological 
systems. Oxidants can be formed by different mechanisms, such as cell metabolism (aerobic 
respiration, immune response, and others), different types of radiation (X-ray, ultraviolet light, 
ultrasound and microwave irradiation) and by Fenton and Fenton-like reactions (reactions 
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catalyzed by transition ion metals) (28-30). Furthermore, oxidants are likely to come from 
endogenous (for example: immune cell activation, inflammation and excessive exercise) or 
exogenous (for example: from air and water pollution, cigarette smoke, alcohol and food) sources 
(31). All biomolecules are potentially targets of oxidants, at the site of their generation or at distant 
places depending on the half-life of the oxidant species (29). 
Because of the damage produced by oxidants, the organisms had to adapt themselves, 
creating numerous antioxidant defenses. Antioxidants are defined as any substance that, when 
present at low concentration compared with those of an oxidizable substrate, significantly delays, 
prevent or removes an oxidative damage to a target molecule (28, 32). There are three lines of 
defense against oxidative damage, being the first the prevention, by protecting against the 
formation of oxidant molecules. The second line of defense is interception by non-enzymatic and/or 
enzymatic antioxidants. The non-enzymatic antioxidants comprise not only the vitamins, like 
vitamin C and E, but also small molecules like glutathione, uric acid, ceruloplasmin or ubiquinone. 
The enzymatic antioxidants included superoxide dismutase, catalase and glutathione peroxidase 
families, among others. Once oxidative stress occurs, there are also mechanisms of protection, 
which repair directly or indirectly (replacement) the damage, and are considered the third line of 
defense (26, 29). 
Healthy organisms produce and need free radicals, but the production of oxidants is usually 
equilibrated by antioxidant defenses. In some cases, moderate levels oxidants could function as 
signal transduction and be benefic for the organism. But in other cases, this balance is disrupted, 
as result of increased oxidant production, or decreased antioxidant defenses, or even both. In 
those cases, cellular response can be varied, ranging from increased proliferation, prevention of 
cell division, senescence and cellular death (by apoptosis or necrosis) (32). Thus, oxidative stress 
has been associated with a wide variety of degenerative processes, diseases and syndromes. It is 
accepted that oxidative DNA damage is responsible for mutagenesis, cell transformation and 
cancer (31, 33). There are also evidences that oxidative stress have a role in cardiovascular 
diseases, including atherosclerosis, arteriosclerosis, heart attacks, strokes and 
ischemia/reperfusion injury (31). Central-nervous-system disorders were also investigated to be 
related to oxidative stress, such as amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's 
and Alzheimer's diseases (31, 34). In addition, chronic (rheumatoid arthritis, lupus erythematosus 
and psoriatic arthritis) and acute inflammatory diseases, ocular diseases (such as cataract) (35), 
diabetes (36), age-related disorders and the aging process itself are correlated to oxidative stress 
(31, 37). 
The first studies of biomolecules oxidative damage were focused on lipid peroxidation, but 
over time, the subject of oxidative damage have been changed from lipids to proteins and DNA. 
However, lately there has been an increasing interest in the study of phospholipid oxidation, not 
only because their association in the membranes, but also because their involvement in other 
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biological processes. So far, oxidized phospholipids are known to be involved in age-related and 
chronic diseases, atherosclerosis, inflammation and immune responses (38). 
 
2.1. OXIDIZED PHOSPHOLIPIDS: STRUCTURE AND FUNCTION 
 
Phospholipids oxidation produces a wide variety of oxidation products which may have 
different biological consequences (11, 38). Phospholipid oxidation are known to occur in the 
unsaturated fatty acids through different mechanisms (explained in the next chapter), leading to 
formation of long chain oxidation products, short chain/truncated oxidation products and adducts 
formed by cross-linking reactions. Phosphatidylcholine is, by far, the most studied phospholipid 
class, with different oxidation products identified either in vitro or in vivo, using several 
methodological approaches, as reviewed elsewhere (38). The biological role of these oxidized 
species depends on the nature of the changes and on their location (11). 
The main consequences of phospholipid oxidation are comprised to alterations of 
membranes properties. Membranes containing oxidized phospholipids become rigid, lose selective 
permeability and membrane potential, alter lipid-protein interactions and under extreme conditions, 
can lose their integrity (11). Oxidized phospholipids are a strong active component of oxidized LDL 
particles, which are involved in the promotion of atherosclerotic lesions by increasing the monocyte 
binding to the endothelium and foam cell formation (11, 39-48). Furthermore, oxidized 
phospholipids induce apoptosis and platelet aggregation due stimulation of platelet activating factor 
(PAF) receptor with PAF-like fragments formed by PC oxidation (11, 44-47, 49). Dual effects can 
be observed in blood coagulation, where oxidized phospholipids can either stimulate or inhibit 
protein C activity (46). The role of oxidized phospholipids in inflammation or immune system is 
wide, since oxidized phospholipids can generate either acute and chronic inflammatory responses, 
but can also have anti-inflammatory properties (11, 45-47). 
Among the pro-inflammatory effects of oxidized phospholipids is the stimulation of 
endothelium to express adhesion molecules and chemokines, increasing the adhesion of 
monocytes. Besides the action on endothelial cells, oxidized phospholipids can induce pro- and 
anti-inflammatory effects on leukocytes depending on the type of inflammation and 
differentiation/activation state of leukocytes. The best known anti-inflammatory property of oxidized 
phospholipids is the inhibition of acute inflammatory responses produced by LPS (bacterial 
lipopolysaccharide), but they also inhibit oxidative burst produced by inflammatory cells and induce 
anti-oxidant and anti-inflammatory genes. Other actions of oxidized phospholipids include 
modulation of vascular smooth muscle cell phenotype, promotion or inhibition of angiogenesis, 
calcification of atherosclerotic lesions, and regulation of endothelium permeability and adaptive 
immune system (function of dendritic cells and T lymphocytes) (45, 46). 
 | 12 
 
 Phosphatidylethanolamines Glycoxidation: Products and Significance 
Most of these studies, regarding phospholipids oxidation, are focused in 
phosphatidylcholines (11, 44-46, 50, 51). Indeed, the biological activity of oxidized phospholipids 
was proposed to be dependent on the structural feature of the sn-2 fatty acyl chain and not on the 
phospholipid class (52, 53). However, the unique properties/functions of 
phosphatidylethanolamines referred before, suggest that biological consequences of 
phosphatidylethanolamines could be specific. In fact, there are few studies regarding specifically 
phosphatidylethanolamines oxidation and the deleterious consequences of oxidized PE. 
 
2.1.1. PHOSPHATIDYLETHANOLAMINE OXIDATION PRODUCTS: MASS 
SPECTROMETRY IDENTIFICATION AND CHARACTERIZATION 
 
PE could suffer modifications under oxidative conditions, PE (and other phospholipids) 
hydroperoxides and hydroxides were detected and quantified using fluorescence high performance 
liquid chromatography (HPLC), in liver extracts treated with a radical generator (54) and in small 
intestine after mice total body irradiation (55). However, little structural information, about oxidation 
products can be obtained in such studies. Mass spectrometry is thus a valuable tool that has been 
employed for identification and characterization of phosphatidylethanolamines oxidation products 
either in vivo or in vitro samples. 
Oxidized phosphatidylethanolamines, containing hydroxyeicosatetraenoic acids (HETEs) 
and epoxyeicosatrienoic acids (EETs), were detected in human red blood cells (56) and in rat liver 
(57). Such oxidative derivatives of arachidonic acid were also found in other PL classes. In rat liver, 
the EET-containing phospholipids were detected by HPLC (57). In red blood cells, the oxidized 
phospholipids were analyzed by HPLC-mass spectrometry after PL hydrolysis. The HETE or EET 
carboxylate anions [M-H]- were detected at m/z 319. The fragmentation of [M-H]- ions allowed the 
distinction between HETE and EET, the identification of six positional isomers of HETE (hydroxyl 
group present at carbons 5, 8, 9, 11, 12 or 15) and the identification of four positional isomers of 
EET (epoxy group located at carbons 5-6, 8-9 11-12 or 14-15). The HETE and EET were found in 
PE, PC and PS, with the highest concentrations of HETEs being found in PE. Additionally the 
treatment of intact red blood cells with a lipid peroxidation initiator substantially increased the 
amount of phospholipids containing HETE and EET. Still, the levels of phospholipids containing 
EET have a greater increase than the ones of HETE, which led to the conclusion that epoxy 
formation resulted from a non-enzymatic mechanism (56). 
Similar studies were preformed with monocytes, macrophages and platelets, but in these 
studies arachidonic acid containing phospholipids were oxidized by lipoxygenase (LOX) enzymatic 
mechanism (58-60). Such oxidation of arachidonic acid into HETE were absent in monocytes, 
macrophages from LOX-/- knockout mice, confirming the occurrence oxidation through the 
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enzymatic mechanism (58, 59). First, Maskrey et al. (58) studied the oxidation products of 
phosphatidylethanolamines which had arachidonic acid at the sn-2 position and some function in 
inflammation was found (see below). In activated human monocytes, a hydroxyl oxidation product 
(hydroxyeicosatetraenoic acid (HETE)) was formed by the action LOX. This specie was esterified in 
oxidized phospholipids, and was detected using precursor ion scan for ion at m/z 319 (carboxylic 
anion of HETE), in the negative mode. In this study, only the PE class was found to have species 
containing HETE acyl chain, a result that was confirmed by liquid chromatography (LC)-MS. Four 
PE species, with esterified HETE at sn-2 position, were identified using this approach. Further LC-
MS/MS of oxidized PE fraction indicated that the four identified products had the same modification 
on arachidonic acid, namely 15-HETE product. The authors concluded that the difference between 
the oxidation products was in sn-1 acyl chain. The oxidation products were identified as 18:0/15-
HETE-PE, 18:0plasmenyl/15-HETE-PE, 18:1plasmenyl/15-HETE-PE, and 16:0plasmenyl/15-
HETE-PE. In human activated platelets (58, 60) and in murine peritoneal macrophages (59) these 
four PE species were also found to be formed but with a different HETE isomer, specifically 12-
HETE, because of an existence of different LOX isoform. Although the products found in platelets 
and macrophages were the same, they were formed by different mechanisms. While oxidation 
products containing HETE were formed in platelets by esterification of freely oxidized HETE, in 
macrophages these products were formed by direct oxidation of phospholipids (59, 60). Activated 
platelets also generated non-esterified thromboxane B2 (58), and two PC containing HETE 
(16:0/12S-HETE-PC and 18:0/12S-HETE-PC) (60), in addition to the three 
plasmenylethanolamines and the diacyl PE containing HETE. Temporal studies of HETE formation 
in platelets revealed that after one hour, the enzymatic precursor of HETE, the hydroperoxy (12-
HpETE), was not efficiently reduced to 12-HETE, thus the formation of decomposition products 
from 12-HpETE, including esterified carbonyls, isoprostanes, epoxides, and short chain aldehydes 
can be observed (60). Moreover, it was evaluated the externalization of oxidized PE species to the 
outer membrane leaflet upon stimulation of murine peritoneal macrophages (59) and platelets (60) 
derivatized with a cell-impermeable reagent. It was found that either macrophages and platelets, 
not only increased the amount of PE containing HETE, but also externalize these oxidized PE (59, 
60). 
Still on the oxidation achieved by the action of LOX, Morgan et al. (61) studied the 
phospholipids containing docosahexaenoic acid (DHA). The oxidation of docosahexaenoic acid 
(DHA) in phospholipids led to formation of hydroxyldocosahexaenoic acid (HDOHE), that under 
MS/MS originated the product ion at m/z 343.2 (negative ion mode). LC-MS/MS precursor ion scan 
of m/z 343.2, allowed the detection of four oxidized phospholipids containing HDOHE in activated 
platelets, all of them belonging to PE class. The four oxidized PE corresponded to two diacyl PE 
and two plasmenylethanolamines bearing either palmitic or stearic acid at sn-1 position and 
HDOHE at sn-2. Furthermore, isomers of HDOHE were also identified after saponification of 
phospholipids, where 14-HDOHE was the most abundant isomer, but 17- and 20-HDOHE isomers 
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were also found. The presence of 14-HDOHE isomer suggested that the oxidation was generated 
by platelet 12-LOX (61). 
Two studies were published reporting the oxidation of PE under Fenton conditions. Khaselev 
and Murphy (62) first characterized the composition of commercial bovine brain 
glycerophosphatidylethanolamines and their subspecies. Further, they oxidized the phospholipid 
mixture with Cu (II) and H2O2. The oxidized phospholipids were analyzed by MS and MS/MS in the 
negative ion mode. They found oxidation of plasmenylethanolamines that resulted in loss of the sn-
1 alkenyl chain with formation of the corresponding 1-lyso-2-acyl-phosphatidylethanolamine. In 
addition, they also detected diacyl phosphatidylethanolamines oxidation products formed by 
insertion of one and two oxygen molecules. They concluded that plasmenylethanolamines 
oxidation was somehow dependent of sn-2 acyl composition and that plasmenylethanolamines 
were more susceptible to oxidation than diacyl phospholipids (62). Domingues et al. (63) studied in 
vitro oxidation of 1-palmitoyl-2-linoleoyl-sn-glycero-3-PE (PLPE), which is a phospholipid from 
phosphatidylethanolamine family. From the analysis of PLPE oxidation products obtained by 
hydroxyl radical generated under Fenton reaction, using liquid chromatography coupled mass 
spectrometry; they were able to indentify several oxidation products, including short chain products 
and long chain products. They identified long chain products with insertion of one to four oxygen 
molecules and long chain product with insertion of one to three oxygen molecules, but with a 
decrease of 2 Da units. These later products, with a decrease of 2 Da units, contain keto groups, 
while the first only contain peroxy and/or hydroxy groups. Several short chain products, of 
truncated sn-2 acyl chain, with different lengths (7-12 carbons), and aldehyde or carboxylic function 
were also identified. The PE oxidation products and their isomers were analyzed by LC-MS/MS. 
Structural characterization allowed to propose several structures for the oxidation products found. 
Like Gugiu et al. (64), it was reported that the major oxidation products, occur by oxidation in 
carbon 9 of sn-2 linoleoyl acyl chain. However they also found extensive oxidation in carbons 11, 
12 and 13, especially when carbon 9 was already oxidized (63). 
Gugiu et al. (64) quantified the phosphatidylethanolamines and oxidized 
phosphatidylethanolamines present in rat retina. They also studied the oxidation of 
phosphatidylethanolamines in vitro with different oxidation systems (Cu (II), UV radiation and 
myeloperoxidase). Using mass spectrometry, LC-MS/MS and MRM (multiple reaction monitoring) 
they identified short chain products with terminal aldehyde (after derivatization with methoxylamine 
hydrochloride) and short chain products with carboxylic acid function (after derivatization with 
pentafluorobenzyl bromide). They found, in rat retinas, predominantly six oxidation products 
resulting from oxidation of 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-PE, 1-palmitoyl-2-
arachidonoyl-sn-glycero-3-PE and 1-palmitoyl-2-linoleoyl-sn-glycero-3-PE. Each PE originated two 
short-chain oxidation products with the same carbon length but with different terminal functions. 
Additionally, different PE originated short-chain oxidation products with different carbon length of 
sn-2 acyl chain, as summarized in the Table I: 1. The same oxidation products were obtained by in 
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vitro oxidation of the same phosphatidylethanolamines with the three different systems. Although 
the extent of oxidation obtained with each system was different, therefore the UV radiation system 
induced more oxidation, followed Cu (II) and finally the myeloperoxidase system (64). 
 
TABLE I: 1 – Short-chain oxidation product of PE found in rat retinas and in vitro oxidation (64). It is represented the PE 
oxidation products, the PE that originates them, and the modifications of sn-2 acyl chain. The sn-2 acyl chain is 
characterized by its carbon length and terminal function. 
Non-modified PE Oxidation products 
Carbon 
length 
Terminal 
function 
1-palmitoyl-2-docosahexaenoyl-
sn-glycero-3-PE 
1-palmitoyl-2-(4-oxobutyroyl)-sn-
glycero-3-PE 
4 carbons 
Aldehyde 
1-palmitoyl-2-(succinoyl)-sn-
glycero-3-PE 
Carboxylic acid 
1-palmitoyl-2-arachidonoyl-sn-
glycero-3-PE 
1-palmitoyl-2-(5-oxovaleroyl)-sn-
glycero-3-PE 
5 carbons 
Aldehyde 
1-palmitoyl-2-(glutaryl)-sn-
glycero-3-PE 
Carboxylic acid 
1-palmitoyl-2-linoleoyl-sn-
glycero-3-PE 
1-palmitoyl-2-(9-oxononanoyl)-
sn-glycero-3-PE 
9 carbons 
Aldehyde 
1-palmitoyl-2-(azeleyl)-sn-
glycero-3-PE 
Carboxylic acid 
 
More recently oxidation products of PE were detected in RAW 264.7 cell extracts, after 
incubation with a radical generator (65-67). With the amine group derivatized for increased 
sensitivity, the compounds were analyzed by MS after HPLC separation. The results revealed a 
decrease in the endogenous PE due to the formation of oxidation products. The oxidation products 
formed include lysoPE, plasmenyl- and phosphatidylethanolamines that contained a sn-2 chain 
shortened aldehyde and plasmenyl- and phosphatidylethanolamines that contained E2-
isoprostanes, F2-isoprostanes, hydroxyoctadecadenoic acid or hydroxyeicosatetraenoic acid 
esterified at sn-2 position. Oxidation products containing sn-2 chain shortened aldehyde had 
different lengths depending on the fatty acid that was oxidized, thus carbon-5, carbon-7 and 
carbon-9 were resultant from oxidation of arachidonic acid, adrenic acid and linoleic acid, 
respectively (65). 
Plasmenylethanolamines oxidation with UV irradiation and Fe2+/ascorbate led to the 
degradation of such compounds with release of various classes of aldehydes (68). The release of 
aldehydes from plasmenylethanolamines, as result of ozone oxidation, with a concomitant 
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formation of lysophosphatidylethanolamines was also observed (69). Those free aldehydes 
immediately disappeared from solution due to possible reaction with other molecules (68). 
 
2.1.2. SECONDARY OXIDATION PRODUCTS: ALDEHYDE MODIFICATION OF PE 
POLAR HEAD 
 
During lipid peroxidation (and non-lipid oxidation) aldehydic short-chain products are 
generated. Those small molecules are very reactive and can easily react with other molecules, 
forming adducts as secondary oxidation products. Most studies demonstrated the formation of 
adducts between lipid peroxidation products and proteins and DNA (26, 38). However, it was also 
demonstrated that PEs are the primary component becoming modified by these aldehydes (70-72). 
 
2.1.2.1. 4-HYDROXY-ALKENALS 
 
Several lipid oxidation products studies are known to react with PE amino group forming 
either Schiff bases or Michael adducts (70). The 4-hydroxy-2(E)-nonenal (HNE) is the lipid 
oxidation product most recognized to generate adducts with PE. Bacot et al. (73) related the 
formation of 4-hydroxy-2(E)-nonenal (4-HNE) from 15-HETE, of 4-hydroxydodeca-(2E,6Z)-dienal 
(4-HDDE) from 12-HETE and 4-hydroxy-2E-hexenal (4-HHE) from docosahexaenoic acid. All three 
short aldehydes were found in vivo, in human plasma, and the degradation of 12-HETE into 4-
HDDE was observed in human platelets. In human plasma, the 4-HNE was the most abundant 
product followed by the other two, which have proximal abundances (73). 
The reaction between HNE and PE was evaluated and analyzed by LC-MS in negative ion 
mode. Three adducts, pyrrole, Schiff and Michael adducts, were found to be produced in this 
reaction, being the Michael adduct the main derivative (74). The different reactivity of the three 
aldehydes, 4-HNE, 4-HDDE and 4-HHE, with the amino group of PE were evaluated with brain 
extracts (73). It was found the formation of aldehyde-PE adducts and that 4-HDDE was more 
reactive than 4-HNE, which, in turn, was more reactive than 4-HHE. Furthermore the reactivity of 
these compounds was more intense in the plasmenylethanolamines than in the diacyl-PE (73). 
More recently, the same group (75) investigated the presence of the same Michael adducts in 
oxidative stress conditions. Human blood platelets, after in vitro induced oxidation, and retinas of 
streptozotocin-induced diabetic rats were tested for the presence of 4-HNE, 4-HHE and 4-HDDE 
free aldehydes and aldehydes-PLPE adducts applying GC-MS. In platelets, under moderate 
oxidative stress induced by diamide, there was a significant increase of 4-HNE and 4-HHE free 
aldehydes but only PE-4-HNE adduct was detected. However, under more aggressive oxidative 
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stress, induced by aspirin combined with mercaptosuccinic acid, the 12-LOX pathway was 
specifically targeted because there was a significant increase of 4-HDDE and only slight increase 
of 4-HNE and 4-HHE free aldehydes. Besides the higher increase of 4-HDDE, the PE-4-HNE 
adduct was formed in higher abundance than PE-4-HDDE adduct and only trace amounts of PE-4-
HHE adducts were detected. In the rat retinas, all adducts, PE-4-HNE, PE-4-HDDE and PE-4-HHE, 
were increased, and the higher increase was obtained for PE-4-HHE (75). 
 
2.1.2.2. ISOLEVUGLANDINS 
 
The isolevuglandins are dialdehydes formed from arachidonic acid oxidation that are 
extraordinarily reactive toward primary amino groups of biomolecules, including PE (70). Detailed 
characterization of two isolevuglandins adducts with PE, by mass spectrometry (LC-MS and LC-
MS/MS, in negative ion mode) were performed by Bernoud-Hubac et al. (76). The two adducts 
found had different m/z values and the product ions were identified as isolevuglandin-PE pyrrole 
and dehydrated reduced isolevuglandin-PE Schiff base adducts (76). Isolevuglandin-PE pyrrole 
adducts were found to be further oxidized by air generating hydroxylactam and lactam end 
products (77). MS characterization of isolevuglandin-PE hydroxylactam-PE and lactam-PE adducts 
were performed by direct infusion MS in the negative ion mode. LC-MS/MS allowed the detection 
of lysoPE-lactams and lysoPE-hydroxylactams formed in vitro through myeloperoxidase-catalyzed 
oxidation of PAPC in the presence of lysoPE. However, these adducts were not detected in human 
plasma during MRM experiments. The detection and quantification of isolevuglandin-PE and 
hydroxylactam-PE in vivo were only achieved using MS after phospholipase A2-catalyzed 
hydrolysis. Elevated levels of isolevuglandin-PE and hydroxylactam-PE, but not lactam-PE adducts 
were found in plasma from patients with age-related macular degeneration and in mouse liver with 
ethanol-induced injury (77). 
 
2.1.2.3. OTHER LIPID AND NON-LIPID OXIDATION PRODUCTS 
 
There are also other lipid oxidized molecules that were documented to form adducts with PE. 
Zamora and Hidalgo (78) studied, using ESI-MS, the ability of the 4,5-epoxy-2-alkenals, secondary 
lipid peroxidation products of docosahexaenoic acid, to form adducts with PE. Stadelmann-Ingrand 
et al. (79) studied the Schiff base adducts formation between PE and the fatty aldehydes produced 
by plasmenyl-phospholipids degradation under oxidative conditions (UV radiation and 
Fe(II)/ascorbate), in brain homogenates. The adducts were further characterized by ESI-MS and 
GC-MS (79). Zemski Berry and Murphy (80), determined the chromatographic and mass 
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spectrometric properties of acrolein-PE adducts. The acrolein reacted with PE to form acrolein-PE 
Michael adduct, which could further react with a second acrolein to form a piperidine adduct by 
aldol condensation. The formation of aldol condensation product, over the Michael adduct, 
occurred even when the ratio of acrolein to PE was less than one. It was established a sensitive 
assay, LC-MS after sample reduction, for the screening of such adducts piperidine that allowed the 
detection acrolein-PE adducts in HL-60 cells exposed to acrolein (80). Tsuji et al. (81) reported the 
modification of PE with an hydroperoxy derivative of linoleic acid, which was generated by LOX 
enzymatic reaction. Interestingly, this is an oxidation product that is not shortened, which reacts 
with PE and leads to the formation of N-hexanoyl-PE (HEPE). The HEPE was hydrolyzed with 
phospholipase D, originating N-hexanoyl-ethanolamine (HEEA) that was analyzed by LC-MS/MS in 
positive ion mode. This approach was successfully used to detect HEPE products in oxidized 
erythrocytes ghosts and in oxidized LDL (81). 
Previous studies reported herein, utilized a directed approach to identify or detect specific 
aldehyde-PE adducts. However Guo et al. (71) recently established an untargeted approach to 
discover new aldehyde-PE species. Aldehydes formed from arachidonic acid and PC-containing 
arachidonic acid oxidation in the presence PE standard were identified and characterized by MS. 
High resolution mass spectrometry and LC-MS/MS allowed the detection of more than 10 species, 
formed with different relative abundances. These compounds were further detected and measured 
(by MRM, see below) in oxidized HDL after deacylation of the acyl chains (71), a similar approach 
to that utilized before in HUVECs aldehyde-PE measurements (82). 
The modification PE amino group is not exclusive of aldehydes formed for lipid oxidation 
products, but can also occur from protein or glucose oxidation products. For instance, PE-glucose 
and PE-acetone adducts had also been detected in human tissues, especially those of diabetic 
patients (9, 83). 
Concerning protein oxidation products, Heller et al. (84) demonstrated the Schiff base 
formation between amino group of phosphatidylethanolamine and p-hydroxyphenylacetaldehyde. 
The p-hydroxyphenylacetaldehyde is a tyrosine oxidation product generated by the 
myeloperoxidase system of phagocytes, in LDL. In an approach that involved phospholipid 
hydrolysis and polar head analyses by GC-MS, this adduct were measured in LDL isolated from 
human atherosclerotic tissue (84). 
 
Since PE oxidation was detected in vivo, it is important to understand what are the 
consequences of the presence of those oxidized PE under biological conditions. 
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2.1.3. BIOLOGICAL CONSEQUENCES OF OXIDIZED 
PHOSPHATIDYLETHANOLAMINES 
 
So far PE was demonstrated to play important biological functions; thereby the alterations in 
PE structure, due to oxidation and/or glycation are likely to be related to cellular dysfunction and 
disease development. 
HETE containing phospholipids (especially PE), are known to be formed from oxidation of 
arachidonic acid, in activation of monocytes, macrophages and platelets, and to have immune 
functions (58-60). Some of these studies also described that the formation of HETE-PE and 
externalization in monocytes and macrophages were dependent on the calcium ionophore 
stimulation (58, 59). In LOX-/- macrophages, ionophore also caused a large increase in native PE 
externalization, thus externalization of PE in wild-type macrophages, was targeted toward oxidized 
species (59). HETE-PE, in culture of human monocytes, inhibited LPS stimulation of tumor 
necrosis factor-α (TNF-α) and granulocyte colony-stimulating factor (G-CSF) generation (59). Thus 
esterified HETE products could play a role in signaling immune regulation and inflammation (58). 
Also LOX-dependent phospholipid peroxidation was associated with the Th2 and not Th1 
lymphocytes inflammatory profile in vivo (59). Externalization of PE and HETE-PE could stimulate 
coagulation by enhancing activity of prothrombinase complex, in a process controlled by LOX (60). 
In fact, it was demonstrated that platelets from a patient with the bleeding disorder Scott syndrome, 
externalized less PE and HETE-PE was not externalized, even though these lipids were generated 
in platelets. This suggested that the lack of HETE-PE may contribute to the bleeding fenotype, 
leading to the assumption that HETE-PE could also be responsible for thrombotic disorders. HETE-
PE were therefore considered to be physiological products, formed by acute receptor/agonist-
dependent activation of human platelets. So HETE-PE was found to be important in thrombin 
generation/homeostasis and platelet function during health and disease (60). 
Still on the procoagulant effect of oxidized PE, Zieseniss et al. (85) analyzed the influence of 
the atherogenic oxidized low density lipoproteins (LDL) on the activity of the platelet 
prothrombinase complex, a major contributor to overall thrombin formation in vivo. First they 
reported that oxidized LDL when incubated with platelets, enhanced the synthesis of the protease, 
and the native LDL did not. They also demonstrate that oxidized LDL stimulated the 
prothrombinase activity by promoting the formation of a procoagulant surface. In order to 
understand what were the oxidized LDL compounds involved in thrombin generation, they analyzed 
every compound activity after several separation steps. This allowed the identification of oxidized 
PE as the lipoprotein component which mediated the strongest stimulation of the platelet thrombin 
generation. Among oxidized diacyl-PE and plasmenylethanolamine, the stimulation of thrombin 
generation was more accelerated with the first one, probably due to, the already reported, 
plasmenylethanolamine resistance to oxidation (85). 
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More recently, oxidized PAPE (1-palmitoyl-2-arachidonoyl-sn-glycero-3-PE) was shown to 
bind, with high affinity, protein C inhibitor (PCI), in a process that competes with heparin for the 
same PCI binding site (86). The binding of oxidized PAPE to PCI, stimulate PCI to inhibit the 
activity of activated Protein C and thrombin. The results suggested that oxidized PAPE may act as 
inducible “heparin analogs”. Thus oxidized PAPE (through PCI) could have both a role in arterial 
thrombosis, promoting blood coagulation and thrombus formation at sites of tissue injury, and have 
additional role in regulation of proteolysis at sites of injury and inflammation (86). 
After identification of PE short-chain oxidation products in the retina, Gugiu et al. (64) 
proposed some potential biological role for these products in the retina. Since phosphatidylcholines 
oxidation is thought to trigger endocytosis by CD36 interaction, they hypothesized that 
phosphatidylethanolamines oxidation could also do the same. CD36 is involved in the regeneration 
of retinal pigment epithelium (RPE) which was damaged by photogenerated radicals. They 
proposed that PE oxidation products, could act as signaling molecules for the cell regeneration, 
contributing to retinal homeostasis. In age-related macular degeneration (AMD) exists an excessive 
production of PE oxidation products, so authors suggested that the excess of PE oxidation 
products could be responsible for the pathological degradation of photoreceptor cells that is 
observed in AMD (64). 
 
2.1.3.1. PLASMENYLETHANOLAMINES INFLUENCE THE OXIDATION RATES  
 
Plasmenylethanolamines (non-modified) was found to have biological roles, influencing the 
oxidation of other molecules. Maeba and Ueta developed a high sensitivity method to detect 
plasmenylethanolamines in human plasma (87). The effects of plasmenylethanolamines in 
oxidation was studied and it was found that the cholesterol oxidation is prevented in the presence 
of plasmenylethanolamine and plasmenylcholine (88). However the plasmenylethanolamine had 
greater ability to reduce cholesterol oxidation in bilayers. So they suggested that 
plasmenylethanolamine could play a role in preventing cholesterol oxidation in biomembranes by 
reducing the oxidizability of cholesterol in bilayers, acting as a physiological antioxidant for 
cholesterol (88). It was also reported the role of plasmenylethanolamines in lowering the 
oxidizability of membranes, because of the high oxidizability of plasmenylethanolamines, either in 
the presence or absence of cholesterol (89, 90). Other studies also reported the anti-oxidant 
properties of plasmenylethanolamines, that acted as scavengers of reactive oxygen species and 
chelators of transition metal ions, thus inhibiting lipid peroxidation (68, 91-95). 
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2.1.3.2. ALDEHYDE-PE ADDUCTS: BIOLOGICAL ROLE 
 
The aldehyde-PE adducts share most of the effects produced by oxidized PE. The pro-
atherogenic role of Schiff adduct, PE-HNE, was also evaluated by Zieseniss et al. (85). It was 
suggested that the imino group between the ethanolamine head group and the aldehyde was the 
major determinant for the stimulation of the prothrombinase activity. The Schiff base PE-aldehyde 
adducts, were the most active components in modified lipoproteins, and were found to increase 
thrombin formation strongly, suggesting a relevant role for oxidized LDL in the development of 
thrombosis in vivo. Also 4-HNE, PE-4-HDDE and PE-4-HNE adducts could alter the platelet 
aggregation and functioning (75). That involvement in platelet function may be important to 
understand the mechanisms leading to the formation of thrombi at the site of the unstable 
atherosclerotic plaques (85). 
PE-adducts with unfragmented oxidized linoleic and arachidonic acids were capable of 
increasing mouse peritoneal macrophage viability and could have potential beneficial or adverse 
effects on plaque size and stability in atherosclerosis (96). Moreover, incubation of human umbilical 
vein endothelial cells (HUVECs) with PE-isolevuglandin adducts led to a dose-dependent increase 
in the expression levels of ICAM-1 (intercellular adhesion molecule-1), VCAM-1 (vascular cell 
adhesion molecule-1) and E-selectin and in the mRNA levels of both MCP-1 (monocyte 
chemotactic protein-1) and IL-8 (interleukin-8) (72). This led to an increase binding of THP-1 
(human acute monocytic leukemia cell line) monocytes through pro-inflammatory mechanisms. 
Also, all the aldehyde-PE species identified by Guo et al. (71) were examined for the ability to 
stimulate THP-1 monocyte adhesion to endothelial cells. Several species were able to increase 
adhesion to endothelial cells, suggesting the PE potential to mediate inflammation associated with 
oxidative injury. Although other biological contributions cannot be excluded. Thus, establishing a 
pathway linking oxidative stress to inflammation may be useful for reducing inflammation (71). In 
conclusion several PE-aldehyde adducts were potent activators of endothelial cells, and therefore 
have the potential to mediate inflammation associated with oxidative injury, contributing to 
atherogenesis (71, 72) 
Bacot et al. (73, 75) detected PE-4-HNE, PE-4HDDE and PE-4-HHE adducts in plasma, 
blood platelets, brain and retina. They supposed that the adduct-containing membranes have 
altered membrane fluidity and activity of anchored proteins, as well as the accessibility of ligands 
and other functional components that might affect cell function (75). Similarly, Bernoud-Hubac et al. 
(76) proposed that PE alterations by isolevuglandins binding could induce different phospholipid 
membrane distribution, affect membrane fluidity, and result in changes in membrane structure and 
function. Alterations in membrane function, like ability to stabilize membrane proteins due to PE-
isolevuglandin adducts was also proposed by Li et al. (77). Membrane structure and the 
interactions of membrane PEs with membrane-bound or cytosolic proteins could be profoundly 
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altered by the conversion of the positively charged amino group of the PEs into a negatively 
charged group upon aldehyde adduction (77). The presence of PE-isolevuglandin adducts in 
membranes changed their properties towards increasing negative (72) or positive (71) membrane 
curvature. Besides PE-isolevuglandin adducts were quickly trafficked to endoplasmic reticulum, 
where potentially alter the membrane curvature. Thus ER stress response signals might be 
triggered by those adducts invoking IL-8 and MCP-1 expression, HUVEC activation and THP-1 
binding. This is a process that was blocked by inhibitors of the ER stress response and revealed 
important links between oxidized lipids, ER stress, inflammation, and atherosclerosis (71, 72). 
PE-isolevuglandin adducts, their oxidized derivatives and acrolein-PE adducts were 
proposed as biomarkers to access the risk of development of membrane disorders or other 
diseases stimulated by oxidative stress such as AMD (75, 77, 80). PE-isolevuglandins, p-
hydroxyphenylacetaldehyde-PE and HEPE-PE formation could be an important pathway for 
converting LDL to a form of oxidized LDL, that can modulate signaling events, foam cell formation 
in vivo, atherosclerosis and other oxidative stress-related disease (76, 81, 84). Furthermore 
glucose-PE adduct formation in atheroma plaques and glycated PE involvement in LDL oxidation 
suggested that glycated PE could also be implicated in the onset of atherosclerosis in diabetic 
patients (12). Altogether these studies revealed the intricate connection that involves oxidative 
stress, membrane function, cell activation and inflammation that could lead to development of 
oxidative stress-related diseases. 
 
3. DIABETES MELLITUS 
 
Diabetes mellitus (DM) is a metabolic disorder of multiple etiology characterized by chronic 
hyperglycemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects 
in insulin secretion, insulin action, or both (97). Diabetes became a serious public health problem, 
with the increasing numbers of prevalence, affecting millions of people worldwide (98, 99). In 
Portugal (2009) the prevalence of diabetes was 11.7% in population between 20-79 years old, a 
number that increases to one third of population (34.9%) if a pre-diabetes stage is also considered 
(100). Several pathogenetic processes are involved in the development of diabetes. These include 
processes which destroy the beta cells of the pancreas with consequent insulin deficiency, and 
others that result in resistance to insulin action (97, 101). These two groups of pathogenetic 
processes lead to the distinction of two types of diabetes, namely type 1 and type 2 diabetes 
mellitus. Type 1 DM is caused by an absolute deficiency of insulin secretion. Type 2 DM, much 
more prevalent, is caused by a combination of resistance to insulin action and an inadequate 
compensatory insulin secretory response. Since the destruction of beta cells of the pancreas with 
consequent insulin deficiency may also be seen in type 2 DM, the distinction between type 1 and 
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type 2 DM could be difficult, thus it is very important to understand the pathogenesis of the 
hyperglycemia (101). 
Deficient insulin action, from inadequate insulin secretion and/or diminished tissue 
responses at one or more points in the complex pathways of hormone action, leads to 
abnormalities of carbohydrate, lipid and protein metabolism. The chronic hyperglycemia (both 
levels and length of exposure) observed in diabetes generate pathological and functional changes 
even before the diagnosis is made. Long-term hyperglycemia leads to damage, dysfunction, and 
failure of various organs, especially eyes, kidney, nerves, heart, blood vessels. These long-term 
complications of DM include progressive development of the specific complications of retinopathy 
with potential blindness, nephropathy leading to renal failure, peripheral neuropathy and/or 
autonomic neuropathy. Patients with diabetes have an increased incidence of atherosclerotic 
cardiovascular, peripheral arterial, and cerebrovascular disease (97, 101). These long-term 
vasculopathy associated with DM are traditionally classified as macro- or microvascular depending 
on the underlying pathophysiology (102-105). Microvascular disease tends to occur predominantly 
in tissues where glucose uptake is independent of insulin activity, like kidney, retina and vascular 
endothelium. The development of microvascular complications arise from a combination of different 
factors that include hyperglycemia, dyslipidemia, oxidative stress and/or formation of advanced 
glycation end-products. Microvascular complication origin altered blood flow and changes in 
endothelial permeability, extravascular protein deposition and coagulation resulting in organ 
dysfunction. Macrovascular diseases include coronary heart disease, cardiomyopathy, stroke and 
atherosclerosis being the last one also related to oxidative stress and oxidized phospholipids. 
Furthermore, interrelation between microvascular and macrovascular pathologies may create a 
vicious cycle of tissue damage, that drives the leading cause of morbidity and mortality in diabetic 
patients. Consequently controlling hyperglycemia is important to protecting the body from diabetic 
complications, to improving longevity and quality of life (102-105). 
 
3.1. OXIDATIVE STRESS IN DIABETES 
 
Current evidence argues against a generalized increase of oxidative stress in human 
diabetes, associated to hyperglycemia. Moreover, it is not well known whether oxidative stress is a 
primary event that occurs early in the course of the disease or whether it is a secondary 
phenomenon that merely reflects end-stage tissue damage (36). During diabetes, persistent 
hyperglycemia causes increased production of free radicals, especially ROS, from glucose auto-
oxidation and increased formation of lipid peroxides. In addition, persistent hyperglycemia is also 
responsible for non-enzymatic protein glycosylation and advanced glycated end-products formation 
(AGEs). Among those, glucose oxidation is believed to be the main source of free radicals, 
although the interrelationship between glycation and oxidative stress is also noted, leading to 
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emergence of the term glycoxidation. On the other hand, antioxidant defense system is also altered 
in DM, with impaired glutathione metabolism, alteration in antioxidant enzymes, catalase and 
superoxide dismutase and decreased ascorbic acid levels (105-108). Furthermore, proteins like 
superoxide dismutase can be inactivated by glycation, turning them unable to detoxify free radicals, 
exacerbating oxidative stress in diabetes (28). Thus hyperglycemia is a major contributor to 
oxidative stress and increased oxidative stress is in turn suggested as mechanism underlying 
development and progression of diabetes and as one major contributor to long-term diabetic 
complications (105-108). 
Oxidative stress conditions can result in the activation of various stress pathways such as 
NF-κB, JNK/SAPK, p38 MAPK, among others, also activated in normal insulin signaling. This cross 
talk between oxidative stress-induced pathways and normal insulin signaling creates the possibility 
for multiple disruptions in the ability of insulin to maintain its normal functions (105). Hyperglycemia, 
in DM, increase the ROS generation and oxidative stress markers (including lipid peroxidation), 
with an accompanying decrease in antioxidant levels. Increased lipid hydroperoxides were 
detected in several tissues, as kidney, liver, heart, brain, plasma, red blood cells, among others, of 
rats with induced diabetes, an indirect evidence of intensified free-radical production (107). Also in 
human plasma, lipid hydroperoxides, malondialdehyde and isoprostanes levels were found to be 
increased in diabetic patients (28, 109). The increase in the lipid peroxidation can be correlated 
with glucose levels (not without some controversy) and be prevented by controlling glycemia with 
insulin (105). The role oxidized LDL and oxidatively modified lipids in atherosclerosis, and their 
increased levels in diabetes are key factors for development of atherosclerosis as a diabetic 
complication (110). Lipid peroxides induce formation of pro-inflammatory cytokines, contributing for 
the high inflammatory state observed in DM (111). 
 
3.2. PHOSPHATIDYLETHANOLAMINES IN DIABETES 
 
Phosphatidylethanolamines, together with phosphatidylserines, are aminophospholipids, 
which have a free amino group present in the polar head, making them susceptible to non-
enzimatic glycation, similar to that occurred in proteins. Thus the concept of the Maillard reaction 
was expanded to include glycation of aminophospholipids (9, 83). 
The Maillard reaction is a process that initiates with the formation of an unstable Schiff base, 
which reaches a steady state within hours and is reversible. Then the rearrangement of the Schiff 
base into an Amadori product occurs, reaching a steady state in approximately 28 days and is also 
a reversible reaction (9, 107). When molecules have slow turnover rates, these Amadori products 
undergo multiple dehydration reactions and rearrangements to irreversibly form AGEs, like 
carboxymethyl- and carboxyethyl-adducts. AGEs also have potential to trigger pathological 
 | 25 
 
 General Introduction 
processes and can be involved in the genesis of many of the irreversible complications of diabetes, 
including expanded extracellular matrix, cellular hypertrophy, hyperplasia, and vascular 
complications (9, 107). AGE proteins, unlike AGE lipids, have been intensively studied; however 
AGE lipids have also been found in diabetic plasma lipoproteins. Some AGEs involvement in 
oxidative stress is already known. AGEs can bind metal ions, making them available for glucose 
oxidation, damaging tissues. Schiff base adducts of methylglyoxal generate radical cations and 
superoxide without metal ion involvement (105). 
First studies evidencing the glycation of phosphatidylethanolamines emerged in the early 
90’s, with the studies of Pamplona et al. (112). Later Ravandi et al. detected glycated PE both in 
vitro (12, 113) and in vivo, in atheroma (12), LDL (12), red blood cells (114) and plasma (114) from 
diabetic patients. Glycated PE was also characterized by LC-MS and MS/MS in the positive and 
the negative ion mode (12, 113-115). Amadori PE adduct formation in LDL, in vitro, originated two 
major species, namely 18:0/18:2-glycated PE and 18:0/20:4-glycated PE. These glycated PE were 
also the major species found in vivo glycated LDL, among other glycated PE species formed, 
including diacyl- and plasmenyl-PE. Furthermore, in glycated LDL, they verified that glycation of PE 
was more extensive than the glycation of apoprotein (12). Moreover, other researchers also 
reported the presence of glycated PE in red blood cells and plasma incubated with glucose, and 
that glycated PE can be degraded by phospholipases (116). In human red blood cells from diabetic 
patients, glycated PE was detected and quantified by LC-MS and found that glycated PE levels 
have a positive correlation with the glycated hemoglobin levels (117). The occurrence of glycated 
PE in plasma of diabetic patients (118) and in plasma, red blood cells, liver, kidney, pancreas, 
cerebrum and cerebellum of diabetic rats (119) was detected and quantified in vivo using LC-
MS/MS neutral loss scan and MRM experiments (118, 119). The PE glycation in rats were 
apparently dependent on the PE fatty acid content. It was found that 18:0/20:4-PE was the first PE 
to be glycated followed by 18:0/18:2-PE. Additionally, glycation was suggested to be used as 
sensitive marker of the early stages of diabetes, since accumulation of carboxymethyl-lysine 
(protein advanced glycation end-product) and glycated hemoglobin was somewhat slower than 
glycated PE (119). Furthermore, carboxymethyl-PE were already detected and quantified in vivo, in 
human red blood cells from diabetic patients (120). In vitro synthesized carboxymethyl-PE and 
carboxyethyl-PE were studied by LC-MS and LC-MS/MS in order to develop a method for further 
detection in vivo. LC-MS/MS with MRM experiments allowed the detection of various species of 
carboxymethyl-PE and carboxyethyl-PE in plasma and red blood cells of healthy and diabetic 
subjects, without significant differences (121). 
Glycation is a reaction that may play an important and primary role in initiating lipid 
peroxidation in vivo (83). Bucala et al. (122) first reported the involvement of lipid content of 
glycated LDL, in LDL susceptibility to oxidation. However, it was not identified any lipid glycated 
product (122). Since then, some studies have reported the involvement of glycated PE in lipid 
peroxidation, however the reason why is not completely understood. Ravandi et al. (12) 
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demonstrated that PE glycation is more easily oxidized probably because an increased exposure to 
the oxidizing agent, produced by the increase of polar head group bulk. Also, glycated PE 
promoted the oxidation of other molecules oxidation (cholesteryl esters in LDL, PC and non-
glycated-PE) with formation of hydroperoxides, aldehydes, isoprostanes and lyso-PL compounds 
(12). The generation of lipid peroxidation in red blood cell membranes by glycated PE occurred 
even in the absence of metal ions (117). On the other hand, Oak et al. (123) synthesized Amadori-
PE and evaluated their ability to induce lipid peroxidation in the presence of transition metal ion. 
With this purpose, they incubated linoleic acid alone, with non-glycated-PE and with Amadori-PE, 
under oxidative conditions. By measuring the amount of oxidation they recognized an increase of 
the linoleic acid oxidation in the presence of Amadori-PE, but not in the presence of non-glycated-
PE. So they concluded that Amadori-PE is capable of generating reactive oxygen species, which 
trigger lipid peroxidation, in a processes that is inhibited by superoxide dismutase, mannitol, 
catalase and EDTA (123). Furthermore, glycated PE levels had a positive correlation with PC and 
PE hydroperoxides in human plasma (118) and in rat plasma and liver (119). Thus glycated PE 
was supposed to be correlated with atherosclerotic complications of diabetic patients with 
associated hyperglycemia, as result of oxidative stress modifications (12, 117-119, 123). 
Little attention has been paid to other biological consequences of glycated PEs than the 
promotion of lipid peroxidation. A study indicated that glycated PE and LDL containing glycated PE 
affect LDL metabolism, by increasing cell-associated lipoprotein when compared with LDL 
containing non-glycated PE (115). The increased LDL uptake by macrophages was accompanied 
by cholesteryl esters and triacylglycerols accumulation in THP-1. Additionally the cholesteryl esters 
and triacylglycerols accumulation had correlation with the increase in PC oxidation. The effect of 
presence of glycated PE in LDL was comparable to that obtained when macrophages were 
incubated with glycated LDL, and were not inhibited by acetylated LDL. So it was proposed that the 
mechanisms involved in that interaction of LDL containing glycated PE and macrophages were not 
dependent of LDL or scavenger receptor, but would be probably dependent on the receptor of 
anionic phospholipids, namely CD36 or AGE receptor (115). In addition, incubation of HUVEC with 
glycated PE enhanced, in a dose depended manner, the proliferation, migration and tube formation 
of these cells, when compared cells treated with non-glycated PE (124). Similarly to the vascular 
endothelial growth factor (VEGF), glycated PE was found to enhance width and length of 
endothelial tubes. Furthermore, HUVEC incubated with glycated PE was found to secrete more 
metalloproteinase (MMP-2), in a dose-dependent manner. This study indicated that glycated PE 
could be important inducers of angiogenesis (124). 
Glycated PE was also thought to induce changes in membrane properties and functioning. In 
vivo, lipid glycation is likely to induce changes in the biosynthesis and turnover of membrane 
phospholipids, the physical properties of membranes and the activity of membrane-bound 
enzymes, besides the susceptibility to oxidative stress (118). The influence of PE glycation in 
membrane protein, PMCA (plasma-membrane Ca2+-ATPase) was evaluated by Levi et al. (125). 
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Only the effects of glycation were studied, and further oxidation was avoided with utilization of a 
saturated PE, nitrogen atmosphere, and a metal ion chelator. They showed that PE glycation, but 
not PMCA glycation, significantly decreased the affinity of lipids for the protein, in two different 
micellar environments. Additionally, significant decrease on lipid affinity for the transmembrane 
surface of erythrocyte protein, band 3, and Na+/K+-ATPase in the presence of glycated PE was 
also found. Furthermore, PMCA was inactivated faster in the presence of glycated lipids than in the 
presence of control PE and PC phospholipids. Therefore PE glycation triggered a structural 
rearrangement of the protein that decreased their stability and increased the sensitivity to thermal 
unfolding. This indicated that under hyperglycemic conditions (uncontrolled diabetes) or long-term 
exposure to glucose (aging), glycation of lipids of cellular membranes may cause a significant 
change in the structure and stability of membrane proteins which may affect the normal functioning 
of the membranes and therefore of the cells (125). 
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AIMS 
 
The association between free radicals, glycation, diabetes, and its complications is not 
completely understood. Until now, the role of oxidized PEs has been associated with some 
pathophysiological conditions, including atherosclerosis, inflammation, Alzheimer disease, among 
others. However the mechanisms and the specific products that produce the reported effects were 
not always clear. Also, the formation of adducts among glucose and PE, as consequence of 
hyperglycemia, the increased susceptibility to oxidation of glycated PE, and the oxidation of other 
glycated or non-glycated molecules, such as other phospholipids, peptides and proteins induced by 
glycated PE are important features reveling the interconnections of oxidative stress and diabetes. 
Thus, studies are need to clarify the mechanism underlying the promotion of oxidation by glycated 
PE, and ultimately, to explore the mechanisms by which increased oxidative stress accelerates the 
development of complications in diabetes. 
The main goal of this study was to develop a model, based on mass spectrometry analysis, 
to better understand the mechanisms involved in the glycated PEs oxidation, to better understand 
the relation structure-activity. Evaluation of biological effects of the products resulting from PE 
glycation, oxidation and glycoxidation on the immune responses were also studied, using flow 
cytometry. 
To achieve this goal, the work was divided into three main objectives: 
• Develop a new sensitive and efficient way of identification of the oxidation products of 
different glycated PEs formed by oxidative stress models, based on LC-MS and MS/MS 
(Chapter III). 
• Evaluate the biological effects of oxidized PEs and glycoxidized PEs on stimulation of 
monocytes and dendritic cells (Chapter IV). 
• Indentify and characterize alterations of PE species found in diabetic liver applying LC-MS 
and MS/MS methodologies (Chapter V). 
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1. OBJECTIVE 
 
The global strategy used to achieve the objective of this work can be divided in two main 
tasks. The first task comprises the structural characterization of oxidation products of glycated PE 
and the evaluation of the effects of oxidation products of glycated PE on the stimulation of 
monocytes and dendritic cells. For that purpose phosphatidylethanolamine standards were initially 
glycated, purified by high performance liquid chromatography (HPLC) and then oxidized by the 
hydroxyl radical generated under the Fenton reaction. The oxidation products formed were 
analyzed by mass spectrometry (MS) with or without previous HPLC separation. To evaluate the 
effects of the different modified phosphatidylethanolamine (PE) in monocytes and myeloid dendritic 
cells (mDCs), the non-modified PE, oxidized PE, glycated PE and glycoxidized PE were then 
incubated with peripheral blood for the evaluation of cell stimulation and cytokine expression 
employing flow cytometry technique. The structure of this work is summarized in the Figure II: 1. 
 
 
FIGURE II: 1 – Flow chart of the work done for the identification of oxidation products of glycated PE and the evaluation of 
glycated PE and glycoxidized PE on stimulation of monocytes and dendritic cells. 
 
The second task comprises the evaluation of phospholipid profile of livers from rats with 
streptozotocin (STZ)-induced diabetes. This work was performed to evaluate the presence of 
glycated and glycoxidized PEs, capable of inducing oxidative stress and inflammation in diabetic 
subjects. The general approach for this task is represented in the Figure II: 2. Briefly, livers from 
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rats with streptozotocin (STZ)-induced diabetes and from non-diabetic rats, were homogenized and 
the phospholipids were extracted with the Folch method (1). In liver extracts, total phospholipids 
and amount of phospholipids per class were quantified. Analyses of phospholipid species were 
then performed by MS, using different approaches. Direct MS analyses of the total lipid extract 
were done in a Q-TOF2 mass spectrometer (Micromass, Manchester, UK.) instrument to obtain MS 
spectra and product ion spectra. Neutral loss and parent ion experiments were done in a triple 
quadrupole Waters Quattro Premier™ XE (Micromass, Manchester, UK. located at Instituto de 
Biologia Molecular e Celular). MS analysis in a linear ion trap LXQ (ThermoFinnigan, San Jose, 
CA, USA) was done after TLC and HPLC separation. 
 
FIGURE II: 2 – Flow chart of the work done for the evaluation of phospholipid profile of livers from rats with streptozotocin-
induced diabetes. 
 
2. OVERVIEW OF THE EXPERIMENTAL APPROACHES 
 
2.1. PE GLYCATION: PREPARATION OF GLYCATED PE STANDARDS 
 
In vitro systems for PE glycation were reported in some previous studies (2-5). Also, in vivo 
glycation was reported to occur (6-10). The objective of glycation reactions performed in this work 
was to produce considerable amounts of glycated PE, which would allow to do oxidative 
experiments and the identification of oxidation products by mass spectrometry strategies. So we 
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opted to increase the yield of the glycation reaction in a shorter incubation period, instead of 
mimicking in vivo conditions. The glycation of PE standards was prepared in a methanol/water 
solution with a final concentration of 3 µM for PE and 0.5 mM for glucose, and reacting in boiling 
water during 30 minutes. To avoid oxidation of PE under the glycation process the reaction were 
conducted under nitrogen atmosphere. After glycation, the recovery of glycated PE and elimination 
of glucose from the reaction mixture was achieved by a modified Folch extraction (1). The organic 
phase containing glycated PE was collected for further purification by HPLC prior to oxidation. The 
schematics of the glycation reaction are presented at the Figure II: 3. 
 
FIGURE II: 3 – Scheme for the glycation of phosphatidylethanolamine. The glucose reacts with the amino group of PE to 
form a Schiff base which undergoes an Amadori rearrangement to yield Amadori-PE (6). 
 
2.2. MECHANISMS OF PHOSPHOLIPID OXIDATION: PROCEDURE OF GLYCATED PE 
OXIDATION BY THE HYDROXYL RADICAL 
 
In living systems, membrane phospholipids are continually exposed to oxidative situations 
(11). Phospholipid oxidation occurs mainly in the unsaturated fatty acyl chains (usually placed at 
the sn-2 position of glycerol), in a process that consists of three stages, initiation, propagation and 
termination. Lipid peroxidation is a chain reaction initiated by free radicals (like HO˙ which is the 
most known potent oxidant) that have the capacity to abstract a hydrogen atom from bis-allylic 
carbon of unsaturated fatty acyl chains, forming lipid carbon centered radical (L˙). This carbon 
centered radical undergoes further molecular rearrangement, forming a conjugated diene. When 
oxygen is present, the L˙ reacts with oxygen, forming a peroxyl radical (LOO˙). This LOO˙ can react 
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with other molecules, propagating the reaction by abstracting a hydrogen radical with formation of a 
lipid hydroperoxide (LOOH). These lipid hydroperoxides (LOOH) can easily decompose into 
several reactive species including: lipid alkoxyl radicals (LO˙), ketenes, alkanes, lipid epoxides, and 
alcohols (LOH). Also lipid alkoxyl radicals can also decompose into alcohols (LOH), short alkanes, 
short alkenes, short aldehydes or short carboxylic acids. The short (or truncated) fatty acyl chains 
are formed by chain cleavage in the vicinity of the local of modification (11-18). For example PAF-
like lipids are oxidation products of plasmenyl PC that contain a truncated fatty acid at sn-2 (17, 
19). Furthermore in oxidation of fatty acids containing more than three double bounds like, 
arachidonic acid, the LOOH may undergo cyclization and rearrangement reactions that originate 
more complex oxidation products, namely prostaglandins (from unesterified arachidonic acid), 
isothromboxanes, isofurans, isolevuglandins and isoprotanes (18, 20). In general, the long-chain 
products are formed first and then could suffer further rearrangements that could lead to cyclization 
or cleavage of the modified fatty acyl chains as the reaction represented at Figure II: 4. The lipid 
peroxidation products have distinct structural features that may render distinct activities (17). 
 
 
FIGURE II: 4 – Lipid peroxidation reaction (A) (21) and molecular alterations (B; adapted from Betteridge (12)). L˙ 
represents lipid alkyl radicals, LOO˙ represents lipid peroxyl radicals and LO˙ represents lipid alkoxyl radicals. 
 
Lipid peroxidation occur in vivo systems, but these reactions can be mimicked by in vitro 
systems, in order to identify the oxidation products formed herein and understand their reactivity 
and functions. The phospholipid oxidation had been studied under diverse in vitro oxidation 
systems. Depending on the oxidation system employed, the lipid peroxidation products formed can 
be different. In vitro lipid peroxidation can be reproduced by enzymatic reactions (using 
lipoxygenase or mieloperoxidase) or non-enzymatic reactions, which can be radicalar or non-
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radicalar (ozone and singlet molecular oxygen) (14, 15). Non-enzymatic radicalar oxidations are 
produced by radiation (22), Fenton and Fenton-like reactions (23) and from azo initiators 
(compounds that generate radicals by their decomposition) (22). 
In this study, oxidation of glycated PE was achieved by the hydroxyl radical generated under 
Fenton reaction. Glycated PE vesicles (final concentration of 50 mM) were prepared in ammonium 
bicarbonate buffer (5 mM, pH 7.4). Then FeCl2 and H2O2 were added to liposome mixture to a final 
concentration of 0.5mM and 50mM, respectively. The reaction mixture was kept at 37°C, in the 
dark for at least 5 days, with daily MS monitoring either in a Q-TOF2 (Micromass, Manchester, UK.) 
instrument or in a linear ion trap LXQ (ThermoFinnigan, San Jose, CA, USA). The new oxidation 
products identified in MS spectra were further analyzed by tandem mass spectrometry. 
 
2.3. CELL STIMULATION WITH GLYCATED PE AND FLOW CYTOMETRY ANALYSIS 
 
Glycated PE and glycoxidized PE obtained by the procedure explained before, were further 
evaluated for the ability to stimulate monocytes and dendritic cells. For that purpose fresh 
peripheral blood were collected from healthy donors. Blood was incubated in a liquid medium 
supplemented with the phospholipid vesicles, prepared in PBS, and Brefeldin-A, to prevent the 
release of cytokines from outside the cells, at 37°C in a 5% CO2 humid atmosphere, in a sterile 
environment for 6 hours. After that samples were labeled with monoclonal antibodies for detection 
of monocytes (CD 33 and HLA-DR), dendritic cells (CD33, HLA-DR, CD14, CD19, CD56 and CD3) 
and intracitoplasmastic cytokines (IL-1β, IL-6, IL-8, MIP-1β and TNF-α). This allows flow cytometry 
identification of monocytes and dendritic cells and analysis of the expression of each cytokine 
under study. 
 
2.4. PREPARATION OF LIVER EXTRACTS FOR LIPIDOMIC ANALYSIS 
 
Proper preparation of samples is important for elucidation of the biochemical and biophysical 
properties of membrane lipids and their cellular functions. Attention should be paid to prevent 
biochemical changes, thus quick procedures, at low temperatures and in the presence of 
antioxidants are commonly used strategies. When the samples are organs and tissues, it is 
necessary to destroy their integrity, with homogenization steps, prior to lipid extraction, in a form 
that they can be subsequently fractionated. The homogenization is highly influenced by the 
operational criteria which differ among tissues. Various homogenization methods have been 
employed based on mechanical disruption (Potter-Elvehjem, rotating blade devices such as Waring 
blendor and Ultraturax, glass beads) or other shear forces (pressure/cavitation, freeze-thaw). Also 
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during homogenization step, the preservation of the membranes as they exist in vivo is 
accomplished with the usage of buffers that mimic the pH and solute composition of the living cells. 
The lipid extraction methods from samples exploit the high solubility of hydrocarbon chains in 
organic solvents, in a procedure that depends on the chemical nature of the lipid components and 
the kind of complexes or associations in which they occur in the cell. The separation is 
accomplished with addition of immiscible solvents to the aqueous sample, like chloroform or 
benzene containing solutions. Membrane associated lipids require polar solvents such as ethanol 
or methanol to disrupt the hydrogen bonding networks or electrostatic forces between lipids and 
proteins and to precipitate proteins. Special care should be taken to minimize risk of lipid oxidation 
and hydrolysis and avoid rapid protein denaturation to improve lipid recovery. There are various 
extraction protocols and the chosen protocol should take in consideration not only the nature of 
lipids and sample, but also the analytical method used (24-26). 
In this study, the livers of STZ-induced diabetic rats were dissected out, after 4 months of the 
intraperitoneal injection of streptozotocin. Homogenization of livers was performed with PBS 
(phosphate buffered saline), mimicking the in vivo pH, and employing mechanical disruption 
(Potter-Elvehjem homogenizer and teflon pestle). Total lipid were extracted from homogenized 
livers by Folch method, reaching a final proportion of chloroform, methanol and water of 8:4:3, by 
volume (1). Total phospholipids were measured by determination of phosphorus amount, after 
digestion with perchloric acid, according to a well-established procedure (27). Total phospholipid 
levels were normalized to protein content determined by biuret method. Phospholipid amount within 
each PL class were determined by phosphorus assay, subsequent to TLC separation. 
Characterization of individual phospholipid within each class was achieved by mass spectrometry 
(MS) after separation by liquid chromatography (LC). HPLC separation were accomplished by the 
adaptation of an existing method (28) and MS experiments were done in a linear ion trap LXQ 
(ThermoFinnigan, San Jose, CA, USA). 
 
3. OVERVIEW OF ANALYTICAL STRATEGIES 
 
3.1. MASS SPECTROMETRY FUNDAMENTALS 
 
In the recent years, with the development of the “omics” fields, is required “high-throughput 
analytical tools” and mass spectrometry has essential role in this field. There are an increasing of 
“omics” fields, from genomics, proteomics, lipidomics and many others. Each specific “omic” field 
comprises a wide range of techniques applied to the study of a specific subject (29, 30). In most 
lipidomics studies, MS constitute the core technology employed either in a global or target manner. 
Global lipidomics consists in identification of all or the majority of lipids of a sample on a single 
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experiment format. Shotgun lipidomics or LC-MS analyses of crude extracts are approaches 
commonly used to identify and quantify as many lipid molecular species as possible. In contrast, 
targeted lipidomics concentrates on one class of lipid and protocols are designed and utilized in a 
class specific manner (31, 32). 
Mass spectrometry is an analytical tool that measures the molecular weight of sample 
constituents, via measurement of mass-to-charge ratios (m/z), and gives structural information, by 
application of tandem mass spectrometry (MS/MS). Mass spectrometers are instruments that 
ionize the samples (ion or molecules) and apply to them electrostatic, magnetostatic or 
electromagnetic fields to separate the ions by their mass-to-charge ratios (m/z). The ionization and 
ion separation occur in the gas phase, so the analyzed compounds need to be vaporized or 
transferred into vacuum either before or during the ionization. Mass spectrometers are generally 
composed by three fundamental parts, which are the ionization source, the mass analyzer and the 
detector (29-31). The Figure II: 5 shows a schematic representation of a mass spectrometer. 
 
 
FIGURE II: 5 – Basic components of a mass spectrometer (29). 
 
There are different ionization sources, mass analyzers and detectors and several 
combinations between the existent components are possible. Furthermore, the system for sample 
introduction on mass spectrometers can be conducted through direct injection or be easily coupled 
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with separation technologies, such as gas chromatography (GC) or high performance liquid 
chromatography (HPLC), which are especially important for the analysis of mixtures, as the cases 
of biological samples (29, 30). MS data is largely dependent on the sample introduction and the 
method of ionization, while the type of mass analyzer does not usually alter the observed chemical 
reactions (33). 
 
3.1.1. IONIZATION SOURCES 
 
Ionization source is the mass spectrometer component that promotes the ionization of the 
molecules so that they can be analyzed. There are different ionization sources that can be used, 
and the choice depends on the sample that needs to be ionized. Electron impact (EI) ionization, 
fast atom bombardment (FAB) ionization, electrospray ionization (ESI) and matrix assisted laser 
desorption ionization (MALDI) are some examples of the existent ionization sources. EI was the 
first ionization source, but this ionization method has some limitations, because promotes 
molecular fragmentation and only ionizes volatile compounds. The development of mass 
spectrometry technology, leaded to the emerging of the “soft” ionization methods, especially ESI 
and MALDI. These ionization sources produce minimal fragmentation, allowing the analysis of 
biomolecules and complex biological samples (29). 
 
3.1.1.1. ELECTROSPRAY IONIZATION 
 
Currently electrospray ionization is the most frequently used and well suited ionization 
technique for lipid analysis (24). ESI is the “softest” ionization technology, thus rarely disrupts the 
chemical nature of the analytes and even non-covalent bonds can be conserved. ESI is used for 
the analysis of large and non-volatile molecules/ions directly from liquid phase. In this ionization 
source, the analyte molecules or ions are present originally in solution and are transferred to the 
gas phase through either solvent or ion evaporation. 
The ionization process is not fully understood, however it is known that the ionization is 
induced at atmospheric pressure by a strong electrostatic potential difference between the syringe 
needle and a counter (cone) electrode, which polarize the solution at the end of the needle and 
spray away the sample from the needle. Positively charged or negatively charged droplets can be 
formed depending on the applied potentials. The solvent evaporates, assisted by a flow of heated 
inert gas, and smaller droplets are formed until the ion desorption occurs. In this process multiple 
charged ions can be easily formed, which is a characteristic feature of ESI. These multiple charged 
ions allow the analysis of high molecular weight molecules, when it is used analysers that have a 
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lower mass limit. One advantage of ESI is that no matrix is needed, which is important for small 
molecules analysis, because the peaks associated with matrix ions (observed in MALDI) do not 
appear in the ESI-MS spectra (29, 30). The Figure II: 6 represents the schematic ESI source and 
the ionization process. 
 
 
FIGURE II: 6 – Electrospray ionization (ESI) source (30). 
 
3.1.1.2. MATRIX ASSISTED LASER DESORPTION IONIZATION 
 
MALDI is another soft ionization technique. It is often used for analyses of proteins, but has 
already been used successfully in lipids (24). MALDI is most frequently used for phospholipid 
analysis after TLC separation, due to the easy MALDI-TLC coupling and for imaging MS (24, 25, 
33-36). In turn, direct phospholipid analysis with MALDI is not so used, due to the complexity of the 
spectra formed (24, 25, 34). In MALDI the sample is mixed with a matrix, crystallized in a solid 
phase and the ionization is promoted by laser light. By irradiation of the matrix, which is in great 
excess to the sample molecules, with a laser beam, the molecules are excited and released to the 
gas phase. In the gas phase, the matrix and the sample interact with each other, and ionization 
occurs by proton transference. In this process, mostly singly charged ions are formed. The matrix is 
an essential part in this ionization method and there are different matrices. The selection of the 
matrix depends on the compounds to be analyzed. In lipid analysis, 2,5-dihydroxybenzoic acid 
(DHB) is the most common matrix used (37). In Figure II: 7 the principle of the matrix assisted laser 
desorption ionization is shown. 
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FIGURE II: 7 – Matrix assisted laser desorption ionization (MALDI) (30). 
 
3.1.2. MASS ANALYZERS 
 
The ions formed in the ionization source are further separated according to their m/z ratios in 
mass analyzers, normally by electric and/or magnetic fields. The properties that characterize mass 
analyzers include: mass accuracy (the error in the exact mass determination compared to the 
theoretical value), resolution (capacity to distinguish two ions with a small mass difference) and 
sensitivity (i.e., the number of ions detected), which depends on the transmittance (number of ions 
that reach the detector/number of ions produced in the source). It should be noted that mass 
analyzers must be compatible with the ionization source used. Quadrupole (Q), ion trap and time-
of-flight (TOF) are the most common mass analyzers. Mass spectrometers can have only one type 
of mass analyzer or have combinations of analyzers. The later ones are called hybrid mass 
spectrometers. Hybrid mass spectrometers allow tandem mass spectrometry (MS/MS) experiments 
and are frequently used in lipid identification and quantification (24, 29, 30). The hybrid Q-TOF is 
an example of a hybrid mass spectrometer that was utilized during the work developed within this 
thesis. 
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3.1.2.1. QUADRUPOLE 
 
The quadrupole (Q) mass analyzer is formed by four parallels metal rods organized in a 
quadrupolar structure. The opposite rods form pairs, which are connected electrically through the 
same voltages. One pair has a specific voltage and the perpendicular pair has the same voltage 
with an opposite signal. Direct current (dc) and radio-frequency (rf) potentials are applied between 
the two opposite pairs of these electrodes to produce a high frequency oscillating electric field. 
Mass separation is made possible by the oscillatory motions of ions in this electric field. Only the 
ions which have a stable trajectory can pass through the analyzer and reach the detector, while the 
others collide with the rods and are lost, never reaching the detector. A stable trajectory is achieved 
with specific values of the dc and rf potentials which selectively filter the ions of interest based on 
their m/z ratios. A mass spectrum is usually obtained by changing both the dc and rf potentials 
while keeping their ratio constant, and detecting how many ions pass through the filter at each m/z 
value (24, 29, 30, 37) 
Quadrupole analyzers are normally used with ESI sources, because of the continuous flow 
of the ions generated in the source. These analyzers have a good reproducibility but generally, low 
mass resolution and accuracy (24, 29, 30, 37). 
 
3.1.2.2. ION TRAP 
 
Ion trap mass analyzers comprise different instruments, namely linear or two-dimensional ion 
trap (LIT), three-dimensional ion trap (QIT) and orbitrap. In the two- and three-dimensional ion 
traps, the ions are captured in a field and then sequentially ejected for separation (24, 29, 30, 37). 
The two-dimensional or quadrupole ion traps have the same principle of quadrupoles, but 
with an additional axial dimension by means of an electric field produced by end-cap electrodes. 
The end-cap electrodes block passage of ions in the axial direction and the ions stay between the 
rods until they are ejected (radial ejection) to the detector. The two-dimensional ion trap works 
similar to the three-dimensional one, but the first one has higher resolution and expanded dynamic 
range, with a larger volume, can store more ions before space-charge affects the performance (24, 
29, 30, 37). 
The QIT (three-dimensional or cylindrical ion trap instrument) is composed of a doughnut-
shaped central ring electrode and two end-cap electrodes, all with hyperbolic geometry. The 
trapping electric field is formed by applying dc and rf potentials to the ring electrode and ground 
potential to the end-cap electrodes. By manipulation of the ratios of the dc and rf field strengths, 
and the analyte ions can be captured and successively ejected, due to mass selective instability, 
 | 48 
 
 Phosphatidylethanolamines Glycoxidation: Products and Significance 
yielding a mass spectrum (24, 29, 30, 37). The ion traps have usually more sensitivity than 
quadrupoles and allow the fragmentation in consecutive steps (MSn) (24, 29, 30, 37). 
In Orbitrap, a different analyzer, ions are also trapped and stored in a potential well. 
However, instead of ejecting the ions for external detection the frequency of the trapped oscillating 
ions is measured. Orbitrap mass spectrometers provide high mass accuracy and resolving power 
(24, 37). 
 
3.1.2.3. TIME-OF-FLIGHT 
 
The time-of-flight (TOF) analyzers separate the ions by applying electric fields that 
accelerate the ions, with a specific kinetic energy. The time that ions take to reach the detector is 
measured and is correlated with the m/z ratio. Since the kinetic energy is the same, the velocity of 
the ions is inversely proportional to the square root of their mass. Thus lighter ions have higher 
velocity and shorter arrival time than the heavier ions, which have lower velocities. The resolution 
of the TOF analyzer is limited by the initial velocity (kinetic energy) and spatial spread of the ions. 
Spatial spread can be compensated by delayed extraction technique (time-lag focusing) and the 
velocity spread is reduced using the reflectron. The reflectron consists of an electrostatic field in 
which the ions must penetrate and switch their trajectory. In reflectron, the ions with same m/z 
value, but different velocities have to travel different distances for all those ions reach the detector 
at the same time. This improves significantly the resolution and mass accuracy of TOF analyzers. 
TOF analyzers are usually coupled to MALDI ionization, but can also be coupled with ESI sources. 
In this case an orthogonal acceleration is usually applied for ions to go to the TOF analyzer. TOF 
analyzers have a good resolution, an excellent sensitivity and a large mass range (24, 29, 30, 37). 
 
3.1.3. DETECTORS 
 
After the sample ionization and ion separation according with their m/z values, the signal of 
each m/z-resolved ion is measured in a detector. The ions hit the detector and the detector 
converts their energy into a current signal that is registered. The most frequently used detectors 
are the electron multipliers, which amplify a weak current of incoming particles by using a series of 
secondary emission electrodes or dynodes to produce a considerably higher current at the anode. 
The microchannel plate or multichannel plate (MCP) is an electron multiplier detector that is often 
utilized in TOF instruments. A MCP is formed by parallel array of channel electron multipliers, 
which amplifies the ions signal. The signal is then registered by the electronic devices and 
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transferred to the computer, which translates the signal in a mass spectrum. A mass spectrum is a 
plot that shows the m/z ratios of the ions versus their relative abundance (24, 30, 37). 
 
3.1.4. TANDEM MASS SPECTROMETRY 
 
Tandem mass spectrometry (MS/MS), is the study of specific ion fragmentations allowing the 
structural characterization of originally non-fragmented ions (precursor ions), which cannot be 
achieved only by direct mass spectrometry. Mass spectra only give the molecular mass information 
and this is insufficient, because of the diverse molecular structures and also existence of isomers. 
The fragmentation pattern obtained is characteristic of structural features of each molecule. 
However, the MS/MS spectra of the same precursor ion can be quite different if they are acquired 
in different instrument configurations. Besides the given useful information about molecular 
structure, MS/MS is a powerful analytical approach for molecular quantification, especially multiple 
reaction monitoring (MRM) experiments (24, 29, 30, 38). 
Tandem mass spectrometry is a technique that uses multiple stages of mass selection and 
mass separation, to elucidate the structural information of specific ions. Typically two or more mass 
analyzers coupled in series are need for MS/MS experiments. In this configuration, an individual 
ion can be selected and isolated, in the first analyzer; then fragmented, in the collision cell; and the 
product ions formed are subsequently measured, in the second analyzer. Ion trap analyzers are 
able to perform MS/MS without coupling with another analyzer, and are also able multiple stages 
mass analysis, the MSn (24, 29, 30, 38). 
A prerequisite for MS/MS technique is that the sample molecules can be ionized intact and 
that they can be induced to fragmentate in some predictable and controllable way after the first 
mass selection step. The ion activation step is crucial to the experiment and ultimately defines what 
types of product/fragment ions are formed. Collision-induced/activated dissociation (CID/CAD) is 
the classic method for ion fragmentation in lipid analysis. CID is produced by collision of a neutral 
gas (helium or argon) and the selected ions, leading to fragmentation. During the collision with the 
gas, part of the kinetic energy of mass-selected precursor ions, which was augmented due to ion 
acceleration through an electric potential drop, is converted into internal (vibrational/rotational) 
energy. When the internal energy of the precursor ion is high enough, ions will break in the weak 
bonds and fragment, allowing to obtain chemical information about most frequent and most 
favorable molecular fragmentation. Depending on the type of mass analyzer, either high-energy 
CID (KeV collision energy in TOF instruments) or low-energy CID (<100 eV in quadrupole and ion 
trap instruments) can be performed (24, 29, 30, 38). 
The fragmentation can be performed either in space or consecutively in time. In space 
fragmentation, ions are analyzed sequentially as they travel through the instrument containing at 
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least two “nontrapping” analyzers. In time fragmentation is, only possible in ion trap analyzers, 
where ion selection, fragmentation and fragment separation occur in the same physical space. The 
selected ion is trapped in the analyzer (while all the other ions are ejected), the fragmentation is 
induced and the fragment ions are then ejected for further detection. In time fragmentation allows 
consecutively repeated steps of selection, fragmentation and analyzes, the MSn experiments, 
which is a valuable tool (29, 30, 38). 
Product ion scan gives information of all the fragment ions of a selected ion, and can be 
accomplished with ion trap (in time fragmentation) and hybrid (in space fragmentation) mass 
spectrometers. Other scan modes can be performed, but only with in space fragmentation (typically 
triple quadrupoles instruments). These include precursor ion scan, neutral loss scan and MRM, as 
summarized in the Table II: 1. Neutral loss and precursor ion scans are used for detection of 
certain class molecules with a certain common functional group. Precursor ion scan mode gives 
information of the precursor ions from which a given fragment is formed, by adjusting the third 
quadrupole with a selected m/z value, while the first quadrupole scans for the precursor ions. The 
neutral loss scan is used for searching compounds that lose a common neutral fragment. For that, 
both the first and the third quadrupoles are scanned in a synchronized way, with a selected fixed 
m/z difference between them. MRM is a useful tool to obtain structural information from different 
molecules in the same sample and to provide reliable quantification. In this case the first and the 
third quadrupoles are set up to monitor only a selected parent ion and a selected fragment, 
respectively. This two-step mass filtering process, analyzes a known fragment of a specific the 
compound, thus providing high specificity and impressive accuracy and precision (30, 38). 
 
TABLE II: 1 – MS/MS scan modes applicable in a triple quadrupole instrument (QqQ). Adapted from Somogyi et al. (30). 
Scan modes Quadrupole 1 (Q1) 
Quadrupole 2 
(q2) 
Quadrupole 3 
(Q3) 
Product ion Select a desired m/z Ion activation/dissociation Scan for all fragment ions 
Precursor ion Scan for parent of a giving fragment (F) Ion activation/dissociation 
Select and monitor 
fragment F 
Neutral loss Scan for parents Ion activation/dissociation Scan with shift of 
mass of the neutral 
Selected/Multiple 
Reaction Monitoring 
(SRM/MRM) 
Select a desired m/z Ion activation/dissociation 
Select and monitor 
desired fragments of 
m/z 
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3.1.5. MASS SPECTROMETRY OF PHOSPHATIDYLETHANOLAMINES 
 
Analysis of phospholipids can be performed with several analytical strategies, and MS is 
considered to be the most important. The combination of sensitivity, specificity, selectivity and 
speed makes MS an ideal technique for analysis of phospholipids (33). The ESI and MALDI are the 
ionization methods used in phospholipid MS analysis. The ionization and fragmentation of 
phospholipids is somewhat different in ESI (39-41) and MALDI (42-44), as reviewed before. Each 
PL polar head group have different structural features, leading to different ionization propensity 
under positive or negative modes (24, 26, 33, 40, 45). 
The PE can be ionized in the positive and in the negative ion modes. In the positive mode, 
ionization is produced by gaining one proton, originating protonated molecular ions [M+H]+, and/or 
by gaining one cation, of which sodium is the most frequent, and originates sodiated molecular ions 
[M+Na]+. Ionization by addition of 2 sodium ions, forming the [M-H+2Na]+ molecular ions can also 
occur, especially in MALDI. In the negative ion mode, the ionization occurs by the loss of one 
proton originating the deprotonated molecular ions [M-H]-, and by the gain of anions (when salts, 
like chlorates, are added) forming the [M+Cl]-. The addition of salts can also be done in the positive 
ion mode, lithium salts are normally added in such cases, originating lithiated molecular ions 
[M+Li]+. This capability of the PE be ionized in the negative ion mode is very useful for the shotgun 
analysis of phospholipid mixtures. Such mixtures contain phosphatidylcholines, which have a 
permanent positive charge, and difficult the detection of other phospholipids due to ion 
suppression. Thus, the phospholipids that have a good ionization in the negative ion mode can be 
easily detected, in this mode, without the interference of phosphatidylcholines (24, 42, 46, 47). 
The glycerophospholipid fragmentation patterns normally reveal information on the lipid polar 
head group and its acyl chain moieties. Generally PL polar head groups can be associated with a 
characteristic fragment, thus neutral loss and precursor ion scans would enable the identification of 
phospholipid classes in complex mixtures (24, 26, 33, 40, 45). The fragmentation of PL [M+H]+ ions 
originates a predominant fragment ion, which corresponds to the loss of the phospholipids polar 
head (33), and allows the discrimination of phospholipid families. Besides the information of polar 
head group, the fragmentation of PL [M+H]+ ions gives information of total number of carbons and 
double bound of the two acyl chains combined. Because of the variety of combinations of different 
fatty acyl moieties could add up to the same molecular mass, further structural information is 
needed. The individual fatty acyl substituents are simply accessed by fragmentation metal adducts 
or deprotonated ions, allowing the unambiguous determination of the lipid species. The 
identification of the length of each fatty acyl moiety, the total number of double bonds on each fatty 
acyl chain and the regiospecificity of the two fatty acyl chains are accessed. However, the fragment 
ions corresponding to carboxylate anions of fatty acids are specially obtained in the negative 
ionization mode (24, 26, 40). 
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In the particular case of PE, the characteristic fragment is originated from neutral loss of 
polar head, which corresponding to a neutral loss of 141 Da (24, 40, 42, 44, 47). The fragmentation 
of the PE [M+H]+ ions yield basically that product ion, thus only limited information is obtained. For 
further information is necessary to do the fragmentation of the PE cation adducts ([M+Na]+, [M+Li]+) 
or [M-H]- ions. Besides the neutral loss of 141 Da, [M+Na]+ and [M+Li]+ precursor molecular ions 
originate more fragment ions, that result from loss of aziridine (- 43Da; part of the polar head) and 
losses of the sn-1 and sn-2 acyl chains. The loss of sn-1 acyl chain is more favorable than the loss 
of sn-2 acyl chains, reflected by higher relative abundance of the ions [M+Na-R1COOH]+ relative to 
[M+Na-R2COOH]+. These differences in the loss of the acyl chains are a valuable characteristic 
that allows the differentiation of the acyl chain position in the glycerol backbone (24, 40, 47). 
Fragmentation of the PE [M-H]- ions originates the carboxylate anions (RCOO-) formed by the loss 
of sn-1 and sn-2 acyl chains, which also have differences in the relative abundance. However, the 
ratio between the two carboxylate anions is dependent on the collision energy applied. Thus the 
identification of the specific location of the acyl chains in the glycerol backbone, in the negative ion 
mode, must take in consideration this factor. At low collision energies, the sn-2 carboxylate anion 
was preferred (ratio greater than 2 to 1); however, at higher collision energies an inversion of that 
ratio was observed (24, 40). 
Moreover, by CID fragmentation it is possible to distinguish the phospholipids subspecies; 
diacyl phospholipids forms two carboxylate anions and plasmenyls (vinyl ether) or plasmanyls 
(alkyl ether) phospholipids forms only one carboxylate anion. Further differentiation of plasmenyls 
and plamanyls phospholipids can be obtained by phospholipid hydrolyzation under mild acidic 
conditions, this attack vinyl ether bonds. By comparison of the spectra before and after hydrolysis, 
it is possible distinguish plasmenyls from plamanyls glycerophospholipids (48). 
 
3.1.6. MASS SPECTROMETRY OF OXIDIZED PHOSPHOLIPIDS 
 
As reported before, PE oxidation can generate a huge variety of oxidation products. This 
variety of phospholipids oxidation products makes difficult the MS analysis of all species in 
samples, especially because of ionization and ion suppression effects. However, the high 
sensitivity of MS and the advantage of obtaining information at molecular level, explains the 
employment of MS to the analysis of oxidized phospholipids. Coupling mass spectrometry with 
liquid-chromatography is the best choice for the detection of a wide range of oxidized PL and 
isomers. LC-MS allows the qualitative and quantitative determination of long and short chain 
oxidation products and lyso-PL without the need for derivatization procedures, and shows good 
linearity and reproducibility across a wide range of concentrations. 
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Targeted approaches can be designed for analyzing specific oxidized products, like neutral 
loss scan of m/z 319 used to detect oxidation products containing HETEs (18, 19). Long chain 
oxidation products could be detected by the addition of oxygen molecules to phospholipids. Thus 
oxidation products containing hydroxyl and peroxyl groups can be identified by the addition of 
multiples of 16 Da to the mass of unoxidized phospholipids. In turn, keto and epoxy groups of 
oxidized phospholipids could be identified by the increment of multiples of 14 Da to the mass of 
unoxidized phospholipids. Truncated oxidized phospholipids are more heterogeneous molecules, 
thus some derivatization techniques can be applied for easier detection and improved sensitivity 
(19). These targeted approaches are necessary to detect oxidized PL in complex biological 
samples. However, it is necessary to know exactly what products are formed and what are their 
fragmentation patterns, thus, in vitro studies are very important for the development of new 
methodologies for detection of oxidized PL. 
 
3.2. CHROMATOGRAPHY FUNDAMENTALS AND APPLICATION ON LIPIDOMICS 
 
Lipid species are routinely analyzed by ESI mass spectrometry via direct infusion or 
integrated with front-end liquid chromatographic separations such as normal- and reverse-phase 
HPLC. Chromatographic separations such as TLC or HLPC can be combined with MS analysis 
using either an in-line or off-line approach. By coupling chromatographic separation to MS, the 
lipidomic analysis is considerably improved, by reducing the complexity of the lipid sample, 
reducing the signal suppression, improving the detection of minor species and allowing the 
detection of isomeric/isobaric species (24-26). 
 
3.2.1. THIN LAYER CHROMATOGRAPHY 
 
Thin layer chromatography (TLC) was the earliest chromatographic method used to assess 
phospholipids (since the early 1960s), and is routinely used today. TLC was developed from paper 
chromatography. The TLC separations are accomplished through a combination of a solid 
stationary phase and a liquid mobile phase. The stationary phase consists of a thin layer coated in 
a flat support. For the separation of phospholipids, the most common plates are glass plates 
coated with silica gel, normal-phase TLC. There are also other stationary phases that can be used 
in phospholipid analysis. The mobile phase consists of a solvent system that varies in polarity. A 
wide variety of organic mobile phases can be applied to separation of virtually all phospholipid 
classes. Chloroform, methanol and water are typical solvents used, but triethylamine, ethanol, 
hexane and isopropanol are also common solvents. Separation of phospholipid classes can be 
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accomplished in one dimensional or two dimensional TLC. After separation phospholipids must be 
visualized, so specific and non-specific stains could be employed for that purpose (24, 25, 49, 50). 
The migration of analytes, like phospholipids, on the stationary phase depends on the 
partition coefficients, retention/retardation factor (Rf), capacity factor of the individual constituents 
on the plate and selectivity of the mobile and stationary phases. During TLC separation, the 
molecules of the solvent compete with the molecules of the analyte for binding sites on the 
stationary phase while the mobile phase passes through the stationary phase. Different partitioning 
between the two phases results in differential rates of migration of the different mixture 
components. Thus, the identification of analytes is based on the retention factor (Rf), which is the 
ratio of migration distance of the analyte from the origin to the migration distance of the flowing 
solvent from the origin. Each phospholipid class has its own Rf value under specific experimental 
conditions. In such normal-phase TLC systems, used for separation of PL classes, the less polar 
compounds have more affinity with the mobile phase and so elute in front of the more polar 
compounds which have higher affinity with the stationary phase (49-51). The TLC system used in 
this work for phospholipid classes separation consisted of silica gel plates developed with 
chloroform/ethanol/water/triethylamine (30/35/7/35, by volume) (52). 
TLC is not a very sensitive methodology, but is a rapid and inexpensive screening tool that 
could be used prior to more sensitive and sophisticated techniques. TLC is often used as a sample 
preparation step to separate phospholipid classes prior to HPLC or MS analysis. Additionally TLC 
can be easily combined with MALDI, in a TLC-MS methodology successfully employed in lipidomic 
studies. However, concerns about oxidative degradation during TLC separation, contamination, 
poor reproducibility and resolution should not be neglected (24, 25, 36, 49, 50, 53). 
 
3.2.2. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
 
High performance liquid chromatography is the most popular technique currently used for the 
separation of lipid classes normally prior to MS analysis. In HPLC separation, the liquid sample is 
driven through a stationary phase, packed in a column, by liquid flow at high pressure (typically 50–
400 bar) provided by mechanical pumps. The diverse components of the sample are differently 
retained in the column and reach the end at different times, in a process that depends on the 
molecular properties of the analytes, the composition of the mobile phase, and column packing 
(stationary phase). At the end of column various detection systems can be coupled, including MS, 
refractive index (RI), ultraviolet (UV), fluorescence and evaporative light scattering detection 
(ELSD), in a way that signal intensity vs. time chromatograms can be plotted (24, 25, 49, 54). 
Different stationary phases with small particle size (3–5 µm are commonly used) and a well-
defined pore diameter can be combined with different mobile phases in an isocratic or gradient 
 | 55 
 
 Procedures and Overview of Analytical Strategies 
elution. Mobile phases can be selected from a wide range of solvents, including water, methanol, 
acetonitrile, chloroform and n-hexane. The selection of the mobile phase relies in solvent properties 
like polarity (which defines the eluent strength) and miscibility. Solvent strength is defined as the 
capability of the solvent to elute a given compound from the stationary phase. Thus, stronger 
solvents elute the analyte from the column faster. The solvent system used for phospholipid 
analysis also depends on the method of detection. Gradient elution programs are normally 
preferred due to the wide range of polarity of the phospholipid classes. Also, multiple 
chromatographic separation techniques may be required for comprehensive lipid identification and 
quantification, due to the great diversity of the physicochemical properties of lipid species (24, 25, 
49, 54). 
Normal-phase HPLC and revered-phase HPLC conditions have been developed for 
phospholipid analysis. In the normal-phase HPLC, the stationary phase is more polar than the 
mobile phase and the interaction between analyte and column has predominantly polar character 
(hydrogen bonding or dipole–dipole interactions, etc.). The most commonly used normal stationary 
phase is silica gel, where the phospholipids are separated by adsorption phenomena. In this 
conditions PL elutes depending on head group polarity, sequentially from non-polar to polar. Thus 
normal-phase HPLC is usually employed for separating glycerophospholipids based on their polar 
head groups (24, 25, 49, 54). The hydrophilic interaction liquid chromatography (HILIC) emerged 
as a variant of normal-phase HPLC (55). HILIC consists of combination between a polar stationary 
phase with an aqueous/polar organic solvent mobile phase, typically acetonitrile in which water is 
introduced to play the role of a stronger eluting solvent. Separations are achieved by different 
interactions, hydrophilic interactions are most predominant, but could be accompanied by others, 
such as hydrophobic or electrostatic interactions. Although HILIC are normally used for highly 
hydrophilic, ionic and polar molecules, such as peptides and monosaccharides, it can also be used 
for separations of amphipathic molecules like phospholipids (28, 55, 56). 
Reverse-phase HPLC is the widely applied version of HPLC, and can be also employed in 
PL analysis. In the reverse-phase HPLC, the stationary phase is less polar than the mobile phase 
and the interaction between analyte and the stationary phase has a predominantly hydrophobic 
character. The most commonly used reverse stationary phase is silica gel covalently modified with 
octadecyl chains (C18), but other modifications can also be used, like butyl (C4) and pentyl (C5) 
chains. In this system individual molecular species, of a particular phospholipid class, are 
separated based on a partition mechanism and will elute based on lipophilicity. Thus 
glycerophospholipids are distinguished based on their fatty acids, chain length and number of 
double bonds. Short, polar, unsaturated fatty acids are eluted faster than longer and saturated fatty 
acids. Reverse-phage HPLC is specially used for separation of oxidized PL species from a specific 
class, which have an increased polarity caused by the position and number of oxygen atoms in the 
molecules (24, 25, 49, 54). 
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HPLC is a useful separation tool for lipid class separations (normal-phase) and for 
separating the molecular species (reverse-phase). HPLC offers speed, resolution, high sensitivity 
and specificity and quantification potential. However, is more expensive than TLC and “memory” 
effects may occur due to remaining contributions of a previous run (24, 25, 49, 50, 54). 
In the work developed under this thesis, HLPC-MS experiments were done with the reverse-
phase and normal-phase conditions. First, reverse-phase HPLC were employed to purify glycated 
PE from non-glycated PE and then LC-MS was employed for the separation of glycated PE 
oxidation products. The purification of glycated PE was achieved in a C4 column (25 cm × 4.6 mm, 
7 µm) and a gradient elution with water and acetonitrile acidified (0.1% formic acid) solvents. The 
separation of oxidation products of glycated PE was achieved in a C5 column (15 cm × 0.5 mm, 5 
µm), using the same water and acetonitrile acidified (0.1% formic acid) solvents but a applying a 
different gradient. Later, HILIC LC-MS was used in liver lipid samples, for separation of 
phospholipid classes. HILIC LC-MS was carried out in a silica column (15 cm × 1 mm, 3 µm) and a 
gradient elution formed by water, acetonitrile and methanol solvent system doped with 1mM of 
ammonium acetate. 
 
3.3. FLOW CYTOMETRY FUNDAMENTALS 
 
Flow cytometry is a very popular and widely used tool to determine the phenotype and 
characteristics of cells as they move in a liquid stream through a laser. It measures physical and 
chemical properties of the cells, given by the light-scattering properties (cell size and internal 
complexity/granularity) and color-discriminated fluorescence. The underlying principle of flow 
cytometry is that light is scattered and fluorescence are emitted when light from the excitation 
source strikes each individual moving particle. There are two distinct types of flow cytometers that 
can be used to acquire data from particles. One type can perform acquisition of light scattering and 
fluorescence only. The other type, the cell sorter, is capable of acquiring scattering and 
fluorescence data, but also has the powerful ability to sort and collect particles (57-61). 
A typical flow cytometer consists of three functional units: (1) one or more laser light sources 
and a sensing system, (2) a hydraulic system, and (3) a computer system. Laser sources are used 
for fluorescence and light-scatter measurements by producing an intense beam of monochromatic 
light which in some systems may be tuned to several different wavelengths. The most common 
lasers used in flow cytometry are argon lasers, which produce light between wavelengths of 351 
and 528 nm (particularly 488 nm). The sensing system comprises the sample/flow chamber and 
the optical assembly. The flow chamber is the instrumental for delivering the cells in suspension to 
the specific point that is intersected by the illuminating beam and the plane of focus of the optical 
assembly. The measurements are performed while the cells pass one by one through the detection 
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point (spot where the cell intercept the stationary laser light), due to a hydrodynamic focusing effect 
created by the sheath fluid. The light emitted by the cells or scattered from them, in the detection 
point, is filtered and directed to the detectors by a variety of mirrors and filters, where the electrical 
signals are measured and the data collected by the computer system (57-61). 
Flow cytometers are designed to measure light scattered by a cell at two different and 
distinct angles, while at the same time measure one or more fluorescence emission signals. As the 
cell passes through the laser beam, light is scattered in all directions. The light scattered in the 
forward direction (FSC), at low angles (0.5–10°) from the axis, is proportional to the square of the 
radius of a sphere and so to the size and surface of the cell or particle. The light that enters the cell 
is reflected and refracted by the nucleus and other cell contents and is detected at 90° right angle, 
an orthogonal or side light scatter (SSC). The intensity of orthogonal light scatter is proportional to 
the granularity of the cell. Light scattering is related to structural and morphological cell features 
and may be a measure of a combination of parameters: (1) the size (projected surface area) of the 
particle, (2) the surface topography (rough or smooth), (3) the OD (OD will be influenced by the 
light absorbed and the refractive index will determine the light refracted through the particle), and 
(4) the internal structure of the particle (granular or uniform). Light scattering allows the 
determination of cell size and internal granularity and also the identification of cell viability (57-61). 
Fluorescence is a key concept in flow cytometry and is proportional to the amount of 
fluorochrome present on particles. The fluorescence is conferred by dyes or fluorochrome 
conjugated monoclonal antibodies (mAbs) specific for molecules either on the surface or in the 
intracellular components of the cell. Each fluorochrome has a clear, distinct peak in its emission 
spectrum represented visually by a characteristic color. Particular care should be taken in choosing 
a fluorochrome capable of being excited by the wavelength of the laser in the instrument. When 
fluorochrome-labeled particles or cells pass through the laser beam, are excited and emit light with 
a specific spectral composition and fluorescence occurs. In most instruments, the collection of the 
fluorescence signal is shared with the orthogonal light collection system. Thus, the existence of 
optical mirrors and filters is essential to remove the unwanted wavelengths and allow only the 
desired wavelengths to pass through to the detector. The photons of required wavelengths reach 
the corresponding detector and are converted in an electrical impulse that is further converted in a 
numerical signal. Pulse peak, the highest sampled value; pulse area, the sum of all the sampled 
values; pulse width or other pulse characteristics are reconstructed and measured from individual 
samples of the impulse using computation system. Immunofluorescence allows the visualization of 
cellular features or structures by linking them to a fluorescent molecule before the analysis. Flow 
cytometry allows the use of multiple fluorochromes in a single experiment and then the 
simultaneous evaluation of different cell features (57-61). 
The quantity and intensity of the fluorescence are recorded and combined by the computer 
system, in a way that individually analyzed particles are interpreted collectively. Data is exhibited 
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on a visual display unit as a frequency distribution that may be single-parameter, dual-parameter 
(usually referred to as dot plots), or multiparameter. Single-parameter histograms usually convey 
information regarding the intensity of fluorescence and number of cells of a given fluorescence, so 
that weakly fluorescent cells are distinguished from those that are strongly fluorescent. Dual-
parameter histograms correlates distribution plots of two parameters, like forward scatter (FSC) 
versus side scatter (SSC). In these dual-parameter histograms, each cell is represented as a dot 
and is positioned on the x and y axes according to the intensities detected for that cell. FSC versus 
SSC plots allow identification of the different cell types within the preparation, based on size and 
granularity, and selection of populations of interest. Gating is a powerful analytic tool that is 
available on any type of dual-parameter histograms that allows the isolation of cell subsets. The 
process consists in the selection of regions of interest, “gates”, where a specified set of scatter 
properties is set to identify fluorescence signals from a desired group of particles only (57-61). 
Flow cytometry rapidly provide quantitative and qualitative measurements from multiple 
fluorochrome stains (either for intracellular or surface components) along with several intrinsic 
measurements of particle characteristics. Physical and/or chemical characteristics can be 
determined, like differentiation of cell types, the presence of membrane receptors and antigens, 
membrane potential, pH, enzyme activity, and DNA content. Thus, heterogeneous populations of 
cells can be visualized in a single dot plot, and morphologically or immunologically different 
subpopulations can be resolved (57-61). 
Flow cytometry is advantageous because allows the analysis of an extremely large number 
of particles in a very short time (up to thousands of particles per second); makes individual 
measurements for each particle on the suspension, rather than bulk measurements of an average 
property for the entire population; and allows simultaneous and multiparametric measurements, 
capacity to collecting 5–20 parameters on each particle. Flow cytometry analysis is a powerful tool 
that has many applications in basic research and clinical practice/diagnostics, like blood cells 
analysis, identification and count of microorganisms (57-61). 
In this work, flow cytometry was used for the evaluation of cytokine expression after cell 
stimulation with glycated and glycoxidized PE. Intracellular staining for specific cytokines requires 
blocking the protein secretion pathway, cell fixation and permeabilization before the mAbs labeling 
process. 
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 Identification of the Oxidation Products of Glycated PEs 
INTRODUCTION 
 
Phosphatidylethanolamines glycation is reaction between PE free amino group present at 
polar head and glucose. PE glycation was found to occur in vivo under hyperglycemia conditions 
and to be associated to oxidative stress. Thus the occurrence of glycated 
phosphatidylethanolamines could increase oxidative stress modifications and be related to diabetic 
complications. However, the fate of glycated phosphatidylethanolamines under oxidative stress is 
unknown and the role of glycated PE in increasing oxidation of other molecules, is not clearly 
understood. 
The work presented in this chapter aimed to study the glycated phosphatidylethanolamines 
oxidation using a Fenton system and MS analytical technique. First were demonstrated the 
oxidation products formed from glycated PE analyzed and then the radical intermediaries formed 
under oxidation conditions were studied with spin trap experiments. 
The results demonstrated, for the first time, the oxidation products of glycated 
phosphatidylethanolamines and allowed the identification of new oxidation sites located at glycated 
polar head. The structural characterization of glycated PE oxidation products and particularly the 
oxidation products of glycated polar head contributed to better understand of glycation and 
oxidation interrelation. Furthermore, glycated polar head oxidation products were found to be 
formed earlier than the ones that occur at unsaturated acyl chains, thus contributing to the 
exponential increase of oxidative stress and oxidative modifications that are known to occur under 
hyperglycemic conditions. 
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 Biological effects of the Oxidation Products of Glycated PEs 
INTRODUCTION 
 
PE glycation was found to occur in vivo under hyperglycemic conditions and has been 
associated to increased oxidative stress. In turn, oxidative stress and oxidative modifications of PL 
(mainly PC) have been related with inflammatory processes and both pro-inflammatory and anti-
inflammatory effects have been attributed to them. Besides protein glycation and advanced 
glycated end products (AGEs) of proteins are known to interfere with vessel wall homeostasis and 
contribute to a chronic inflammatory state in diabetes. However, the role of glycated, glycoxidized 
and oxidized phosphatidylethanolamines in the inflammatory responses had never been previously 
studied. 
In this work, we aimed to study the influence of glycated, glycoxidized and oxidized 
phosphatidylethanolamines in the stimulation of antigen presenting cells, specifically monocytes 
and myeloid dendritic cells. To do so, peripheral blood was incubated with three different modified 
PEs, with different propensity to oxidation. Cell stimulation was evaluated using flow cytometry, 
after incubation and labeling with monoclonal antibodies directed to different cytokines (IL-1β, IL-6, 
IL-8, MIP-1β and TNF-α), and to cellular antigens (CD 33 HLA-DR, CD14, CD19, CD56 and CD3). 
Monocytes and dendritic cells were indentified and the expression of each cytokine under study 
was evaluated by frequency of cytokine-expressing cells and mean fluorescence intensity. 
The results demonstrated, for the first time that glycated, glycoxidized and oxidized 
phosphatidylethanolamines produced an increase of the levels of cells expressing cytokines in 
comparison to the basal state. However, that increase was lower than the one obtained with LPS 
stimulus (positive control). In general, the results showed that oxidative modifications produced 
lower levels of cytokine-expressing cells when compared to the respective non-oxidized 
compounds (OxPE < PE and GluOxPE < GluPE). Additionally, the glycated compounds showed 
higher levels of cytokine-expressing cells when compared with non-glycated compounds (GluPE > 
PE and GluOxPE > OxPE). No variations were found the mean fluorescence intensity. 
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ABSTRACT 
 
Lipid glycation is a non-enzymatic reaction between glucose and the free amino group of 
aminophospholipids, particularly in chronic hyperglycemia. Glycated phosphatidylethanolamine 
have been found in plasma and atherosclerotic plaques of diabetic patients and was correlated with 
increased oxidative and inflammatory stress in diabetes. However, the biological roles of glycated 
lipids are not fully understood. In this study, we evaluated the effect of palmitoyl-oleolyl-
phosphatidylethanolamine (POPE) oxidation, glycation and glycoxidation products on monocyte 
and myeloid dendritic cell stimulation. Flow cytometry analysis was used to evaluate the capability 
of each modified PE to induce the expression of different cytokines (IL-1β, IL-6, IL-8, MIP-1β and 
TNF-α) in monocytes or myeloid dendritic cells (mDC). Our results showed that PE modifications 
induced different effect on the stimulation of cells producing cytokines. All PE modifications induced 
higher frequencies of cytokine producing cells than basal state. Higher stimulation levels were 
obtained with glycated POPE, followed by glycoxidized POPE. In contrast, oxidized POPE 
negatively regulated the frequency of monocytes and mDC producing cytokines, when compared 
with non-modified POPE. In conclusion, we verified that PE glycation, compared with oxidation and 
glycation plus oxidation, had higher ability to stimulate monocytes and mDC. Thus detection of 
increased levels of PE glycation in diabetes could be considered a predictor of an inflammatory 
state. 
 
KEYWORDS: phosphatidylethanolamine; glycation, oxidation; phospholipids, glycoxidation, 
cytokines, flow cytometry, inflammation and diabetes. 
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INTRODUCTION 
 
Glycation is a well-known non enzymatic reaction between glucose (or other reducing 
sugars) and free amino groups of biomolecules, and is particularly relevant in diabetic patients with 
chronic hyperglycemia. Glycation of proteins and the effect of protein glycation in the development 
of diabetic complications have been thoroughly studied, but not the lipid glycation. Protein glycation 
and advanced glycated end products (AGEs) of proteins have pro-atherogenic action, interfering 
with vessel wall homeostasis and contributing to a chronic inflammation state that occurs in 
diabetes (1). Protein glycation has also been associated with angiopathy and the development of 
atherosclerosis, renal, eye and neurological diseases (2). Aminophospholipids, such as 
phosphatidylethanolamines and phosphatidylserines, have a free amino group in the phospholipid 
polar head group that can participate in glycation reactions. In fact, glycated 
phosphatidylethanolamines (GluPEs) were detected in vivo, in plasma and red blood cells of 
diabetic patients and in plasma of rats treated with streptozotocin, having a positive correlation with 
glycated hemoglobin (3-6). Glycated PE are major LDL lipid glycation products, and were 
associated with atherosclerotic complications of diabetic patients with associated hyperglycemia, 
as a result of an increase in lipid peroxidation (6). GluPEs were found to be more easily oxidized 
than non glycated PE, and were associated with an increase of ROS production, enhancing lipid 
peroxidation and cross-oxidative modification of other molecules (7). It was also suggested that 
GluPEs could have a role in angiogenesis, atherosclerosis, inflammation and other diabetic 
complications (6, 8). Glycation of PE induced major alterations on the polar head group (9), 
increasing the size of the polar group and the polarity. These changes in the molecular structure 
may be responsible for distinct molecular properties and biological effects (10, 11). 
Oxidation reactions are also responsible for structural changes in PEs. Oxidation of PE 
was studied using mass spectrometry (MS), in vivo and in vitro systems (12). This study showed 
the presence of oxidative modification in unsaturated fatty acyl chains similar to the oxidation of 
phosphatidylcholine (OxPC) (10). Some studies reported that phospholipid oxidation products 
accumulate in tissues and atherosclerotic plaques mediating inflammation and immune response 
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(13-15). Different effects in inflammation have been described for oxidized phospholipids, varying 
from pro-inflammatory and anti-inflammatory effects or modulation of adaptive immunity, as 
reviewed by Bochkov et al. (10). The pro-inflammatory effects of oxidized phosphatidylcholines 
(OxPC) were attributed to promotion of monocyte binding to endothelial cells, through induction of 
expression of various adhesion molecules in endothelial cells, and also induction of growth factors 
and cytokines (10, 16). Anti-inflammatory effects OxPCs were attributed to different mechanisms, 
like induction of drug metabolism phase II genes and activation of antioxidant enzymes (10, 16). 
Furthermore, OxPLs could also disturb the endothelial barrier function, by increasing endothelial 
permeability or promoting endothelial protection (10, 16). The biological activity of oxidized 
phospholipids was proposed to be dependent on the nature of the sn-2 fatty acyl chain, thus not 
depending on the sn-3 fatty acyl chain or the phospholipid class (14, 17). However, there is not 
enough evidence to support this claim. Also, oxidation of glycated PE induces the simultaneous 
oxidation of the glucose moiety, the fatty acyl chains and the glycated polar head with formation of 
distinct polar head moieties (9) but the biological significance of these products were not evaluated. 
The limited number of studies is not enough to guaranty that this proposal is applicable to all the 
products formed during oxidation of the distinct phospholipids, bearing some of them so distinct 
structural properties. Still, many biological effects of glycated phospholipids and derived 
glycoxidized PE remain uncertain and their biological role is not fully understood. 
The objectives of this research were to determine whether glycation and oxidation of PE 
can be associated with a pro-inflammatory effect that could be associated to diabetic inflammatory 
state that underlies progression of diabetic complications. To do so, we evaluated the ability of 
native palmitoyl-oleoyl-phosphatidylethanolamine (POPE), oxidized POPE, glycated POPE and 
glycoxidized PE products to stimulate peripheral blood monocytes and myeloid dendritic cells. For 
that purpose, expression of cytokines IL-1β, IL-6, IL-8, MIP-1β and TNF-α were determined by flow 
cytometry. Oxidized POPE, glycated POPE and glycoxidized POPE were also characterized using 
electrospray mass spectrometry. 
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EXPERIMENTAL 
 
Chemicals 
The 2-oleoyl-1-palmitoyl-sn-glycero-3-phosphatidylethanolamine (POPE) was purchased 
from Sigma-Aldrich (Madrid, Spain). FeCl2 and H2O2 (30%, w/v) used for the peroxidation reaction 
were acquired from Merck (Darmstadt, Germany). The water was of MilliQ purity filtered through a 
0.22-µm filter (Millipore, USA), and all solvents used were HPLC grade. For stimulation of 
monocytes and dendritic cells RPMI-1640 medium was purchased from Gibco; Paisley, Scotland, 
UK, Brefeldin-A and lipopolysaccharide (LPS) from Escherichia coli (serotype 055:B5) from Sigma, 
St. Louis, MO and interferon-γ (IFN-γ) from Promega, Madison, WI. Monoclonal antibodies: anti-
HLA-DR—peridin chlorophyll protein (PerCPcy 5.5) (clone L243), anti-CD33—allophycocyanin 
(APC) (clone P67.6), anti-interleukin (IL)-1β (clone AS10), anti-IL-8 (clone AS14A) were purchased 
from BDB, San Jose, CA, USA; anti-IL-6 (clone MQ2- 6A3), MIP-1β (clone D21-1351) and anti-
tumour necrosis factor (TNF)-α (clone Mab11) were purchased from BD Pharmingen, San Diego, 
CA, USA and Dendritic Cell Exclusion Kit—flourescein isothiocyanate (FITC) was purchased from 
Cytognos, Salamanca, Spain. Phosphate-buffered saline (PBS) was purchased from Dulbecco 1x, 
Biochrom AG, Berlin, Germany and permeabilization kit, INTRACELL was purchased from 
Immunostep, Salamanca, Spain. 
 
Preparation of Glycated PE 
POPE was glycated in a methanol/water solution with a final concentration of 3 µM for 
POPE and 0.5 mM of glucose, reacting in boiling water during 30 minutes, according with a 
previous optimized procedure (9). Then, the glycated POPE was extracted from the reaction 
mixture using a modified Folch method (18), and the organic phases were collected. Glycated 
POPE was then purified by HPLC, on a Waters Alliance HPLC system (Model 2690, Milford, USA) 
using a C4 column (25 cm x 4.6 mm, 7 µm) (Jones Chromatography, Llanbradach, UK). The 
mobile phase A consisted of 97.5% water and 2.5% acetonitrile with 0.1% (v/v) of formic acid. The 
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mobile phase B consisted of acetonitrile with formic acid (0.1%, v/v). 10µL of diluted (1:8 (v/v), in 
75% methanol) glycation mixture was introduced into column and the solvent gradient was 
programmed as follows: gradient started with 55% of B and held isocratically for 5 minutes before 
increased to 70% of B during 15 minutes, followed by other linear increase to 100% B over 10 
minutes, and then returned to initial conditions (55% of B) during 10 minutes. Glycated POPE 
eluted from 16.0 to 16.7 minutes and POPE eluted from 19.3 to 20.1 minutes. The collected 
fractions were dried and oxidized under the following conditions. 
 
Preparation of Oxidation Mixtures 
The phospholipid vesicles (non-glycated POPE and glycated POPE) were prepared from 
stock solutions of 1 mg/mL dried under nitrogen stream. Ammonium bicarbonate buffer (5 mM, pH 
7.4) was added to give final concentration of 50 mM of phospholipid and the mixture was vortexed 
(19). Oxidation was initiated by adding FeCl2 to final concentration of 0.5mM and H2O2 to a final 
concentration of 50mM. Non-oxidized POPE and glycated POPE were performed using water 
instead of hydrogen peroxide. The mixture was incubated at 37°C in the dark for 5 days, after that 
the compounds were extracted using a modification of the Folch method (18) with chloroform-
methanol (2:1, v/v) and re-suspended in same volume of PBS. Phospholipid vesicles were 
prepared by the addition of PBS to phospholipids and glycated phospholipid extracts. The mixtures 
were shaken mechanically on a vortex mixer for 10 min and then sonicated for 1 minute in a 
sonicator. 
 
Mass Spectrometry 
ESI mass spectra were acquired on a Waters (Micromass) Q-TOF2 (Manchester, U.K.) 
equipped with a Z-spray ESI source and on a linear ion trap LXQ (ThermoFinnigan, San Jose, CA, 
USA) mass spectrometers. Q-TOF2 conditions in positive mode were as follow: flow rate, 10 
µL.min-1; cone voltage, 30 V; capillary voltage, 3 kV, source temperature, 80ºC; desolvation 
temperature, 150ºC, resolution was set to about 9,000 (FWHM). Tandem mass spectra (MS/MS) 
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were acquired by collision-induced decomposition (CID), using argon as the collision gas 
(measured pressure in the Penning gauge ~ 6x10-5 mBar). The collision energy ranged from 20 to 
30 eV. Data acquisition was carried out with a MassLynx 4.0 data system. The LXQ conditions in 
negative mode were as follows: electrospray voltage was - 4.7 kV; capillary temperature was 275 
ºC and the sheath gas flow was 8 U. Normalized collision energyTM (CE) was varied between 17 
and 20 (arbitrary units) for MS/MS. Data acquisition was carried out on a Xcalibur data system 
(V2.0). 
 
Samples 
A total of 10 peripheral blood (PB) samples were collected from healthy adult subjects. The 
mean age of the healthy individuals whose peripheral blood was used to monocyte and mDC 
cultures were 29+/- 7 years. From these individuals, 4 (40%) were males and 6 (60%) were 
females. Informed consent, according to local ethics committee, was obtained from all individuals 
enrolled in this study. All PB samples were collected in heparin as anticoagulant and immediately 
processed for the analysis of cytokine production. 
 
In vitro Stimulation of Cytokine Production by mDCs and Monocytes 
For better results, we stimulated monocytes and myeloid dendritic cells (mDC) in separated 
cultures. For stimulation of mDCs, we diluted 500 µl of PB sample 1/1 (vol/vol), in RPMI-1640 
medium, supplemented with 2 mM L-glutamine. Additionally, we added 100 ng/ml of 
lipopolysaccharide (LPS) plus 100 U/ml of interferon-γ to one tube to stimulate the cells (positive 
control), in other tube we added 20 µg of POPE plus 100 U/ml of IFN-γ, while the other tube was 
incubated without stimulation and used as negative control. To the study of cytokine production, we 
added 10 µg/ml of Brefeldin-A to all tubes to prevent the release of cytokines outside the cells. In 
all cases, incubation was performed at 37°C in a 5% CO2 humid atmosphere, in a sterile 
environment for 6h. 
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The protocol for monocyte stimulation was the same as mDC stimulation, but in the case of 
monocytes without the addition of IFN-γ. 
 
Flow Cytometric Analysis of Intracytoplasmic Cytokine Production 
Immediately after the incubation period, all samples were distributed in different tubes (200 
µl/tube) in order to analyze the expression of each cytokine under study, by monocytes and mDCs 
subset. 
In order to identify mDC subset, a 10 µl of Dendritic Cell Exclusion Kit combined with 10 µl 
of HLA-DR-PerCPcy 5.5 and 5 µl of CD33-APC were added to each tube. After gentle mixing, cells 
were sequentially incubated for 10 min at room temperature, in the darkness and washed once in 
with 2 ml of PBS (5 min at 540x g). After discarding the supernatant, cells were fixed and 
permeabilized with INTRACELL, according to manufacturer’s instructions and stained with PE-
conjugated mAb directed against different human intracytoplasmic cytokines: IL-1β (10 µl), IL-6 (10 
µl), IL-8 (10 µl), MIP-1β (1.5 µl) and TNF-α (1.5 µl). Each anti-cytokine mAb reagent was placed in 
a separate tube containing either the stimulated or the unstimulated sample. The tubes were 
incubated for 10 min at room temperature in the darkness. Then, cells were washed twice with 2 ml 
of PBS (5 min at 540x g) and resuspended in 250 µl of PBS. In monocytes cultures, 10 µl of anti-
HLA-DR-PerCP, 5 µl of anti-CD33-APC and the cytokines reported before were added to each 
tube. In this case, the Dendritic Cell Exclusion Kit was not added to the sample. Incubation and 
washing steps were the same preformed for mDC. 
 
Flow Cytometry Data Acquisition and Analysis 
Data acquisition for mDC was performed in two consecutive steps in a FACSCalibur flow 
cytometer (BDB, San Jose, USA) equipped with an argon ion laser and a red diode laser. In a first 
step, 2 x104 events, corresponding to all nucleated cells present in the sample, were collected and 
information on them stored. In a second step, information was stored exclusively for those cells 
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included in a live gate containing HLA-DR+ events, in a minimum of 2x105 events. For data 
acquisition and analysis, the CellQuest (BDB, San Jose, USA) and INFINICYT (Cytognos, 
Salamanca, Spain) software programs were used. 
mDCs were identified by the combined expression of CD33bright and HLA-DRbright and 
absence of CD14, CD19, CD56 and CD3 with intermediate forward (FSC) and side scatter (SSC) 
between those of lymphocytes and monocytes. 
For monocytes cultures, the data acquisition was performed in one step in a FACSCalibur 
flow cytometer (BDB, San Jose, USA). For this, 5 x105 events, corresponding to all nucleated cells 
present in the sample, were collected and information on them stored. We identified monocytes as 
expressing CD14, CD33 and HLA-DR and by their FSC and SSC characteristics. 
 
Statistical Methods 
Mean values and their standard deviations, as well as median values and range, were 
calculated for each variable under study by using the SPSS software program (SPSS 17.0, 
Chicago, USA). The statistical significance of the differences observed between groups was 
assessed using the nonparametric Mann-Whitney U test. P values< 0.05 were considered to be 
associated with statistically significant differences between groups. 
 
RESULTS 
 
The capability of phosphatidylethanolamine oxidation, glycation and glycoxidation products 
to enhance cytokine production was evaluated using POPE. Although POPE is not the most 
abundant PE specie in plasma, the glycated POPE was already detected in plasma and in 
atherosclerotic plaques from diabetic patients (4, 6). Glycated POPE (previously synthesized and 
purified) and native POPE were oxidized by the hydroxyl radical under Fenton conditions to obtain 
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OxPOPE and GluOxPOPE, respectively, that were characterized by electrospray mass 
spectrometry (ESI-MS and ESI-MS/MS). 
 
Characterization of POPE and glycated POPE oxidation products by MS 
Oxidation products of POPE and GluPOPE formed in the presence of hydroxyl radical 
generated by Fenton reaction conditions were characterized by ESI-MS and MS/MS. Oxidation of 
other PE and glycated PE species induced by the hydroxyl radical were already studied using 
mass spectrometry in our lab (9, 20), and by other groups, utilizing different methods for induce 
oxidation (21, 22). POPE (m/z 718.5) oxidation leaded to the formation of long chain oxidation 
products, namely keto (m/z 732.5), hydroxy (m/z 734.5), keto-hydroxy (m/z 748.5), dihydroxy and 
peroxy (m/z 750.5) derivatives, with modifications localized on carbons 8, 9, 10 and 11, of sn-2 acyl 
chain. It were not detected short chain products, due to cleavage of long chain sn-2 oxidation 
products, similar to what was observed previously for oxidized 2-oleoyl-1-palmitoyl-sn-glycero-3-
phosphatidylcholine (POPC) (23). Table 1 summarizes the oxidation products of POPE identified 
by MS and MS/MS. Oxidation of GluPOPE led to the formation of different oxidation products. 
Glycated long chain products obtained from oxidation of GluPOPE (m/z 880.5) were products with 
keto (m/z 894.5), hydroxy (m/z 896.5), dihydroxy (m/z 912.5) and peroxy (m/z 912.5) derivatives in 
sn-2 acyl chain, as summarized in Table 1. Additionally, oxidation products of POPE (m/z 732.5, 
734.5 and 750.5) were also formed, due to oxidative cleavage of GluPOPE with loss of glucose, as 
observed previously in GluPLPE oxidation (9). Furthermore, the negative ion mass spectra allowed 
to identify oxidation products formed due to oxidative modification in glucose moiety present in the 
glycated polar head. The ions at m/z 906.5, identified as glycated POPE+2O-4Da, suggested the 
formation of two keto-groups in glycated ethanolamine (which corresponds to m/z 880.5 observed 
in di-palmitoyl-phosphatidylethanolamine, dPPE). The ion at m/z 744.5, was identified as product 
with a polar head group –OCH2CH2NHCOH (formed due to oxidative cleavage of glucose, similarly 
to the ion m/z 718.5 observed previously in dPPE) (9). The structures of the oxidation products are 
represented in the Scheme 1. 
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TABLE 1 – POPE oxidation products and GluPOPE oxidation products found in positive ion mode, and their modifications 
on sn-2 acyl chain. 
Ion (m/z) 
Retention 
time 
(minutes) 
Modification Modified Carbon 
Indicative 
Fragments 
(m/z) 
Structure 
Reference 
732.5 
(718.5+14) 26 Keto-derivative 
C-8 
C-9 
C-10 
C-11 
453.4 
467.4 
481.4, 169.1 
183.2 
(20) 
734.5 
(718.5+16) 27 
Hydroxy-
derivative 
C-9 
C-10 
467.4 
451.4 
748.5 
(718.5+30) 25 
Hydroxy-Keto-
derivative 
C-9 
C-10 
C-11 
467.5 
479.5 
465.5 
750.5 
(718.5+32) 
 
23 di-Hydroxy-derivative 
C-8 
C-9 
C-10 
453.4 
467.5 
481.5 
25 Peroxy-derivative 
C-8 
C-9 
C-10 
453.4 
467.5 
481.5 
894.5 
(880.5+14) 25 Keto-derivative 
C-8 
C-9 
C-10 
C-11 
453.4 
467.4 
481.4 
183.2 
896.5 
(880.5+16) 26 
Hydroxy-
derivative 
C-9 
C-10 
467.4 
451.4 
912.5 
(880.5+32) 
23 di-Hydroxy-derivative 
C-8 
C-9 
C-10 
455.4 
467.5 
481.5 
25 Peroxy-derivative 
C-8 
C-9 
C-10 
453.4 
467.5 
481.5 
 
The non-modified POPE, glycated POPE, oxidized POPE (with insertion of oxygen 
molecules in sn-2 acyl chain) and glycoxidized POPE (with insertion of oxygen molecules in sn-2 
acyl chain and/or oxidation of in glycated polar head) were evaluated for their effects on cytokine 
production in cells of the immune system. Glycated POPE was modified in the polar head group, 
oxidized POPE contained oxidative modifications in the unsaturated fatty acyl chain of sn-2 
position, while glycoxidized POPE had oxidative modifications in polar head group and in the fatty 
acyl chain.  
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SCHEME 1 – Structures of the oxidation products formed from POPE and GluPOPE oxidation. The oxidation products 
formed by Sn-2 oxidation were the same for POPE and GluPOPE, and were formed by insertion oxygen molecules (+ 14 
Da, + 16 Da, + 30 Da, or + 32 Da). In such products, X represents –(CH2)2NH2 or –(CH2)2NC6H12O5 if they are formed from 
oxidation of POPE or GluPOPE, respectively. The oxidation of GluPOPE also yields products with modifications in polar 
head. 
 
Cytokine produced by monocytes and mDC 
The capability of native POPE and modified POPE (GluPOPE, OxPOPE and GluOxPOPE) 
to induce the production of different cytokines by peripheral blood monocytes and myeloid dendritic 
cells (mDCs) were studied. The frequencies of cytokine-producing cells (monocytes or mDC), as 
well as the total amount of cytokines produced per cell, expressed as mean fluorescent intensity 
(MFI), were evaluated in this study, in attempt to establish the relation between PE oxidation and/or 
glycation and the level of activation of antigen-presenting cells, specifically monocytes and myeloid 
dendritic cells. 
First of all, we tested different conditions of stimulation with POPE (different POPE quantity 
in the presence and absence of recombinant IFN-γ) in order to obtain a maximum of cells 
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producing cytokines. Different amounts of POPE were tested (10, 20, 30, 40 and 50 µg), and the 
best results were obtained with 20 µg of POPE. IFN-γ was only added to stimulate mDCs, since 
monocytes did not need IFN-γ to respond to lipid stimulation. 
After procedure optimization, we studied the production of IL-1β, IL-6, IL-8, MIP-1β and 
TNF-α by monocytes and mDC at basal level (negative control), and upon stimulation with LPS for 
monocytes and LPS plus IFN-γ for mDC (positive control), with non-modified POPE, GluPOPE, 
OxPOPE and GluOxPOPE. The results of stimulation with non-modified POPE were first compared 
with positive and negative controls. Subsequently, the results obtained from the stimulation with the 
different modified POPE were compared with each other, in order to determinate the modification 
that induced a higher effect on stimulation of these cells, and thus on cytokine production. 
For all studied cytokines, we found a significant increase in the frequencies of monocytes 
and mDC expressing cytokines after stimulation with POPE compared with negative control 
(p<0.05; Table 2; Figure 1). This means that POPE stimulated both cell populations, increasing the 
frequency of cytokine producing cells. POPE stimulation did not affect the amount of each cytokine 
produced per cell, given by the mean fluorescent intensity (MFI), for cytokines IL-1β, IL-6 and IL-8, 
while the amount of TNF-α and MIP-1β per monocytes (not per mDC), tended to be higher than 
those observed in negative control (Table 2). These results showed that the stimulation with POPE 
induced an increase in the percentage of monocytes and DC producing cytokines, but did not 
affect, significantly, the amount of cytokines per cell, in both cell types, when compared to the 
negative control. Native POPE induced cells to produce cytokines; however, this stimulus was 
lower than the one obtained with LPS, reflecting either lower number of cells producing cytokines 
and lower amounts of cytokines produced per cell. 
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TABLE 2 – Frequency of cytokine producing monocyte and mDC and amount of each cytokine per cell (MFI), after LPS 
plus IFN-γ (positive control); after POPE plus IFN-γ stimulation in the case of mDC cultures; after POPE stimulation in 
monocytes cultures and without stimulation (negative control). 
 
 
Monocyte mDC 
 
 
% MFI % MFI 
TNF-α 
Control 5.7 ± 2.5 68 ± 53 6.6 ± 4.1 22 ± 8 
LPS 83.3 ± 14.9 275 ± 172 82.1 ± 19.4 56 ± 52 
POPE 21.6 ± 5.3e 197 ± 113 23.8 ± 3.2e 20 ± 4 
MIP-1β 
Control 12.7 ± 4.8 194 ± 133 8.3 ± 6.2 33 ± 14 
LPS 90.0 ± 10.8 294 ± 196 88.3 ± 20.3 98 ± 56 
POPE 37.9 ± 4.4e 353 ± 91 40.0 ± 11.0e 29 ± 9 
IL-6 
Control 6.2 ± 3.7 23 ± 8 7.1 ± 4.4 16 ± 5 
LPS 88.1 ± 13.0 50 ± 13 81.7 ± 9.4 43 ± 22 
POPE 22.2 ± 14.7e 24 ± 5 21.0 ± 7.3e 13 ± 3 
IL-8 
Control 6.8 ± 3.1 22 ± 6 5.7 ± 2.9 16 ± 5 
LPS 83.6 ± 16.7 39 ± 19 89.5 ± 9.5 32 ± 17 
POPE 21.1 ± 6.7e 25 ± 5 15.3 ± 2.5e 16 ± 5 
IL-1β 
Control 8.6 ± 3.7 22 ± 6 4.5 ± 2.1 17 ± 4 
LPS 88.2 ± 15.6 49 ± 16 87.0 ± 8.2 33 ± 11 
POPE 31.7 ± 6.4e 24 ± 4 17.6 ± 8.8e 17 ± 6 
Results are expressed as mean ± standard deviation. %, percentage of positive cells; MFI, mean fluorescence intensity of 
positive cells. Statistically significant differences were considered when p<0.05 (Mann–Whitney U test). [e POPE versus 
Negative Control]. 
 
Stimulation with PE modifications 
After the evidence that POPE was able to stimulate the production of cytokines, the next 
step was to determine the effects of OxPOPE, GluPOPE and GluOxPOPE on cytokine production 
(IL-1β, IL-6, IL-8, MIP-1β and TNF-α) by monocytes and mDC. The dot-plots with levels of TNF-α 
obtained with different POPE stimulation are present in figure 2. 
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FIGURE 1 – Frequency of cytokine producing monocyte and mDC after stimulation with LPS (positive control), POPE, 
GluPOPE, OxPOPE, GluOxPOPE and without stimulation (negative control). In mDC cultures the stimulation with POPE 
and their glycation and/or oxidation products were carried out in the presence of IFN-γ. Statistically significant differences 
were considered when p<0.05 (Mann–Whitney U test). [a POPE versus Negative Control] [b POPE versus GluPOPE] [c 
POPE versus OxPOPE] [d POPE versus GluOxPOPE] [e GluOxPOPE versus GluPOPE] [f GluOxPOPE versus OxPOPE]. 
 
After stimulation with OxPOPE (compared with POPE) we observed a statistically 
significant decrease in the frequency of monocytes producing TNFα, MIP-1β and IL-1β and in the 
frequency of mDC producing TNF-α and MIP-1β (p<0.05; Table 3; Figure 1). Despite the decrease 
in the percentage of cells producing cytokines after stimulation with OxPOPE (compared with 
POPE), the amount of cytokines at single cell level revealed no statistically significant differences 
(Table 3). 
When monocytes and mDC were stimulated with GluPOPE, the frequency of cells that 
produce cytokines was increased, when compared to stimulation with POPE. The observed 
increase was statistically significant for TNF-α, MIP-1β and IL-8 in monocytes and for TNF-α, IL-6, 
IL-8 and IL-1β in mDC (p<0.05; Table 3; Figure 1). However, the amount of cytokines produced per 
cell (MFI) was not altered. Thus, GluPOPE positively regulated the frequency of monocytes and 
mDC producing cytokines, although the amount of cytokines produced per cell tend to be similar 
with those obtained with POPE. 
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TABLE 3 – Frequency of cytokine producing monocyte and mDC, and amount of each cytokine per cell (MFI), following 
POPE, GluPOPE, OxPOPE, GluOxPOPE stimulation. In mDC cultures the stimulation with POPE and their glycation and/or 
oxidation products were carried out in the presence of IFN-γ. 
  
Monocyte mDC 
  
% MFI % MFI 
TNF-α 
POPE 21.6 ± 5.3 197 ± 113 23.8 ± 3.2 20 ± 4 
GluPOPE 35.5 ± 4.8b 170 ± 128 44.6 ± 10.2b 19 ± 5 
OxPOPE 14.4 ± 3.8a,d 188 ± 49 14.6 ± 3.3a,d 23 ± 1 
GluOxPOPE 24.6 ± 4.3e 225 ± 64e 25.5 ± 6.8e 20 ± 7 
MIP-1β 
POPE 37.9 ± 4.4 353 ± 91 40.0 ± 11.0 29 ± 9 
GluPOPE 50.0 ± 3.6b 352 ± 67 53.0 ± 27.9 37 ± 8 
OxPOPE 28.7 ± 3.6a,d 412 ± 80d 25.7 ± 6.7a 42 ± 14 
GluOxPOPE 37.6 ± 5.2e 395 ± 114e 31.4 ± 1.1c 36 ± 13 
IL-6 
POPE 22.2 ± 14.7 24 ± 5 21.0 ± 7.3 13 ± 3 
GluPOPE 29.1 ± 13.2 35 ± 18 40.2 ± 6.0b 12 ± 4 
OxPOPE 17.8 ± 2.7 d 26 ± 8d 17.2 ± 5.1d 14 ± 6 
GluOxPOPE 22.3 ± 5.2e 28 ± 7 27.8 ± 5.5e 14 ± 4 
IL-8 
POPE 21.1 ± 6.7 25 ± 5 15.3 ± 2.5 16 ± 5 
GluPOPE 38.9 ± 14.8b 27 ± 12 32.0 ± 10.9b 15 ± 5 
OxPOPE 22.8 ± 13.8 26 ± 8 14.6 ± 2.6d 20 ± 6 
GluOxPOPE 27.7 ± 15.9 27 ± 9 21.2 ± 2.5c 15 ± 5 
IL-1β 
POPE 31.7 ± 6.4 24 ± 4 17.6 ± 8.8 17 ± 6 
GluPOPE 38.6 ± 5.0 32 ± 8b 38.4 ± 10.8b 16 ± 7 
OxPOPE 15.5 ± 3.3a,d 29 ± 8 17.7 ± 3.6d 19 ± 7 
GluOxPOPE 19.8 ± 3.9c, e 27 ± 6 23.3 ± 4.6e 17 ± 10 
Results are expressed as mean ± standard deviation. %, percentage of positive cells; MFI, mean fluorescence intensity of 
positive cells. Statistically significant differences were considered when p<0.05 (Mann–Whitney U test). [a POPE versus 
OxPOPE] [b POPE versus GluPOPE] [c POPE versus GluOxPOPE] [d GluOxPOPE versus OxPOPE] [e GluOxPOPE 
versus GluPOPE]. 
 
The GluOxPOPE (oxidized GluPOPE), induced a lower cell stimulation in comparison with 
GluPOPE, and similar, for the majority of the studied cytokines, to those stimulation obtained with 
OxPOPE related to POPE. The lower frequency of cells producing cytokines after GluOxPOPE 
stimulation (in comparison with GluPOPE) was observed for almost all studied cytokines in both 
monocytes and mDC, reaching statistical significance for IL-1β, IL-6, TNF-α and MIP-1β in 
monocytes (p<0.05; Table 3; Figure 1). However, the amount of cytokines produced (MFI) per 
mDC was not altered and per monocytes we only observed a significant increase in the amount of 
TNF-α and MIP-1β (p<0.05) when compared with GluPOPE. 
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Regarding GluOxPOPE stimulation, in relation to OxPOPE activation, the GluOxPOPE 
presented higher cell stimulation, with a higher frequency of monocytes/mDC producing cytokines, 
in the same way of results from GluPOPE stimulation compared with POPE stimulation. This 
difference is statistically significant in monocytes for MIP-1β, IL-6, IL-1β and TNF-α, and in mDC for 
all cytokines with exception of MIP-1β (p<0.05; Table 3; Figure 1).  
 
 
FIGURE 2 – Expression of TNF-α in monocyte and mDC after stimulation with LPS (positive control), POPE, GluPOPE, 
OxPOPE, GluOxPOPE and without stimulation (negative control). 
 
In summary, our results demonstrated that glycation and/or oxidation of PE produced 
different effects on monocyte and mDC stimulation. Furthermore their effect on the frequency of 
monocytes/mDC producing cytokines was not necessary the same on the amount of cytokine 
produce per monocytes/mDC. In fact, although the amount of cytokine per cell was, in most cases, 
did not change, the total of cytokines production was enhanced due to the increase number of cell 
that produce cytokines. 
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DISCUSSION 
 
Previous studies reported elevated plasma levels of some of the cytokines studied, IL-6 
(24-27), IL-8 (28, 29) and TNF-α (24, 25), in diabetic patients with associated hyperglycemia. IL-1β 
and MIP-1β were not reported to be increased in diabetic patients, but it is probable that they would 
be also increased in inflammatory conditions with associated hyperglycemia. In fact IL-1β, together 
with TNF-α and IL-6, are pro-inflammatory cytokines that are involved in mediating acute 
inflammatory responses (30). In addition, MIP-1β, like IL-8, is a chemotactic cytokine, involved in 
acute and chronic inflammatory responses mainly by recruiting pro-inflammatory cells (monocytes, 
dendritic, NK and T cells) (30, 31). 
Hyperglycemia is usually associated with an increase of glycation levels of proteins and 
lipids (aminophospholipids) and is also associated with an increase of oxidative status of cells and 
plasma, concomitant with an increase of plasma levels of cytokines (IL-6 and TNF-α) (25). In the 
present work we aimed to evaluate if distinct modifications of PE structure, derived from 
hyperglycemia, could have influence on monocyte stimulation, and so, be related to elevated 
plasma levels of cytokines in diabetic patients. 
In this study, the monocytes and mDCs were stimulated directly by addition of free 
phospholipids to blood and cytokine production was evaluated by flow cytometry. In the majority of 
cases, the amount of cytokine produced per cell was not changed, but an increase in the number of 
cell that produce cytokines leads to an unregulated cytokine production. In fact, Pickup et al. 
hypothesized before that the increased serum levels of cytokines in diabetic patients was not due 
to circulating cells but most probably to endothelial cells or adipocytes (32). Our results, 
demonstrate that monocytes and dendritic cells respond to stimulation with PE and PE 
modifications, but do not alter their cytokine production per cell. We observed that oxidized 
compounds induce lower stimulation of monocytes and mDCs when compared with non-modified 
PE (OxPOPE < POPE and GluOxPOPE < GluPOPE) and the opposite was expected, since 
oxidized lipid are, in general considered pro-inflammatory agents. Previous studies on the effect of 
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oxidized phospholipids either using endothelial cells or low density lipoprotein (LDL), revealed that 
oxidized phospholipids activate the endothelium binding of monocytes and macrophage 
proliferation (13, 33-35). Endothelial cells treated with OxPAPC presented different protein 
phosphorylation levels, including high levels of β1-integrin phosphorylation (among others), a 
protein that is known to be involved in monocyte binding to endothelial cells (36). These findings 
suggested that OxPAPC modulate endothelial cell migration and barrier function (36). In this study, 
phospholipids were added directly to blood, thus the stimulation was not mediated by LDL or 
endothelial cells, and that probably leaded to lower stimulation of monocytes and mDCs. So we 
could suppose that endothelial cells play an important role on monocyte stimulation induced by 
oxidized phospholipids and without them, the effects of oxidized phospholipids, were not so 
prominent. On the other side, GluPOPE showed higher effects on mDCs/monocytes, revealing that 
profound alterations on PE structure, attributable to glycation, could induce cell stimulation. In fact, 
previous studies with AGE-LDL demonstrated an increased inflammatory state due to irreversible 
glycation products, with increasing of IL-6, TNF-α and monocyte chemoattractant protein-1 (MCP-
1) production (37-40). Although these studies used AGE-LDL without knowing whose specific 
compounds were responsible for the production of the elevated inflammatory levels. Since LDL 
have both proteins and lipids, and both of them can undergo glycation and oxidation, it seems 
reasonable to separate both lipidic and proteic fractions of LDL to evaluate their effects. Regarding 
that, Sonoki et al. correlated the lyso-phosphatidylcholine (formed by oxidation of PC) content in 
LDL with MCP-1 mRNA expression in human umbilical vein endothelial cells (HUVEC) (41). 
Besides the studies with AGE-LDL, studies with AGE-albumin revealed induction of expression of 
VEGF, MCP-1, TNF-α, IL-8, IL-1β, MIP-1β, macrophage-colony stimulating factor (M-CSF) and 
expression of tissue factor in macrophages due to different AGE-albumin (42-49) and also 
induction of DCs maturation, which enlarge their capacity to stimulate T-cell (50). To our knowledge 
no studies were done with glycated phospholipids. Here we stimulated mDCs/monocytes with free 
GluPE and we demonstrated that glycated phospholipids alone can induce stimulation of cells. So 
we supposed that PE glycation is the major feature, above other structural modifications of 
phospholipids, involved in increasing the inflammatory state. 
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Overall for both cell populations, it was observed that after stimulation with non-modified 
POPE and modified POPE, there were a higher percentage of cells producing cytokines due to 
stimulation with glycated compounds (either oxidized or not), in comparison to the correspondent 
(oxidized or non-oxidized) non-glycated compounds. Interestingly oxidized compounds (glycated 
and non-glycated) had lower effect on cell stimulation than the correspondent non-oxidized 
compounds. However, these effects were not accompanied by the same results in the amount of 
cytokine produced per cell that are not affected. Even so, it was possible to infer that PE glycation 
increase the stimulation of circulating monocytes and mDC and this increase in the stimulation of 
cells appear to be impaired by oxidation of glycated PE.  
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ABSTRACT 
 
Glycation of phosphatidylethanolamine (PE) is a reaction that is known to occur under the 
chronic hyperglycemic conditions found in diabetic patients. Glycated phosphatidylethanolamines 
were found in plasma and atherosclerotic plaques of diabetic patients, and its presence was 
correlated with increased oxidative stress. Oxidative stress can also promote the formation of new 
glycoxidized PE species. Although it is recognized that glycated proteins have a role in the onset of 
inflammation and diabetes related diseases. Moreover, upregulation of cytokines and other 
inflammatory mediators can be observed not only in diabetes, but also under oxidized 
phosphatidylcholine stimulation. In this study, we evaluated the effect of dipalmitoyl-
phosphatidylethanolamine (DPPE) and lineolyl-palmitoyl-phosphatidylethanolamine (PLPE) 
structural oxidation (OxPE), glycation (GluPE) and glycoxidation (GluOxPE), on monocyte and 
myeloid dendritic cell (mDC) stimulation. Expression of cytokines, IL-1β, IL-6, IL-8, MIP-1β and 
TNF-α, were determined, using flow cytometry after stimulation of monocytes and myeloid dendritic 
cells with native PEs, oxidized PEs, glycated PEs and glycoxidized PEs. Native PE, PLPE and 
DPPE, and all modified PEs were able to increase the stimulation levels of monocytes and mDCs 
in relation to basal state. Variations in stimulation levels induced by the different PE modifications 
were observed in the frequency of cytokine-producing cells, but not in the amount of cytokine 
produced per cell. Generally, in monocytes and mDCs stimulation, GluOxPLPE and GluDPPE were 
the PLPE/DPPE modifications that induced the most pronounced increase in cytokine production. 
However the GluOxDPPE was the DPPE modification that produced the lowest stimulation levels 
of mDCs and monocytes. Our results indicate that glycated PE and glycoxidized PE may have an 
important role in contributing to the low-grade systemic inflammation associated with diabetes and 
to the development of diabetic complications. 
 
KEYWORDS: phospholipids, glycoxidation, glycation, oxidation, flow cytometry, atherosclerosis, 
diabetes, inflammation.  
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INTRODUCTION 
 
Phosphatidylethanolamine (PE) is the second most abundant phospholipid class in 
mammalian cell membranes and lipoproteins (1). Modifications in PE structure can have 
deleterious effects on the properties of cellular membranes, altering their function and conditioning 
cell homeostasis. PE can be modified in consequence of oxidation in the unsaturated fatty acyl 
chains and/ or due to glycation in the polar head group, particularly in hyperglycemia (2, 3). PE 
oxidation products (4-7) and glycated PE (8-11) were found in vivo in retina, in plasma and 
erythrocytes, and have been associated with retinopathy (7), blood coagulation (12) and diabetic 
complications, such as atherosclerosis (3). In general, the oxidation of other phospholipids has 
been associated with other pathophysiological conditions, including inflammation (2, 4, 13). 
Nevertheless, the biological effects in inflammation and immune response of modified PE, namely 
oxidized PE, glycated PE and glycoxidized PE were not been comprehensively studied. 
It is well known that oxidized lipids are important signaling molecules in inflammation and 
immune response and can play distinct biological roles, depending on their specific structure (4). 
Oxidized phosphatidylcholines, and particularly oxidized 2-arachidonoyl-1-palmitoyl-sn-glycero-3-
phosphatidylcholine (oxPAPC), have been the most intensely studied oxidized phospholipids. So 
far, oxPAPC is recognized to induce distinct inflammatory effects, ranging from anti-inflammatory to 
pro-inflammatory properties, effects on blood coagulation, on endothelial barrier and angiogenic 
activity, as recently reviewed (4). The oxidized phospholipids are recognized by innate and 
adaptive immune system through antibodies (IgG and IgM) directed to oxidized LDL, binding to 
scavenger receptors (like CD36) and to C-reactive protein, leading to activation of various 
intracellular signaling mechanisms. Pro-inflammatory effects of oxidized phospholipids include the 
ability to stimulate the production of chemokines, activation of adhesion molecules and adhesion of 
monocytes to endothelial cells. Those are important mechanisms involved in foam cell formation 
and development of atherosclerotic lesions, in which oxPAPC can play a role (4). 
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Immunological changes, including altered levels of specific cytokines, as well as changes 
in the number and activation state of different leukocyte populations and increased cell apoptosis, 
were also found in diabetes mellitus (14-16). The upregulation of cytokines and other inflammatory 
mediators, observed during diabetes, leads to persistent low-grade inflammation and endothelial 
dysfunction that ultimately leads to diabetic vascular complications, including atherosclerosis (14, 
17, 18). However, the mediators involved in the inflammation processes and their role in the 
development of diabetic microvascular diseases is still unclear (17, 18). Additionally, it is well 
known that oxidative stress is enhanced under chronic hyperglycemia conditions like those found in 
diabetes mellitus. Glycated PE increases oxidative stress and promote oxidation of other 
biomolecules (11, 19). Also, the oxidation of glycated PE species generates advanced glycated 
end products (AGES) (20, 21) and other oxidation products (22). Lipid AGEs and lipid oxidation 
was found to be increased in low density lipoprotein (LDL) of diabetic patients (23) and AGEs-PE 
species were detected in erythrocytes and plasma of diabetic patients (24). This suggests that the 
presence of oxidized, glycated and/or glycoxidized PE could have an active role in the upregulation 
of cytokines and in the development of the inflammatory status associated with diabetes. 
In this study, we analyzed the potential of oxidized PE, glycated PE and glycoxidized PE to 
stimulate peripheral blood monocytes and dendritic cells. Two PE species, bearing different sn-2 
fatty acyl chains, namely 2-linoleoyl-1-palmitoyl-phosphatidylethanolamine (PLPE) and 1,2-
dipalmitoyl-phosphatidylethanolamine (DPPE) were used. PLPE is susceptible to oxidation in acyl 
chain, but in contrary, DPPE is not, because contains two saturated fatty acids. These PE were 
selected to evaluate the oxidative modifications of acyl chain and polar head group in the 
stimulation of monocytes and dendritic cells. Expression of various cytokines was determined by 
flow cytometry after stimulation of the immune cells with native PE, oxidized PE, glycated PE and 
glycoxidized PE. 
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EXPERIMENTAL 
 
Chemicals 
2-linoleoyl-1-palmitoyl-sn-glycero-3-phosphatidylethanolamine (PLPE) and 1,2-dipalmitoyl-
sn-glycero-3-phosphatidylethanolamine (DPPE), were purchased from Sigma-Aldrich (Madrid, 
Spain). FeCl2 and H2O2 (30%, w/v) used for the peroxidation reaction were acquired from Merck 
(Darmstadt, Germany). The water was of MilliQ purity filtered through a 0.22-µm filter (Millipore, 
USA), and all solvents used were HPLC grade. For cell stimulation, RPMI-1640 medium was 
purchased from Gibco (Paisley, Scotland, UK) Brefeldin-A and lipopolysaccharide (LPS) from 
Escherichia coli (serotype 055:B5) from Sigma (St. Louis, MO, USA) and interferon-γ (IFN-γ) from 
Promega (Madison, WI, USA). The conjugated monoclonal antibodies: anti-HLA-DR peridin 
chlorophyll protein (PerCPcy 5.5) (clone L243), anti-CD33 allophycocyanin (APC) (clone P67.6), 
anti-interleukin (IL)-1β phycoerythin (PE) (clone AS10) and anti-IL-8 PE (clone AS14A) were 
purchased from BDB (San Jose, CA, USA); anti-IL-6 PE (clone MQ2- 6A3), macrophage 
inflammatory protein (MIP)-1β PE (clone D21-1351) and anti-tumor necrosis factor (TNF)-α PE 
(clone Mab11) was purchased from BD Pharmingen (San Diego, CA, USA) and Dendritic Cell 
Exclusion Kit flourescein isothiocyanate (FITC) were purchased from Cytognos (Salamanca, 
Spain). Phosphate-buffered saline (PBS) was purchased from Dulbecco 1x, Biochrom AG (Berlin, 
Germany) and permeabilization kit, INTRACELL, was purchased from Immunostep (Salamanca, 
Spain). 
 
Preparation of Glycated PE and Oxidation Mixtures 
Phospholipids (PLPE and DPPE) (final concentration of 3 µM) were glycated in a 
methanol/water solution supplemented with glucose (0.5 mM), during 30 minutes in boiling water. 
Then, glycated PE was extracted from the reaction mixture using a modified Folch method (25), 
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and purified by HPLC as reported before (22). The glycated and non-glycated fractions were 
collected, dried and oxidized under the following conditions: 
The phospholipid vesicles (non-glycated PE and glycated PE) were prepared from stock 
solutions of 1 mg/mL dried under nitrogen stream. Ammonium bicarbonate buffer (5 mM, pH 7.4) 
was added to 50 mM of phospholipid and the mixture was vortexed (26). Oxidation was initiated by 
adding FeCl2 to final concentration of 0.5 mM and H2O2 to a final concentration of 50mM. Non-
oxidized PE and glycated PE were prepared the same way but using water instead of hydrogen 
peroxide. The mixture was incubated at 37°C in the dark for 5 days, after that the compounds were 
extracted using a modification of the Folch method (25) with chloroform-methanol (2:1, v/v) and re-
suspended in same volume of PBS. Phospholipid vesicles were prepared by the addition of PBS to 
dried phospholipids and glycated phospholipid extracts and vortexed for 10 minutes. 
 
Reactions of glycation and oxidation were controlled by ESI mass spectra, acquired on a 
Waters (Micromass, Manchester, UK) Q-TOF2 (Micromass, Manchester, UK) equipped with a Z-
spray ESI source and/or on a linear ion trap LXQ (ThermoFinnigan, San Jose, CA, USA) mass 
spectrometers. 
 
Samples 
A total of 10 peripheral blood (PB) samples from healthy adult subjects (4 males and 6 
females) were analyzed. Informed consent, according to local ethics committee, was obtained from 
all individuals enrolled in this study. Monocytes and myeloid dendritic cells (mDC) were stimulated 
in separated cultures. 5 samples were utilized for monocyte stimulation (mean age: 29+/- 7 years), 
and the other 5 samples were utilized for mDC cultures (mean age: 26+/- 2 years). All PB samples 
were collected in heparin as anticoagulant and immediately processed as follow. 
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In vitro Stimulation of Cytokine Production by mDCs and Monocytes 
Stimulation of monocytes and mDCs were performed in PB samples that were previously 
diluted 1:1 (vol/vol) in RPMI 1640 complete culture medium, supplemented with 2 mM L-glutamine. 
To prevent the cellular release of cytokines, Brefeldin-A (10 µg/ml) was added to all tubes. 
Phospholipids mixtures (20 µg) were added alone (monocyte stimulation) or in combination with 
100 U/ml of IFN-γ (mDC stimulation) to the respective tube. Positive control was performed by 
addition of LPS (100 ng/ml) alone (monocyte stimulation) or in combination with 100 U/ml of IFN-γ 
(mDC stimulation); and the negative control was performed in the absence of both LPS and IFN-γ. 
All samples were then incubated in a sterile environment and 5% CO2 humid atmosphere, at 37°C 
during 6 hours. 
The phospholipid mixtures tested for cell stimulation were native PLPE, native DPPE, 
oxidized PLPE, oxidized DPPE, glycated PLPE, glycated DPPE, glycoxidized PLPE and 
glycoxidized DPPE. 
 
Flow Cytometric Analysis of Intracytoplasmic Cytokine Production 
After incubation, all samples (phospholipid stimulations, positive and negative controls) 
were distributed in different tubes (200 µl diluted PB/tube) and stained with monoclonal antibodies, 
in order to analyze the expression of the different cytokines under study. For that purpose, 10 µl of 
HLA-DR-PerCPcy 5.5 and 5 µl of CD33-APC were added to each tube. In case of mDC subset, 10 
µl of Dendritic Cell Exclusion Kit were additionally added. Cells were sequentially incubated for 10 
min at room temperature, in the darkness, washed once with 2 ml of PBS (5 min at 540x g) and the 
supernatant was discarded. Then cells were fixed and permeabilized with INTRACELL according to 
manufacturer’s instructions and stained with PE-conjugated mAb directed against different human 
intracytoplasmatic cytokines: IL-1β (10 µl), IL-6 (10 µl), IL-8 (10 µl), MIP-1β (1.5 µl) and TNF-α (1.5 
µl). Each anti-cytokine mAb was placed in a different tube containing either the stimulated or the 
unstimulated sample. The samples were incubated for 10 min at room temperature in the darkness, 
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washed twice with 2 ml of PBS (5 min at 540x g) and resuspended in 250 µl of PBS for flow 
cytometry acquisition. 
 
Flow Cytometry Data Acquisition and Analysis 
Data acquisition was performed in a FACSCalibur flow cytometer (BDB, San Jose, USA) 
equipped with an argon ion laser and a red diode laser, and was different for mDC and monocyte 
samples. Data from mDC samples were acquired in two consecutive steps. First, information of all 
nucleated cells (2x104 events), was collected and stored. Secondly, information of HLA-DR+ events 
(minimum of 2x105 events) was collected in a live gate and stored. The software programs used for 
data acquisition and analysis were, respectively, the CellQuest (BDB, San Jose, USA) and 
INFINICYT (Cytognos, Salamanca, Spain). mDCs were identified by the combined expression of 
CD33 and HLA-DR and absence of CD14, CD19, CD56 and CD3 with intermediate forward (FSC) 
and side scatter (SSC) between those of lymphocytes and monocytes. Data from monocytes were 
acquired in one step, where all nucleated cells (5x105 events) present in the sample, were 
collected and information on them stored. Monocytes were identified through the expression CD33 
and HLA-DR and their FSC and SSC characteristics. 
 
Statistical Methods 
Mean values and standard deviations, as well as median values and range, were 
calculated for each variable under study by using the SPSS software program (SPSS 17.0, 
Chicago, USA). The statistical significance of the differences observed between groups was 
assessed using the nonparametric Mann-Whitney U test. p values < 0.05 were considered to be 
associated with statistically significant differences between groups. 
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RESULTS 
 
The oxidation products of DPPE, PLPE and the oxidation products of their glycated 
derivatives were identified recently using LC-MS and MS/MS (22, 27). It was found that DPPE is 
hardly oxidized due to the presence of two saturated fatty acyl chains, although some oxidation 
may occur at polar head group. In turn, PLPE oxidation was more extensive and the oxidation 
products formed were generally due to oxidation at linoleoyl sn-2 acyl chain. Furthermore, it was 
found that glycated derivatives originated more oxidized species than the non-glycated 
compounds, as result of oxidation of the glucose moiety and oxidative cleavage of glycated polar 
head group. Thus, oxidation of glycated PLPE, can yield oxidation products with modifications 
simultaneously at glycated polar head and at sn-2 unsaturated acyl chain (22, 27, 28). 
The capability of these native PE (DPPE and PLPE) and the correspondent modified PE: 
glycated PE (GluPE), oxidized PE (OxPE) and glycoxidized PE (GluOxPE), to induce the 
production of different cytokines (IL-1β, IL-6, IL-8, MIP-1β and TNF-α) in peripheral blood 
monocytes and mDCs were studied. The frequency of cytokine-producing cells (monocytes or 
mDC), as well as the total amount of cytokines produced per cell, expressed as mean fluorescence 
intensity (MFI), were determined for each condition. The differences induced in the activation of 
antigen-presenting cells due to fatty acyl composition/oxidation and/or glycation were also 
evaluated. 
 
Cytokine-producing monocytes and mDCs after stimulation with native PE (DPPE 
and PLPE) 
The conditions used for stimulation of monocytes and mDCs were optimized with non-
modified PLPE and DPPE. The parameters tested were the amount of PE and the presence or 
absence of IFN-γ. The amount of PLPE and DPPE that produced higher frequency of cytokine-
producing cells (monocytes and mDCs) was found to be 20 µg. For higher (30, 40 and 50 µg) and 
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lower (10 µg) amounts of PE, lower frequency of cytokine-producing cells (monocytes and mDCs) 
were obtained. The addition of IFN-γ was not needed to obtain a response of monocytes to PE 
stimulus, however mDCs did not respond to PE stimulation in the absence of IFN-γ, thus IFN-γ was 
added to all mDCs stimulating experiments. 
The percentage of cytokine-producing cells and the amount of cytokine produced per cell 
induced by PLPE and DPPE stimulation, in monocytes and mDC, were compared with basal 
production level (negative control) and LPS stimulus (positive control). Non-modified PLPE and 
DPPE were found to induce significant increase of the percentage of cells (monocytes and mDCs) 
that express the cytokines under study (IL-1β, IL-6, IL-8, MIP-1β and TNF-α) in comparison to 
negative control (p<0.05; Table 1). However those percentages were always lower than the ones 
obtained after LPS stimulation (positive control). With respect to the amount of cytokines produced 
per cell, given by mean fluorescent intensity (MFI), native PLPE and DPPE also induced higher 
values than negative control and lower than LPS stimulus, for all cytokines in study. Statistically 
significant increases were observed in TNF-α produced by monocytes and in IL-1β, IL-6, IL-8 
produced by mDCs after stimulation with DPPE and in MIP-1β produced by mDCs after stimulation 
with PLPE. Interestingly, for mDC, either the amount of all cytokines and the frequency of mDC 
expressing cytokines, tend to be higher upon stimulation with DPPE than with PLPE. 
 
TABLE 1 – Frequency of cytokine-producing monocytes and mDC, and amount of cytokine produced per cell (MFI), without 
stimulus (negative control) and after stimulation with LPS (positive control), DPPE and PLPE. mDC cultures were carried out 
in the presence of IFN-γ, while the monocyte cultures were preformed without IFN-γ. 
  
Monocyte mDC 
  
% positive cells MFI % positive cells MFI 
TNF-α 
Control 5.7 ± 2.5 68 ± 53 6.6 ± 4.1 22 ± 8 
LPS 83.3 ± 14.9 275 ± 172 82.1 ± 19.4 56 ± 52 
DPPE 57.1 ± 24.6a 193 ± 116a 53.9 ± 19.8a 21 ± 4 
PLPE 60.1 ± 6.6b 101 ± 79 19.6 ± 9.0b 17 ± 4 
MIP-1β 
Control 12.7 ± 4.8 194 ± 133 8.3 ± 6.2 33 ± 14 
LPS 90.0 ± 10.8 294 ± 196 88.3 ± 20.3 98 ± 56 
DPPE 61.6 ± 36.4a 163 ± 88 47.5 ± 19.9a 39 ± 23 
PLPE 64.3 ± 30.3b 141 ± 93 23.2 ± 8.9b 55 ± 34b 
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IL-6 
Control 6.2 ± 3.7 23 ± 8 7.1 ± 4.4 16 ± 5 
LPS 88.1 ± 13.0 50 ± 13 81.7 ± 9.4 43 ± 22 
DPPE 59.1 ± 27.5a 36 ± 22 61.2 ± 17.1a 27 ± 7a 
PLPE 50.1 ± 27.8b 31 ± 19 22.5 ± 12.2b 16 ± 3 
IL-8 
Control 6.8 ± 3.1 22 ± 6 5.7 ± 2.9 16 ± 5 
LPS 83.6 ± 16.7 39 ± 19 89.5 ± 9.5 32 ± 17 
DPPE 71.4 ± 20.8a 28 ± 16 64.2 ± 23.7a 25 ± 8a 
PLPE 37.9 ± 24.2b 26 ± 14 22.5 ± 10.7b 19 ± 5 
IL-1β 
Control 8.6 ± 3.7 22 ± 6 4.5 ± 2.1 17 ± 4 
LPS 88.2 ± 15.6 49 ± 16 87.0 ± 8.2 33 ± 11 
DPPE 56.3 ± 39.8a 32 ± 20 33.2 ± 21.0a 25 ± 4a 
PLPE 61.7 ± 26.8b 28 ± 12 16.2 ± 3.5b 17 ± 1 
Results are expressed as mean ± standard deviation. MFI, mean fluorescence intensity of positive cells. Statistically 
significant differences were considered when p < 0.05 (Mann–Whitney U test). [a DPPE versus Negative Control] [b PLPE 
versus Negative Control]. 
 
Cytokine-producing monocytes and mDC after stimulation with modified PE 
Knowing that PLPE and DPPE are able to stimulate monocytes and mDCs, the next goal 
was to evaluate how the modifications of PE (oxidation, glycation and glycoxidation) affect cytokine 
production (IL-1β, IL-6, IL-8, MIP-1β and TNF-α) in monocytes and mDC. It was found that all of 
those PE modifications were able to induce an increased frequency of cells producing cytokines 
relative to the negative control (Tables 2 and 3 and Figures 1 and 2). However variations in the 
stimulation levels were dependent on the PE modification, cell type and/or cytokine considered. 
Stimulation with oxidized PE (OxDPPE and OxPLPE) 
Stimulation of monocytes with oxidized DPPE (OxDPPE) showed frequencies of cells 
expressing cytokines similar to non-modified DPPE stimulation, probably due to the very low 
oxidation of this PE (Table 2 and Figure 1). Oxidized PLPE was found to decrease the frequency of 
monocytes expressing all cytokines when compared with native PLPE. This decrease in the 
frequency of monocytes producing cytokines treated with OxPLPE was statistically significant for 
IL-1β and TNF-α (p < 0.05). However, the frequency of monocytes expressing cytokines was 
 | 134 
 
 Phosphatidylethanolamines Glycoxidation: Products and Significance 
higher under OxPLPE stimulation than in the basal state. The number of cytokines produced per 
monocyte (MFI) upon OxDPPE/OxPLPE stimulation, when compared with DPPE/PLPE stimulation, 
was almost identical (Tables 2 and 3). 
 
TABLE 2 – Frequency of cytokine producing monocyte and mDC and amount of each cytokine per cell (MFI), following 
DPPE, GluDPPE, OxDPPE, GluOxDPPE plus IFN-γ stimulation. 
  
Monocyte mDC 
  
% positive cells MFI % positive cells MFI 
TNF-α 
DPPE 57.1 ± 24.6 193 ± 116 53.9 ± 19.8 21 ± 4 
OxDPPE 58.1 ± 37.8 237 ± 133b 25.1 ± 3.2a 19 ± 6 
GluDPPE 60.6 ± 31.0 190 ± 35b 32.8 ± 14.6 18 ± 5 
GluOxDPPE 39.6 ± 36.4a 30 ± 14 24.1 ± 14.3a 17 ± 5 
MIP-1β 
DPPE 61.6 ± 36.4 163 ± 88 47.5 ± 19.9 39 ± 23 
OxDPPE 67.9 ± 33.4 123 ± 78 55.4 ± 8.0b 44 ± 21 
GluDPPE 69.5 ± 38.7 158 ± 84 68.2 ± 28.8b 34 ± 13 
GluOxDPPE 53.5 ± 29.2 115 ± 80 18.3 ± 5.3a 29 ± 12 
IL-6 
DPPE 59.1 ± 27.5 36 ± 22 61.2 ± 17.1 27 ± 7 
OxDPPE 61.4 ± 32.8 41 ± 24 44.3 ± 12.6b 20 ± 6 
GluDPPE 76.0 ± 14.9 40 ± 20 35.4 ± 9.6a,b 19 ± 6a 
GluOxDPPE 34.5 ± 20.8 28 ± 13 18.9 ± 7.1a 16 ± 6a 
IL-8 
DPPE 71.4 ± 20.8 28 ± 16 64.2 ± 23.7 25 ± 8 
OxDPPE 56.1 ± 31.1 26 ± 14 62.2 ± 19.3b 18 ± 4 
GluDPPE 68.5 ± 22.3b 23 ± 7 26.0 ± 8.2a 18 ± 4 
GluOxDPPE 50.6 ± 27.1 19 ± 5 22.8 ± 11.2a 16 ± 5a 
IL-1β 
DPPE 56.3 ± 39.8 32 ± 20 33.2 ± 21.0 25 ± 4 
OxDPPE 66.3 ± 29.0 27 ± 16 26.4 ± 10.2b 20 ± 6 
GluDPPE 61.9 ± 35.4 31 ± 17 53.4 ± 27.3b 21 ± 4 
GluOxDPPE 42.4 ± 37.3 32 ± 26 15.4 ± 9.8a 18 ± 5 
Results are expressed as mean ± standard deviation. MFI, mean fluorescence intensity of positive cells. Statistically 
significant differences were considered when p < 0.05 (Mann–Whitney U test). a shows statistical significance when 
compared with DPPE, and b statistical significance when compared with GluOxDPPE. 
 
Stimulation of mDCs with OxDPPE induced a significant decrease of the frequency of TNF-
α producing-cells related to stimulation with non-modified DPPE. Stimulation of mDCs with 
OxPLPE did not induce significant variations on the frequency of cytokine-producing cells when 
compared with non-modified PLPE. The number of cytokines produced per mDCs (MFI) upon 
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OxDPPE/OxPLPE stimulation, when compared with DPPE/PLPE stimulation, was almost the 
same, with exception of the MFI of TNF-α, that was increased under OxPLPE stimulation (Tables 2 
and 3). 
 
TABLE 3 – Frequency of cytokine producing monocyte and mDC and amount of each cytokine per cell (MFI), following 
PLPE, GluPLPE, OxPLPE, GluOxPLPE plus IFN-γ stimulation. 
  
Monocyte mDC 
  
% positive cells MFI % positive cells MFI 
TNF-α 
PLPE 60.1 ± 6.6 101 ± 79 19.6 ± 9.0 17 ± 4 
OxPLPE 20.5 ± 17.2a,b 54 ± 22 22.9 ± 12.6 20 ± 9a 
GluPLPE 37.9 ± 26.1 88 ± 42 20.5 ± 6.9 15 ± 2a 
GluOxPLPE 66.8 ± 17.6 103 ± 63 26.6 ± 8.8 16 ± 2 
MIP-1β 
PLPE 64.3 ± 30.3 141 ± 93 23.2 ± 8.9 55 ± 34 
OxPLPE 56.1 ± 25.9 101 ± 58b 32.2 ± 23.3 33 ± 9 
GluPLPE 52.7 ± 26.9 120 ± 83b 13.5 ± 6.4b 28 ± 9 
GluOxPLPE 61.7 ± 35.9 241 ± 56 24.2 ± 6.5a 30 ± 6 
IL-6 
PLPE 50.1 ± 27.8 31 ± 19 22.5 ± 12.2 16 ± 3 
OxPLPE 21.6 ± 10.1 25 ± 14 42.6 ± 34.7 15 ± 2 
GluPLPE 30.8 ± 17.1 40 ± 30 21.3 ± 5.4 14 ± 3 
GluOxPLPE 50.2 ± 34.3 37 ± 26 19.9 ± 11.5 16 ± 4 
IL-8 
PLPE 37.9 ± 24.2 26 ± 14 22.5 ± 10.7 19 ± 5 
OxPLPE 19.2 ± 9.9 21 ± 6 25.9 ± 16.3 15 ± 2 
GluPLPE 41.9 ± 27.5 49 ± 37 15.8 ± 5.2a 15 ± 3a 
GluOxPLPE 56.4 ± 34.6 32 ± 20 18.3 ± 5.2 17 ± 3 
IL-1β 
PLPE 61.7 ± 26.8 28 ± 12 16.2 ± 3.5 17 ± 1 
OxPLPE 18.1 ± 12.0a 23 ± 6 16.4 ± 8.5 16 ± 1 
GluPLPE 40.9 ± 10.1 34 ± 24 42.6 ± 35.9 17 ± 3 
GluOxPLPE 49.2 ± 37.5 32 ± 19 18.6 ± 4.7 16 ± 1 
Results are expressed as mean ± standard deviation. MFI, mean fluorescence intensity of positive cells. Statistically 
significant differences were considered when p < 0.05 (Mann–Whitney U test). a shows statistical significance when 
compared with DPPE, and b statistical significance when compared with GluOxDPPE. 
 
Stimulation with glycated PE (GluDPPE and GluPLPE) 
The effect of glycated PE on monocytes and mDCs stimulation levels was also evaluated, 
when compared with the effect of non-modified PE. In monocytes, GluDPPE and GluPLPE did not 
show any significant differences in the frequency of cells expressing cytokines. The number of 
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cytokines produced per monocyte (MFI) upon GluDPPE/GluPLPE stimulation, when compared with 
DPPE/PLPE stimulation, showed no significant variations (Tables 2 and 3). Besides GluDPPE and 
GluPLPE stimulation were similar to the DPPE/PLPE, they both induced higher frequency of 
monocytes expressing cytokines when compared with the basal state. 
In mDCs, both GluDPPE and GluPLPE induced a decrease of the frequency of cells 
expressing several cytokines in comparison with non-modified PE. The effects of GluPE in mDCs 
were more evident than on monocytes, and some statistically significant decreases were found in 
mDCs. The frequency of cells expressing IL-8 was significantly reduced upon stimulation with 
GluDPPE or GluPLPE. Also, the frequency of mDCs expressing IL-6 was significantly reduced, but 
only upon stimulation with GluDPPE. The amount of cytokines produced per cell (MFI) did not 
change significantly with exposition to glycated PE. However the MFI of TNF-α and IL-8 that was 
significantly reduced under GluPLPE stimulation and MFI of IL-6 that was significantly reduced 
under GluDPPE stimulation. 
Stimulation with glycoxidized PE (GluOxPLPE or GluOxDPPE) 
Glycoxidized PE (GluOxPLPE or GluOxDPPE) effects on cell stimulation, when compared 
to glycated PE (GluPE), are different upon GluOxDPPE and GluOxPLPE, either in monocytes and 
mDCs. GluOxDPPE significantly decreased the frequency of monocytes expressing IL-8 and the 
frequency of mDCs expressing MIP-1β, IL-6 and IL-1β. In opposition, GluOxPLPE significantly 
increased the frequency of mDCs expressing MIP-1β. Also, the MFI of TNF-α was significantly 
decreased in monocytes stimulated with GluOxDPPE, while the MFI of MIP-1β was significantly 
increased in monocytes stimulated with GluOxPLPE. 
Additionally Glycoxidized PE (GluOxPLPE or GluOxDPPE) effects on cell stimulation, 
when compared to oxidized PE (OxPE), are also different upon GluOxDPPE and GluOxPLPE. 
GluOxDPPE stimulation significantly reduced the frequency of mDCs expressing all cytokines in 
study, except TNF-α. While GluOxPLPE stimulation significantly increased the frequency of 
monocytes expressing TNF-α. Accordingly, the amount of TNF-α produced per monocyte, given by 
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MFI, was significantly reduced under GluOxDPPE and the amount of MIP-1β produced per 
monocyte, was significantly increased under GluOxPLPE. 
 
 
FIGURE 1 – Frequency of cytokine producing monocyte and mDC after stimulation with DPPE, GluDPPE, OxDPPE and 
GluOxDPPE. The mDC cultures were carried out in the presence of IFN-γ, while the monocyte cultures were performed 
without IFN-γ. Statistically significant differences were considered when p<0.05 (Mann–Whitney U test). [a DPPE versus 
OxDPPE] [b DPPE versus GluDPPE] [c DPPE versus GluOxDPPE] [d OxDPPE versus GluOxDPPE] [e GluOxDPPE versus 
GluDPPE]. 
 
 
FIGURE 2 – Frequency of cytokine producing monocyte and mDC after stimulation with PLPE, GluPLPE, OxPLPE and 
GluOxPLPE. The mDC cultures were carried out in the presence of IFN-γ, while the monocyte cultures were performed 
without IFN-γ. Statistically significant differences were considered when p<0.05 (Mann–Whitney U test). [a PLPE versus 
OxPLPE] [b PLPE versus GluPLPE] [c PLPE versus GluOxPLPE] [d OxPLPE versus GluOxPLPE] [e GluOxPLPE versus 
GluPLPE]. 
 
In summary, our results demonstrated that different oxidative modifications (oxidation on 
polar head or oxidation on acyl chains) and glycation had different effects on cell stimulation and 
affect differentially monocytes and mDCs. Both native and modified PE had the ability to stimulate 
peripheral blood monocytes and mDC, as they raised the percentage of cytokine producing cells, 
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though to a lesser extent than LPS did. However, the effect on the frequency of monocytes/mDC 
producing cytokines was not the same observed on the amount of cytokine produce per 
monocytes/mDC. Although the amount of cytokine per cell did not change in most cases, the total 
amount of cytokine produced was enhanced or reduced due to the variations in the frequency of 
cell producing cytokines. These results also showed that in monocytes and mDCs, GluDPPE, was 
the DPPE modification that showed a more pronounced effect in enhancing the expression of 
cytokines. Among the modifications of PLPE studied, the more pronounced effect was observed 
when using GluOxPLPE. In contrast, GluOxDPPE was the DPPE modification that showed a less 
pronounced effect in increasing the expression of cytokines, either in monocytes and mDCs. 
 
DISCUSSION 
 
The effects of PAPC oxidation products on inflammation have been characterized and 
shown to stimulate several cell types and various signal-transducing pathways, as reviewed 
elsewhere (4). IL-8 is the best documented cytokine known to be increased due to OxPL 
stimulation (4, 29-31). Also, it has been reported that in human derived macrophages TNF-α, IL-6 
and IL-1β production can be enhanced by oxidized PC (32, 33). In the present work, we aimed to 
evaluate the influence of different PE modifications (oxidation and glycation) on monocyte and 
mDCs stimulation. Particularly, the production of the pro-inflammatory cytokines, namely IL-1β, IL-
6, IL-8, MIP-1β and TNF-α, were studied. 
Our results showed that glycation and oxidative modifications of DPPE and PLPE had 
different effects on immune cells. Monocytes and mDCs responded differently to the same oxidized 
compounds, specifically in the case of PLPE. mDCs were more susceptible to PE stimulation, 
showing higher occurrence of statistically significant differences. Stimulation with glycated PE 
induced higher cell stimulation levels than with non-glycated compounds (GluDPPE > DPPE and 
GluOxPLPE > OxPLPE) similar to what was observed before with glycated POPE (34). However, 
oxidized compounds usually induced lower stimulation levels than the non-oxidized correspondent 
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compounds (OxDPPE < DPPE, GluOxDPPE < GluDPPE and OxPLPE < PLPE). Some exceptions 
were found, particularly when studying PLPE modifications, where GluPLPE and GluOxPLPE were 
respectively responsible for inducing the smallest and highest increase of monocytes and mDCs 
stimulation. 
When comparing non-modified compounds, DPPE was found to induce higher frequency of 
cell expressing cytokines than PLPE, probably because of the presence of saturated fatty acid in 
the sn-2 position, which is unusual in living systems. The saturated fatty acid in the sn-2 position is 
resistant to oxidation, so the oxidation in DPPE is minimal and only occurs in the polar head. One 
reason for the levels of monocyte stimulation with OxDPPE incubation were not reduced, when 
compared native DPPE. Interestingly, in mDCs, OxDPPE incubation decreased the frequency of 
cells expressing cytokines, when compared with the non-modified DPPE. In accordance to what 
was observed with OxPOPE (34) and OxPLPE incubations, when compared with the respective 
native PE, that reduced the cell stimulation. 
GluDPPE incubation increased the stimulation of monocytes when compared with DPPE 
incubation, as previously described for GluPOPE (34). However, GluDPPE decreased mDCs 
stimulation when compared with DPPE, the stimulation induced was the highest among all studied 
DPPE modifications. Additionally, GluPLPE decreased monocyte stimulation and mDCs stimulation 
when compared with native PLPE. The levels of monocytes and mDCs stimulation were also 
different upon incubation with GluOxDPPE and GluOxPLPE, when compared with GluDPPE and 
GluPLPE respectively. While GluOxDPPE was found to decrease monocytes and mDCs 
stimulation, GluOxPLPE was found to increase those cells stimulation. The decreased stimulation 
observed with GluOxDPPE incubation is in agreement with the previous findings when using 
GluPOPE stimulation (34). This behavior can be explained by the formation of oxidation products 
leading to the loss of glucose moiety and, consequently, to the reduction of the capability for cell 
stimulation. Still, the increase in monocyte and mDCs stimulation related to GluOxPLPE, can be 
due to the fact that glycated compounds produce higher amounts of oxidation products (22). In 
addition, GluOxPLPE can have oxidative modifications simultaneously in polar head and in the fatty 
acyl chain, which could be responsible for the enhanced cytokine production. This suggests that PL 
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which are difficult to be oxidized, as POPE and DPPE, or those with low oxidation levels, would 
produce lower stimulation levels of monocytes and mDCs. Whereas PL with higher oxidation 
levels, like those observed with GluPLPE would produce higher levels of monocytes and mDCs 
stimulation. 
It is interesting to note that, in mDCs, MIP-1β was the cytokine that was most affected upon 
stimulation with GluOxPE. Thus, MIP-1β production could be more affected upon glycoxidized PE 
stimulation than the other cytokines. MIP-1β is a chemotactic cytokine, involved in acute and 
chronic inflammatory responses mainly by recruiting pro-inflammatory cells (monocytes, dendritic, 
NK and T cells) (35). Also the expression of this cytokine in OxPAPC-stimulated murine arteries 
has been reported (36). We have also observed that mDCs stimulations with GluDPPE and 
GluPLPE enhanced the frequency of cells producing IL-1β. IL-1β is a pro-inflammatory cytokine 
and an important signaling molecule in the immune response. Increased IL-1β levels were 
associated with type 2 diabetes mellitus related inflammatory state (37). This cytokine has also an 
important role in chronic inflammation, increasing the expression of adhesion molecules and is also 
an angiogenic factor (38). 
The present results revealed that glycated PE and glycoxidized PE may have important 
inflammatory effect and may play a role in endothelial cell activation and monocyte adhesion, which 
are thought to be important in atheroma formation. 
 
CONCLUSION 
 
The results showed that native PE and all PE modifications studied in this work induced 
different levels of cell stimulation, but all to levels that were higher than basal state. Stimulation of 
monocytes with non-modified DPPE and modified DPPE leaded to a higher percentage of cells 
producing cytokines. The observed levels of induction could be ordered as follows: stimulation with 
glycated PE compounds > oxidized PE compounds > glycoxidized PE compounds. In mDCs, the 
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order of stimulation was non-modified DPPE > glycated > oxidized > glycoxidized compounds. 
After stimulation of monocytes with non-modified PLPE and modified PLPE the higher frequency of 
cells producing cytokines was observed when incubating cells with glycoxidized PLPE. Oxidized 
PLPE in monocyte stimulation and glycated PLPE in mDC stimulation were the found to have lower 
stimulation levels. These effects were not accompanied by the same results in the amount of 
cytokine produced per cell, which did not show major differences. The observations leaded to the 
hypothesis that cell stimulation is more responsive to modifications in PE polar head. Also, these 
results showed that that MIP-1β and IL-1β are the cytokines that are most affected by stimulation 
with glycated and glycoxidized compounds. 
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INTRODUCTION 
 
Diabetes mellitus (DM) is a common metabolic disease characterized by hyperglycemia. The 
hyperglycemia conditions observed in diabetes mellitus are associated with perturbations in lipid 
homeostasis and increased oxidative stress. Furthermore, hyperglycemia is also associated with 
PE and protein glycation that, in turn, is associated to increased inflammatory state and oxidative 
stress. Such disturbances of lipid structure and homeostasis together with increased oxidative 
stress affect membrane properties and could impair cellular functions. Also, the liver can suffer the 
deleterious effect of the hyperglycemia and liver disease can arise with the time course of DM. 
The present work aimed to evaluate changes in PE species of liver under uncontrolled 
hyperglycemia, found diabetic rats. The liver was chosen due to its involvement in glucose and lipid 
homeostasis. The livers from diabetic rats, streptozotocin-injected animals, were collected after 
four mouths of uncontrolled hyperglycemia and hepatic damage was confirmed by morphologic 
analysis of liver sections. The variations of phospholipid distribution between classes were 
determined using phosphorous assays and the variations in PL species were evaluated with HILIC 
LC-MS and LC-MS/MS. Variations in the fatty acids sterified into lipids were further confirmed by 
GC-FID. 
The results showed a variation in the relative amount of liver phospholipid classes in T1DM 
rats and a remodeling in PL fatty acyl chains, concomitant with signs of hepatic damage. The PE 
class was found to be increased in liver of T1DM rats. A remodeling of acyl chains were observed 
in PE and other classes, and consisted of a reduction in the amount of 16:0 and an increase of 
18:0 and 18:2 acyl chains. 
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HIGHLIGHTS 
• T1DM is associated with changes in liver lipid profile. 
• Relative contents of PC, LPC and SM decrease, while the other PL classes increase. 
• Remodeling of acyl chains comprises reduction of 16:0 and increase of 18:0 and 18:2. 
• PL changes can have significance in liver dysfunction as a diabetic complication. 
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ABSTRACT 
 
Background: Hepatic lipid homeostasis is known to be altered with diabetes mellitus, causing 
disturbances in cellular membrane properties, ultimately leading to liver damage and related 
complications. The present work aimed to evaluate changes in the liver phospholipid profile after 
four months of uncontrolled hyperglycemia. 
Methods: Twenty Wister rats were divided in two groups: the control group and streptozotocin 
(T1DM) treated group. After four months, animals from both groups were sacrificed and 
morphological characterization of liver alterations was performed and related with serum markers 
of hepatic damage. Total lipid extracts were obtained from liver and phospholipid (PL) classes were 
quantified. Lipid molecular species were determined by HILIC LC-MS and LC-MS/MS, and lipid 
fatty acids by GC-MS. 
Results: Concomitantly with signs of hepatic damage, we found a variation in the relative amount 
of liver phospholipid classes in T1DM rats, characterized by a decrease in all PL classes with 
choline head group, and by an increase in the relative content of other PL classes. A remodeling in 
PL fatty acyl chains was also observed in T1DM liver, with a similar pattern to all the PL classes. 
Remodeling of acyl chains consisted of a reduction in the amount of 16:0 and an increase of 18:0 
and 18:2 acyl chains. 
Conclusions: The observed changes in T1DM lipid content may contribute to altered membrane 
properties and changes in lipid signaling, which may impact the hepatic function, worsening the 
metabolic alterations that characterize the pathogenesis of type 1 diabetes mellitus. 
 
 
KEYWORDS: Phospholipids, fatty acid remodeling, type 1 diabetes mellitus, mass spectrometry, 
liquid chromatography. 
 
 | 151 
 
 Alterations of PE Species under Hyperglycemia 
INTRODUCTION 
 
Diabetes mellitus is a common metabolic disease characterized by hyperglycemia, due to 
insulin deficiency (type 1 Diabetes Mellitus, T1DM) or insulin resistance (type 2 Diabetes Mellitus, 
T2DM). Uncontrolled hyperglycemia is usually associated with the development of diabetic 
complications, increasing disease morbidity and mortality with significant impact on society and in 
economy (1, 2). Therefore, it is crucial to better understand the consequences of uncontrolled 
hyperglycemia to avoid and prevent the development of diabetes-related diseases. 
Recently, different studies highlighted that uncontrolled hyperglycemia can have a deleterious 
impact in liver homeostasis (3-5). In fact, DM is known to be associated with an increased risk of 
chronic liver disease, including non-alcoholic fatty liver disease (NAFLD) and hepatocellular 
carcinoma (6, 7). T2DM patients usually have high plasmatic levels of transaminases alanine 
aminotransferase (ALT) and aspartate aminotransferase (AST), which is also not an uncommon 
feature in T1DM (6, 8, 9). Elevation of plasma ALT (as well as of other liver enzymes) is a signal of 
liver damage that is usually associated with NAFLD risk factors and with other diabetic 
complications, like retinopathy and neuropathy (5-8). This increase of liver enzymes in the plasma 
is correlated with elevated glycated hemoglobin, triglycerides and total cholesterol, supporting the 
hypothesis that liver disease can occur with the time course of T1DM (8, 9). The DM-related liver 
late changes are characterized by an altered liver metabolites profile (fatty acyl CoAs, amino acids 
and acylcarnitines), increased formation of advanced glycation end products (AGEs) and reactive 
oxygen species, DNA fragmentation, increased expression of inflammatory markers, and apoptotic 
cell death (3, 10). 
In DM, insulin deficiency and hyperglycemia can disturb hepatic lipid homeostasis, causing 
abnormal lipid profile and, ultimately, diabetes-related complications. Furthermore, alterations in 
phospholipid profile could be responsible for disturbances in cellular membrane properties, such as 
regulation of membrane proteins and cellular transduction pathways, which can exacerbate the 
initial stimulus promoted by hyperglycemia. In fact, alterations in phospholipid profile due to STZ-
induced diabetes were already observed in heart tissue (11, 12) and in retina (13). Also, 
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disturbance of lipids was observed in several liver diseases, including non-alcoholic fatty liver, non-
alcoholic steatohepatitis (14), and alcoholic fatty liver diseases (15). Only few studies had focused 
on the lipid profile of diabetic liver, but some discrepancies were found on the results published so 
far. While some authors reported the increase of cholesterol, free fatty acids, triacylglycerols and 
phospholipid content in diabetic liver (16, 17) and liver microssomes (18, 19), others observed a 
decrease in such lipids (20). However, none of these studies reported the alterations of the 
phospholipid molecular species profile in T1DM liver. 
The present work aimed to evaluate the changes in the liver phospholipid profile of long 
term hyperglycemia induced by streptozotocin-administration in Wistar rats (a well characterized 
animal model of T1DM). Phospholipid classes and their molecular species composition were 
quantified and the lipid profile was determined by LC-MS and LC-MS/MS, using a lipidomic 
approach. Alterations induced by diabetes were pointed in terms of potential effects in hepatic 
function leading to hepatopathy. 
 
MATERIAL AND METHODS 
Chemicals 
Streptozotocin [N-(Methylnitrosocarbamoyl)-a-D-glucosamine] was obtained from Sigma 
Chemical Co. (St Louis, MO, USA), and prepared prior to use in 100 mM citrate, pH 4.5. 
Phospholipid internal standards (1',3'-bis[1,2-dimyristoyl-sn-glycero-3-phospho]-sn-glycerol (CL), 
1,2-dimyristoyl-sn-glycero-3-phosphocholine (dMPC), 1-nonadecanoyl-2-hydroxy-sn-glycero-3-
phosphocholine (LPC), 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (dMPE), 1,2-dimyristoyl-
sn-glycero-3-phosphate (dMPA), 1,2-dimyristoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (dMPG), 
1,2-dimyristoyl-sn-glycero-3-phospho-L-serine (dMPS) and 1,2-dipalmitoyl-sn-glycero-3-phospho-
(1'-myo-inositol) (dPPI)) were purchased to Avanti polar lipids, Inc (Alabaster, AL, USA). Malachite 
green and primuline were purchased from Sigma (St Louis, MO, USA), triethylamine and 
potassium hydroxide were purchased from Merck (Darmstadt, Germany) and perchloric acid from 
Panreac (Barcelona, Spain). Acetonitrile, chloroform, methanol and hexane from Fisher Scientific 
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(Leicestershire, UK) were of HPLC grade and were used without further purification. All other 
reagents and chemicals used were of highest grade of purity commercially available. The water 
was of MilliQ purity filtered through a 0.22-mm filter (Millipore, USA). 
Animals 
Male Wistar rats weighing 150 - 200 g at 6-8 weeks of age were used at this study (n=20). 
During the experimental protocol, the animals were housed in collective cages (4 rats per cage) in 
a room at normal environment (21–24 °C; ~50–60% humidity) receiving food and water ad libitum 
in 12 h light/dark cycles. Housing and experimental treatment were in accordance with Guide for 
the Care and Use of Laboratory Animals from the Institute for Laboratory Animal Research (21). 
The experimental procedures were complied with the current national laws and were approved by 
local Ethics Committee. 
Induction of Experimental Diabetes 
The animals were randomly divided into two groups (n=10 per group): type 1 diabetic group 
(T1DM) and control group (CONT). In T1DM, hyperglycemia was induced with a single 
intraperitoneal injection of streptozotocin (STZ; 60 mg/kg), after a 16-h fasting period. CONT 
animals were injected with citrate solution. Values of weight and blood glucose (from the tail vein 
with Glucocard (A. Menarini Diagnostics, Florence, Italy) were taken just before STZ administration 
and weekly until the end of the protocol. Animals were considered hyperglycemic when blood 
glucose exceeded 250 mg/dl. After 4 months, animals were with an anesthetic overdose 
(pentobarbital, 10 mg/100 g ip) and the liver was dissected out, divided in several portions for light 
microscopy and lipidomic analysis. Serum levels of transaminases, glucose, cholesterol and 
triglycerides were determined in duplicate on an AutoAnalyzer (PRESTIGE 24i, Cormay PZ). 
Glycated hemoglobin HbA1c was measured in whole blood samples using a commercial kit (code 
11045) from Biosystems (Biosystems Reagents and Instruments, Barcelona, Spain). 
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Light Microscopy 
After excision, several pieces (2-4 mm3) from each hepatic lobe were fixed in 4% 
formaldehyde, during 24 hours, dehydrated with graded ethanol and further included in paraffin 
blocks. Five µm thick sections were cut and individually collected to silane-prep slides. After 
deparaffinization with xylene, sections were rehydrated and stained with hematoxylin-eosin 
following standard procedures. Slides were observed with a light photomicroscope (Axio Imager 
A1, Carl Zeiss) and a qualitative analysis of tissue structure organization, including the sinusoidal 
dimensions, the hepatocyte morphology and arrangement, as well as the presence of necrotic 
areas or cellular infiltration was made. 
 
Lipidomic Analysis 
Phospholipid quantification by phosphorous assays 
Liver tissue was homogeneized in phosphate buffer saline (PBS) pH 7.4. Total lipids were 
then extracted by Folch method (22) using a chloroform:methanol (2:1, v/v) solution. After 
extraction, total phospholipids (PL) were calculated by colorimetric determination of phosphorus, 
after digestion with perchloric acid at 180°C, as described before (23). The amount of PL within 
each class was measured by the same method after thin layer chromatography (TLC) separation. 
Total phospholipid content from liver were normalized to protein amount (12). Protein concentration 
of liver homogenates were determined by the biuret method using bovine serum as standard (24). 
Separation of phospholipids classes by Thin Layer Chromatography 
TLC was used for separate PL classes present in the total lipid extract (approximately 60 
µg of total PL). Silica gel plates with a concentrating zone of 2.5x20cm (Merck, Darmstadt, 
Germany) were developed with chloroform/ethanol/water/triethylamine (35:30:7:35, v/v/v/v) (25) 
solvent mixture. Lipid spots were visualized with UV (λ=254 nm) after primuline spray and PL 
classes were identified by means of their Rf values. 
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Phospholipid quantification by 31P NMR spectroscopy 
Relative quantification of PC, PE and SM classes was also carried out by 31P NMR. 
Extracts were dissolved in a ternary mixture of chloroform:methanol:water (5:4:1), forming a single 
homogeneous phase. 31P NMR spectra were acquired on a Bruker Avance DRX-500 spectrometer 
(Bruker, Rheinstetten, Germany) operating at 202.5 MHz for 31P observation, using a 5-mm QNP 
probe. 31P NMR spectra were acquired at 298 K using a 1D sequence with proton decoupling 
(‘zgdc’ in Bruker library), by collecting 512 scans into 32768 data points, with a spectral width of 
5000 Hz and a relaxation delay of 4 s. The spectra were processed with a line broadening of 2.00 
Hz and a zero filling factor of 2, manually phased and baseline corrected. Chemical shifts were 
referenced to 85% H3PO4 external reference at 0.00 ppm. The assignment of resonances to 
different phospholipids was based on the 31P spectra registered for solutions of standard 
compounds. 
Phospholipid characterization by LC-MS 
Characterization of individual phospholipid within each class was achieved by mass 
spectrometry (MS) after separation by liquid chromatography (LC). HPLC system (Waters Alliance 
2690) were used with a Ascentis® Si column (15 cm × 1 mm, 3 µm) and a precolumn split (Acurate, 
LC Packings, USA) in order to obtain a flow rate of 20 µL.min-1. The solvent system consisted in two 
mobile phases as follows: mobile phase A (Acetonitrile:Methanol:H2O; 55:35:10 (v/v/v) with 1mM 
ammonium acetate) and mobile phase B (Acetonitrile:Methanol 60:40 (v/v) with 1mM ammonium 
acetate). Initially, 0% mobile phase A was held isocratically for 20 min followed by linear increase 
to 100% of A within 5 min and maintained for 40 min. Samples (10 µg of total phospholipid) were 
separated by HPLC, which was coupled to a linear ion trap (LXQ; ThermoFinnigan, San Jose, CA, 
USA) mass spectrometer. The LXQ were operated in both positive (electrospray voltage + 5 kV) 
and negative (electrospray voltage - 4.7 kV) with 275 ºC capillary temperature and the sheath gas 
flow of 8 U. Normalized collision energyTM (CE) varied between 20 and 27 (arbitrary units) for 
MS/MS. Data acquisition was carried out on the Xcalibur data system (V2.0). Relative 
quantification of individual phospholipid species were determined by the ratio between the area of 
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reconstructed ion chromatogram of a given m/z value against the area of the reconstructed ion 
chromatogram of the respective class. 
Fatty acid analysis by GC-FID 
Total fatty acyl substituents’ were measured by GC after transesterification of lipid liver 
extracts (approximately 200 µg of total PL). Fatty acids were prepared using a methanolic solution 
of potassium hydroxide (2M) according to the previously described method (26). DMPE 
phospholipid (50 µg) and C17 (7.5 µg) fatty methyl ester were used as internal standards. 2 µl of 
the hexane solution containing methylated fatty acids was submitted to GC analysis. The GC 
injection port was programmed at 523.15 K and the detector at 543.15 K. Oven temperature was 
programmed as follows: initially stayed 3 min at 323.15 K, raised to 453.15 K (25 K.min-1), held 
isothermal for 6 min, with a subsequent increase to 533.15 K (40 K.min-1) and maintained there for 
3 min, performing 19 min totally. The carrier gas was hydrogen flowing at 1.7 mL.min-1. The gas 
chromatograph (Clarus 400, PerkinElmer, Inc. USA) was equipped with DB-1 column with 30 m 
length, 0.25 mm internal diameter and 0.15 µm film thickness (J&W Scientific, Agilent 
Technologies, Folsom, CA, USA) and a flame ionization detector. 
Statistical Methods 
The results are presented as mean values and their standard deviations (mean ± SD) for 
each experimental group. The Kolmogorov–Smirnov test was used to test normality of distribution 
for all data. Since all variables were normal distributed, significant differences between groups 
were evaluated with the unpaired Student's t-test. Statistical Package for the Social Sciences 
(version 17.0; SPSS Inc, Chicago, IL, USA) was used for all analyses. P values <0.05 were 
considered to be statistically significant. 
 
RESULTS 
 
Streptozotocin-injected rats presented a significant body weight loss and a marked 
increase in blood glucose levels, which are signs of uncontrolled type 1 diabetes mellitus. 
Prolonged hyperglycemia, in this group, was confirmed by the significant increased levels of 
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hemoglobin A1c compared to the CONT group. During the experimental protocol, polyuria and 
polydipsia were noticed in STZ-injected rats, further supporting the diabetic condition. T1DM-
related hepatic damage was given by serum hepatic enzyme activities, with increased levels of 
serum ALT (alanine aminotransferase) and AST (aspartate aminotransferase), relatively to control 
group, with statistically significant differences noticed for ALT. The overall status of T1DM and 
CONT groups is summarized in Table 1. 
 
TABLE 4 – Characterization of animals’ response to STZ administration. Values are expressed as mean ± standard 
deviation. 
Experimental group CONT T1DM 
Body weight (g) 437.1 ± 58.4 251.0 ± 43.1# 
Glycemia (mg.dL-1) 66.3 ± 15.0 577.1 ± 234.0# 
HbA1c (% total Hb) 3.96 ± 0.80 6.28 ± 1.12# 
AST (U.L-1) 50.7 ± 5.8 66.0 ± 20.2 
ALT (U.L-1) 25.1 ± 4.8 65.9 ± 31.3‡ 
Cholesterol (mg.dL-1) 57.3 ± 8.2 94.0 ± 17.7# 
HDL (mg.dL-1) 20.0 ± 1.9 48.0 ± 15.8# 
Triglycerides (mg.dL-1) 136.0 ± 40.6 168.9 ± 44.8 
Liver Phospholipids (µg.mg protein-1) 190.0 ± 67.1 211.7 ± 41.7 
(‡p<0.005, #p<0.001) 
 
T1DM-related hepatic damage was confirmed by morphologic analysis of liver sections. 
Indeed, whereas in the liver from control animals it was observed several lobules with preserved 
architecture (Figure 1A), the liver from diabetic animals presented increased amount of connective 
tissue with cellular infiltration. Numerous Kupffer cells were apparent in the Disse space and 
disperse focal areas of necrosis were observed (Figure 1B-C). These alterations in the liver 
structure from T1DM rats were paralleled by a decreased content of phospholipids with 
phosphocholine head group (lysophosphatidylcholines, phosphatidylcholines and sphingomyelins) 
and by an increase in phosphatidylethanolamines and phosphatidylinositols, based on phosphorus 
amount per class after TLC separation (Figure 2). Complementary analysis by 31P NMR was also 
used to quantify the PL content (Figure 2), allowing the relative quantification of PC, SM and PE. 
The tendency for PC and SM classes’ decrease was confirmed and a significant increase of the PE 
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class in diabetic liver animals compared to controls was observed. The other phospholipid classes 
were not quantified by 31P NMR analysis because of their lower abundance. 
 
 
FIGURE 1 – Representative photomicrographs of liver from animals of control (A) and diabetes mellitus groups (B, C, and 
D). In A it can be observed several lobules with a preserved structure. A portal triad can be seen in B (arrows) surrounded 
by an increased amount of connective tissue with cellular infiltration. In C, it is depicted a portal triad (*) surrounded by 
connective tissue and an area of cellular necrosis, where some picnotic nucleus are notorious; numerous exuberant nucleus 
in the Disse space (arrows), suggestive of Kupffer cells, and a nodular cell infiltration (#) are also evident. Nodular cell 
infiltrations (arrows) are also observable in D. 
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FIGURE 2 – Amount of liver phospholipid per class in control and diabetic rats. A and B corresponds to the data obtained by 
colorimetric assay preformed after TLC separation. A contains the results of all classes and B only contains the results of 
the classes that were analyzed by NMR. C shows the results obtained by NMR spectroscopy. (Values are means ± SD, 
*p<0.05). 
 
Phospholipid species profile by LC-MS and LC-MS/MS 
Individual phospholipid molecular species within each class were analyzed by LC-MS and 
LC-MS/MS and the chromatograms are presented in Figure 3. MS data are present by means of 
relative abundance per class and, depending on the phospholipid classes, the spectra were 
analyzed in positive or negative ion modes. Lysophosphatidylcholines (LPC), phosphatidylcholines 
(PC) and sphingomyelins (SM) were analyzed in the positive ion mode. Phosphatidylethanolamines 
(PE) and lysophosphatidylethanolamines (LPE) were analyzed in both positive and negative ion 
modes. Cardiolipins (CL), phosphatidylserines (PS) and phosphatidylinositols (PI) were analyzed 
exclusively in the negative ion mode. MS/MS was performed for each ion to identify and confirm 
their structure, according to the typical fragmentation pathways (27). Comparison of CONT and 
T1DM LC-MS data showed changes in lipid profile of PC, PI, PE and CL classes. LPC, SM (Figure 
S1) and PS did not show significant differences between control and diabetic groups, thus were not 
reported herein. 
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FIGURE 3 – Total ion chromatograms obtained by HILIC-LC-MS of phospholipids and triglycerides from the hepatic total 
lipid extracts of control and T1DM rats. The top chromatograms correspond to CONT hepatic lipid extracts and the bottom 
chromatograms correspond to T1DM hepatic lipid extracts. The left chromatograms were obtained in the positive mode for 
the detection of TG, PE, PC, SM and LPC classes. The right chromatograms were obtained in the negative mode for the 
detection of PI, CL; PE and PS classes. 
 
 
FIGURE S1 – SM molecular species relative composition in control and diabetic livers (Values are means ± SD, *p<0.05). 
 
In PC classes, spectra of controls and diabetes showed the same PC [MH]+ ions. The most 
abundant ions for both LC-MS spectra were observed at m/z 758.6 (16:0/18:2-PC), 782.6 
(16:0/20:4-PC) and 810.6 (18:0/20:4-PC), as summarized in Figure 4. Comparison of control and 
diabetic liver revealed changes in the relative abundance of species with significant differences for 
almost all PC species identified. While some species showed higher relative abundance in T1DM, 
other species showed higher relative abundance in CONT. For instance, considering the most 
abundant PC species it was possible to observe that in T1DM liver, the 18:0/20:4-PC and 
16:0/18:2-PC species were increased while the 16:0/20:4-PC specie was decreased. It seems that 
PC species bearing 18:0 acyl chains had a more pronounced increase in T1DM when compared 
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with those bearing 16:0 acyl chain, suggestive of PC fatty acyl substitution at sn-1 position with 
accumulation of 18:0 acyl chain over 16:0 acyl chain. 
 
 
FIGURE 4 – PC molecular species relative composition in control and diabetic livers (Values are means ± SD, *p<0.05, 
**p<0.005 and ***p<0.001). 
 
LC-MS analyses of the PE class were acquired in both positive and negative ion modes. 
Positive spectra, with formation of [M+H]+ ions, showed the same molecular species of PE in 
CONT and T1DM (Figure 5). The major PE ions were observed at m/z 716.5 (16:0/18:2-PE), 740.5 
(16:0/20:4-PE), 764.5 (18:0/18:2-PE) and 768.5 (18:0/20:4-PE); however, minor contribution of 
other isobaric species cannot be excluded. Besides the observation of the same molecular ions, 
significant differences in the relative abundance of the ions were notorious between CONT and 
T1DM (Figure 5). Comparing PE profile of liver extracts, it was noticed that 16:0/20:4-PE and 
16:0/18:2-PE were more abundant in CONT than in T1DM, while the other ions were more 
abundant in T1DM group. 
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FIGURE 5 – PE molecular species relative composition in control and diabetic livers (Values are means ± SD, *p<0.05 and 
***p<0.001). 
 
Additionally, in LPE spectra, the phospholipid with 16:0 acyl chain (m/z 454.3) was more 
abundant in control, whereas phospholipids with longer acyl chains tended to be higher in T1DM, 
but only 18:2-LPE (m/z 482.3) showed a significant increase. Altogether, similarly to what was 
observed in PC spectra, the species containing the 16:0 acyl chains at the sn-1 position seemed to 
be more abundant in the controls, while the species with 18:0 acyl chain at the sn-1 position were 
more abundant in the diabetic animals.  
LC-MS spectra of the PI class, in the negative ion mode with formation of the [M-H]-, 
showed a major ion at m/z 885.5 corresponding to 18:0/20:4-PI, with no relative abundance 
variation between control and diabetic livers (Figure 6, top). Nevertheless, T1DM and CONT 
spectra showed minor ions with differences in their relative abundance, namely at m/z 857.5 
(16:0/20:4-PI) and 861.5 (18:0/18:2-PI). The 16:0/20:4-PI (16:0 acyl chains at the sn-1 position) 
and 18:0/18:2-PI (18:0 acyl chain at the sn-1 position) were respectively decreased and increased 
in T1DM. 
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FIGURE 6 – PI (in the top) and CL (in the bottom) molecular species relative composition in control and diabetic livers 
(Values are means ± SD, *p<0.05, **p<0.005 and ***p<0.001). 
 
Cardiolipin species were identified by LC-MS in negative mode as [M-H]- ions. By 
comparing the spectra of diabetic and control livers, we were able to see notorious differences in 
the cardiolipin molecular species profile. In both groups, the specie at m/z 1447.5 (corresponding to 
18:2/18:2/18:2/18:2-CL) was the most abundant one, still was more abundant in the diabetic than in 
the control group (Figure 6, bottom). Moreover, the CL species at m/z 1421.5 (16:1/18:2/18:2/18:2-
CL) and 1423.5 (16:0/18:2/18:2/18:2-CL) were more abundant in the control group. The CL specie 
at m/z 1475.5 (20:2/18:2/18:2/18:2-CL and 20:3/18:1/18:2/18:2-CL) was significantly increased in 
the liver from diabetic animals. This remodeling in the CL fatty acyl chains was similar to the 
observed for other PL classes, with 16:0 sn-1 acyl chain being more abundant in the control group. 
 
Triacylglycerols species profile by LC-MS and LC-MS/MS 
Triacylglycerol (TG) molecular ions present in lipid extracts from the liver of control and 
STZ-injected rats, were observed in positive ion mode as ammonium adducts ([M+NH4]+). Both LC-
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MS spectra showed several molecular ions, which differ in their relative abundance (Figure 7). The 
most evident difference was observed for the abundant ion at m/z 874.7 (mainly 16:0/18:1/18:2-
TG) in CONT and the ion at m/z 872.7 (mainly 16:0/18:2/18:2-TG) in T1DM. Moreover, the 
comparison of TG profile between groups demonstrated a decrease (over 50%) in the abundance 
of the species at m/z 848.7 (mainly 16:0/16:0/18:2-TG) and a significant increase in the abundance 
of the species at m/z 898.7 (mainly 16:0/20:4/18:2-TG), 898.7 (mainly 18:1/18:2/18:2-TG) and 
920.7 (mainly 16:0/22:6/18:2-TG). Collectively data suggest that triacylglycerols are predisposed to 
alterations in molecular species related with the hyperglycemic status, which are expressed either 
by alterations in the relative abundance of compounds and by altered isobaric contribution for the 
same m/z value.  
 
 
FIGURE 7 – TG molecular species relative composition in control and diabetic livers (Values are means ± SD, *p<0.05, 
**p<0.005 and ***p<0.001). 
 
GC analysis of fatty acyl chains from the total lipid extracts confirmed the differences found 
by LC-MS for T1DM and CONT acyl chains (Figure 8). These results demonstrated a significant 
decrease of 16:0, 16:1 and 18:1 acyl chains in T1DM group. Simultaneously, there was a 
significant increase of 18:0, 18:2 and 22:6 acyl chains in T1DM compared to controls. Interestingly, 
20:4 acyl chains did not show any variation between animals. 
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FIGURE 8 – Fatty acyl substituent’s of total lipid extracts from control and diabetic livers, analyzed by GC. The table 
contains information about the sum of saturated, unsaturated, monoene (MUFA) and polyene (PUFA) fatty acids, the double 
bond index (number of double bonds for 100 moles fatty acids) and the unsaturated/saturated ratio. (Values are means ± 
SD, *p<0.05 and ***p<0.001). 
 
DISCUSSION 
 
The prevalence of hepatobiliary diseases is increased in patients with diabetes mellitus. 
Also, T1DM is associated with hemochromatosis and autoimmune hepatitis (28). To better 
understand the lipid alterations that occur in the liver from type 1 diabetic subjects, we determined 
the lipidomic profile of hepatic tissue from STZ-injected rats. This is a well-characterized animal 
model of T1DM. STZ has a half-life of 6 h being readily metabolized, and not exerting a direct effect 
on liver enzymes, such as in the activity of the antioxidant ones (29). In the present study, we 
observed that four months of hyperglycemia resulted in hepatic structural changes suggestive of 
fibrosis/inflammation and impaired metabolism underlined by alterations in the lipid profile, mainly 
characterized by an elevation in the amount of lipids bearing longer acyl chains. 
 
In this study, we have noticed that the relative abundance of PL classes with choline head 
group (PC, LPC and SM) decreased in the liver from diabetic animals, while all the other PL 
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classes showed an increase (Figure 2). A decrease in the PC content was already been observed 
in alcoholic and non-alcoholic liver diseases (14, 15) and were generally associated with type 2 
diabetes mellitus (28). This suggests that liver dysfunction is accompanied with changes in the 
phospholipid profile, with a typical decrease of PC and other phosphocholine lipids. Perturbation of 
phosphocholine metabolism might result from alterations in phospholipid biosynthesis and/or 
metabolism. Since PC is mainly synthesized in the liver, it is possible that liver damage may be 
related with impaired PC biosynthesis with a consequent decrease of PC content. Dysregulation of 
PC biosynthesis in the liver has been reported in T1DM (30) and T2DM (31) and it was suggest to 
be, at least partially, a result of alterations in transmethylation processes (32). Thus, PC synthesis 
via hepatic phosphatidylethanolamine N-mehyl transferase (PEMT) can be affected (30). 
Deficiency of PEMT would lead to decreased hepatic levels of choline-containing phospholipids. 
However, it was found that in T1DM, PEMT expression was increased, suggesting that an 
augmented requirement of PC during diabetes leaded a decrease on PC content (30). Van der 
Veen et al. (33) reported that a percentage of PC from liver cell membranes are converted into 
triglycerides. These authors found that when hepatic PC levels are reduced, VLDL secretion is 
diminished, resulting in hepatic accumulation of TG. This suggests that an additional requirement 
of PC for the TG biosynthesis in liver could exacerbate the decrease of PC content that was 
observed in the damaged liver of diabetics (33). No alterations in CL content were observed in the 
liver of T1DM in comparison to controls, in contrast to the decrease of CL levels previously 
reported in diabetic cardiomyopathy (12). This dissimilarity seems to reflect the functional 
specialization of tissues and organs response to hyperglycemia. The myocardium is specialized in 
energy production, showing more alterations in CL content, while the liver, important in regulating 
body homeostasis and metabolism, revealed changes that could affect membrane function and cell 
signaling. For instance, the decrease in PC/PE ratio is known to alter cell membrane function and 
was observed in non-alcoholic steatohepatitis (34). 
Besides PL classes’ alterations, a PL remodeling with fatty acyl substitution was also 
observed in lipids from T1DM liver. We found a similar pattern to all PL classes, which was 
characterized by a reduction in the amount of 16:0 acyl chains and an increase of 18:0 and 22:6 
acyl chains. Similar results were reported by Douillet et al. (20), who demonstrated a T1DM-related 
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decrease in 16:0, 18:1, 18:2; 18:3 and 22:5 and an increase in 18:0, 20:3, 20:4 and 22:6 total fatty 
acids in the liver. Our results are also in accordance with Ghebremeskel et al. (35), that 
documented a decrease in saturated and monounsaturated free fatty acids and TG-acyl chains 
with a concomitant increase in n-6 and n-3 polyunsaturated free fatty acids and TG-acyl chains in 
the liver from STZ-injected animals. On the contrary, other authors reported a decrease in 20:4 (16, 
18, 36) and an increase in 16:0 (16) fatty acids. These alterations in the fatty acid content related 
with diabetes mellitus seem to be due to alterations in the synthesis, desaturation, degradation, 
oxidation and/or incorporation (into phospholipids) of fatty acids. The increase of phospholipids 
containing 18:0 acyls chains, but not the decrease of those containing 16:0, can be explained by 
diabetes-related preferential synthesis of saturated fatty acids (16). Regarding the increase of 22:6 
acyl chain, the dysregulation of the mechanism of 20:4 and 22:6 distribution between the TG and 
PL seems unlikely because a similar alteration in fatty acyl substitution was found in both PL and 
TG (35). This phenomenon seems to be universal so it is possible that it could be due to altered 
synthesis (including alteration of elongases), and/or altered phospholipase A2 or acyltransferases 
enzymatic activity (37). Changes in fatty acyl profile in retina and liver from T1DM animals were 
correlated with the down regulation of some elongases (13). These authors found a decrease in 
elongase 2 (Elovl2) and 6 (Elovl6) and a decrease in desaturases in the liver, which was 
associated with an increase in 18:2 acyl chain. No other changes were observed in liver fatty acyl 
profile. The reduction of elongases 4 (Elovl4) and 2 (Elovl2) expression levels observed in retina 
was correlated with a decrease in 22:6, and a decrease in the ratio of n-3 to n-6 polyunsaturated 
fatty acids (13). Our results reveal an increased 18:2 acyl chain that could be explained by a 
reduction of these enzymes activity/expression levels; however, other mechanisms must be 
involved since elongases activity cannot explain the increase of 22:6 acyl chain and the alteration 
of 18:0/16:0 ratio. The decrease of 16:0 acyl chains and the increase of 18:0 acyl chains at sn-1 
position can be also explained by dysregulated hepatic PC metabolism, since one of PC 
biosynthetic pathways favors the presence of 16:0 acyl chains and the other favors the presence of 
18:0 acyl chains. Therefore the dysregulation of hepatic PC metabolism could lead to the observed 
increased 18:0/16:0 ratio in T1DM, as already reported in T2DM (31). Additionally, the activity of 
palmitoyl-CoA chain elongation (PCE), an enzyme that catalyzes stearic acid (18:0) formation from 
 | 168 
 
 Phosphatidylethanolamines Glycoxidation: Products and Significance 
palmitic acid (16:0), increases in the liver upon glucose and fructose administration (38). Although 
the authors report a decrease of PCE activity in diabetic animals (38), our results clearly show an 
increase in the 18:0/16:0 ratio, suggesting that PCE activity could be increased. 
In conclusion, our study indicates that the hepatic damage that occurs in T1DM, 
morphologically characterized by fibrosis, necrosis and cellular infiltration, is associated with the 
remodeling of liver lipid content. The observed changes in the lipid content may contribute to 
alteration of membrane properties and changes in lipid signaling, which impact liver function and 
consequently whole body homeostasis. Overall, data highlight the role of lipid profile remodeling on 
liver dysfunction, a hypothesis that needs to be further explored for the early diagnostic, monitoring 
and evaluation of liver disease in consequence of uncontrolled type 1 diabetes mellitus. 
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 Conclusions 
Comprehensive characterization of glycated and glycoxidized phosphatidylethanolamines 
was achieved using mass spectrometry strategies. Glycation of biomolecules is a well-known 
reaction that occurs in vivo, particularly in hyperglycemia. Glycation of aminophospholipids are still 
an underexplored field, however protein glycation has been extensively studied and is recognized 
as an important adverse outcome of diabetes mellitus. Glycated proteins are known to increase the 
oxidative stress and the inflammation that underlie diabetic complications, such as atherosclerosis. 
Phosphatidylethanolamine is the most abundant class of phospholipids which has a free 
amino group, prone to undergo glycation. Glycated PE was analyzed by mass spectrometry, in 
positive and negative ion modes, using PE standards, and the major fragmentation pathways were 
identified under tandem mass spectrometry conditions (MS/MS). The typical fragmentation of 
glycated PE, in positive ion mode, corresponds to the loss glycated polar head, loss of 303 Da, 
while, in the negative ion mode, the main fragmentation is attributed to the loss of glucose, loss of 
162 Da. 
Since diabetes is associated with an increase of the oxidative stress status, we studied the 
modifications of glycated PE species induced by the hydroxyl radical. Using mass spectrometry, in 
positive and negative ion modes, it were identified the glycated PE radical intermediaries and the 
glycated PE oxidation products formed after reaction of glycated PE with hydroxyl radical, in the 
presence or absence of spin traps. These studies allowed the characterization of glycated PE 
oxidation, for the first time. Also, specific fragmentation patterns were assigned, essential for future 
detection of glycoxidation in vivo. This work contributed to understand the role of glycated PE on 
molecular susceptibility to oxidation and the interrelation between glycation and oxidation. It was 
demonstrated that besides oxidation of unsaturated sn-2 acyl chains, which is known to occur in 
phospholipids, other oxidation products were formed from glycated polar head oxidation. Oxidation 
of glycated polar head was confirmed by the study of a glycated PE with two fully saturated 
(palmitoyl) acyl chains. The identification by MS, of the radical intermediary adducts bearing the 
spin trap molecule linked to the glucose moiety reinforce the role of glucose in the oxidation of 
glycated species. All the glycated PE originated oxidation products by insertion of oxygen 
molecules in glycated polar head and/or in sn-2 acyl chain, by truncation of sn-2 and by truncation 
of glycated polar head. Also, glycated polar head oxidation was found to occur sooner than the 
oxidation of unsaturated acyl chains. Hence, the glycation of polar head increase the targets of 
oxidation and could be responsible for the exponential increase oxidative stress modifications that 
is known to occur under hyperglycemic conditions. 
The stimulation of monocytes and dendritic cell was performed to determine the role of PE 
glycation in inflammation associated with diabetes. This study also revealed the inflammatory 
properties of glycated, glycoxidized and oxidized PE. All PE modifications were found to increase 
the frequency of monocytes and dendritic cells that express cytokines, when compared with basal 
level, but with an effect that was lower than the LPS. The different modifications showed to induce 
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different levels of cytokine-expressing cells. In general, the results showed that oxidative 
modifications produced lower levels of cytokine-expressing cells when compared to the 
correspondent non-oxidized compounds (OxPE < PE and GluOxPE < GluPE). Also the glycated 
compounds showed higher levels of cytokine-expressing cells when compared with non-glycated 
compounds (GluPE > PE and GluOxPE > OxPE). An exception to this was found with glycoxidized 
PLPE that increased the levels of cytokine-expressing cells when compared to glycated PLPE. This 
can be explained by the exponential increase of oxidative stress modifications, due to combined 
effect of glycation and linoleic acid oxidation, which is higher than oleic acid oxidation. In 
conclusion, cell stimulation and cytokine production was more pronounced when the PE polar head 
was modified. Additionally, low oxidation levels could reduce stimulation levels while higher 
oxidation levels could synergically increase those stimulation levels. Thus, glycated PE and 
glycoxidized PE may have important effect contributing to the low-grade systemic inflammation 
associated with diabetes, which could contribute to the development of diabetic complications. 
The analysis of the livers of the T1DM rats showed that under prolonged hyperglycemia 
there were alterations of the phospholipidome that were associated with signs of hepatic damage, 
namely fibrosis, necrosis and cellular infiltration. Those alterations of phospholipidome included 
variations relative amount of liver phospholipid classes, and in the PL species with a remodeling in 
PL fatty acyl chains. A remodeling of acyl chains consisted of a reduction in the amount of 16:0 and 
an increase of 18:0 and 18:2 acyl chains. The alterations of PL species were found to occur in 
almost all PL classes, including PE. Unfortunately, no PE glycation and PE glycoxidation were 
found in diabetic liver, provably due to ion suppression phenomena, thus a directed approach for 
glycated PE would be necessary to specifically detected in biological samples. Also, the observed 
changes in the lipid content could be an indication that regulatory mechanisms were triggered, 
allowing the elimination of oxidized species. Such alteration on phospholipids could contribute to 
alteration of membrane properties and changes in lipid signaling, which may impact the liver 
function and consequently, whole body homeostasis. So the phospholipidome alterations that were 
found could be an important predictor of liver dysfunction in consequence of uncontrolled type 1 
diabetes mellitus. 
This study provided evidence on the role of hyperglycemia in alterations of PE structure, 
glycation and oxidation, in the PE content and PE species remodeling in the liver of diabetic rats 
(T1DM). It was explored the role glycation on the susceptibility of glycated PE to oxidation and the 
role of glycoxidized and glycated products in inducing cytokine production in monocytes and 
dendritic cells. Hence, the work contributed to better understanding of the intricate connections 
between hyperglycemia, oxidative stress, inflammation and diabetes that ultimately would lead to 
the development of diabetic complications. 
